{"title":"Medical specialties, branches of medicine Books","description":"","products":[{"product_id":"oxford-handbook-of-clinical-specialties-9780198827191","title":"Oxford Handbook of Clinical Specialties","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003eFor over thirty years, the Oxford Handbook of Clinical Specialties has guided students and junior doctors through their clinical placements, renowned for providing all the information needed for both practice and revision in a deceptively small package. Now in its eleventh edition, the Handbook has been revitalized by an expanded team of specialty experts and junior doctors to guide readers through each of the specialties encountered through medical school and Foundation Programme rotations, while remaining true to the humanity and patient focus of the original edition. Updated with the latest advice and clinical guidelines, packed full of high-quality illustrations, boxes, tables, and classifications, and with a brand new chapter on how to survive your junior doctor years and beyond, this handbook is ideal for both study and use at direct point of care. Each chapter is clear and concise and filled with medical gems, with features including ribbons to mark your most-used pages and mnemonics to help you memorize and retain key facts. With reassuring and friendly advice throughout, this is the ultimate guide and revision tool for every medical student and junior doctor for each clinical specialty placement. This well-loved Handbook remains the perfect companion to the Oxford Handbook of Clinical Medicine, together encompassing the entire spectrum of clinical medicine and unmatched by any competitor in their class, helping you become the doctor you want to be.\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTrade Review\u003c\/b\u003e\u003cbr\u003ePretty much a must -- have for medical students having clinical placements, great summaries of all the most important conditions within numerous clinical specialties. Got delivered in perfect condition. * Amazon Review *\u003cbr\u003eAbsolutely perfect if you've also got the handbook of clinical medicine. Between the two they basically cover most of the med school curriculum. Use this along side NICE CKS, BMJ best practice and passmed and you're sorted. * Medical student, Amazon *\u003cbr\u003eDue to the easy-to-read nature of the handbook and the concise way in which is written we would recommend the book to any medical student who is wanting to grasp the concepts of their specialities learning. It has all the information in one place- perfect for notetaking and revision. * North Wing Magazine *\u003cbr\u003eAs a GP Registrar, I find this book of immense value during my hospital rotations, as well as during my rotation at the GP Surgery. It is also serving me as a source of information to prepare for the Applied Knowledge Test needed for my Certificate of Completion of Training. * Dr Michael Zar, GP Registrar, Glycosmedia *\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTable of Contents\u003c\/b\u003e\u003cbr\u003e1: Charlotte Goumalatsou: Obstetrics 2: Charlotte Goumalatsou: Gynaecology 3: Simon Buckley: Paediatrics 4: Alastair Denniston, Priscilla Mathewson: Ophthalmology 5: Nicholas Steventon: Ear, nose, and throat 6: Sanju Arianayagam: Dermatology 7: Juliet Clutton: Orthopaedics 8: Juliet Clutton: Trauma 9: Blair Graham: Emergency medicine 10: Terry Collingwood: Pre-hospital emergency medicine 11: Nina Hjelde: Anaesthesia 12: Gil Myers: Psychiatry 13: Andrew Baldwin: General practice 14: Andrew Baldwin: Eponymous syndromes 15: Andrew Baldwin, Gil Myers: Doctors' health and performance","brand":"Oxford University Press","offers":[{"title":"Default Title","offer_id":48732799500631,"sku":"9780198827191","price":31.34,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0817\/1739\/5799\/files\/9780198827191.jpg?v=1719998448"},{"product_id":"birth-of-the-living-god-9780226721026","title":"Birth of the Living God","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003e","brand":"The University of Chicago Press","offers":[{"title":"Default Title","offer_id":48732917170519,"sku":"9780226721026","price":22.8,"currency_code":"GBP","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0817\/1739\/5799\/files\/9780226721026.jpg?v=1719998940"},{"product_id":"wireless-computing-in-medicine-9781118993590","title":"Wireless Computing in Medicine","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003e\u003cp\u003e\u003cb\u003eProvides a comprehensive overview of wireless computing in medicine, with technological, medical, and legal advances\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eThis book brings together the latest work of leading scientists in the disciplines of Computing, Medicine, and Law, in the field of Wireless Health. The book is organized into three main sections. The first section discusses the use of distributed computing in medicine. It concentrates on methods for treating chronic diseases and cognitive disabilities like Alzheimer's, Autism, etc. It also discusses how to improve portability and accuracy of monitoring instruments and reduce the redundancy of data. It emphasizes the privacy and security of using such devices. The role of mobile sensing, wireless power and Markov decision process in distributed computing is also examined. The second section covers nanomedicine and discusses how the drug delivery strategies for chronic diseases can be efficiently improved by Nanotechnology enabled materials and devices su\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTable of Contents\u003c\/b\u003e\u003cbr\u003e\u003c\/p\u003e\u003cp\u003eContributors xiii\u003c\/p\u003e \u003cp\u003eForeword xvii\u003c\/p\u003e \u003cp\u003ePreface xix\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePART I INTRODUCTION 1\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003e1 Introduction to Wireless Computing in Medicine 3\u003c\/b\u003e\u003cbr\u003e\u003ci\u003eAmber Bhargava, Mary Mehrnoosh Eshaghian-Wilner, Arushi Gupta, Alekhya Sai Nuduru Pati, Kodiak Ravicz, and Pujal Trivedi\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e1.1 Introduction, 3\u003c\/p\u003e \u003cp\u003e1.2 Definition of Terms, 5\u003c\/p\u003e \u003cp\u003e1.3 Brief History of Wireless Healthcare, 5\u003c\/p\u003e \u003cp\u003e1.4 What is Wireless Computing? 6\u003c\/p\u003e \u003cp\u003e1.5 Distributed Computing, 7\u003c\/p\u003e \u003cp\u003e1.6 Nanotechnology in Medicine, 10\u003c\/p\u003e \u003cp\u003e1.7 Ethics of Medical Wireless Computing, 12\u003c\/p\u003e \u003cp\u003e1.8 Privacy in Wireless Computing, 13\u003c\/p\u003e \u003cp\u003e1.9 Conclusion, 14\u003c\/p\u003e \u003cp\u003eReferences, 14\u003c\/p\u003e \u003cp\u003e\u003cb\u003e2 Nanocomputing and Cloud Computing 17\u003c\/b\u003e\u003cbr\u003e\u003ci\u003eT. Soren Craig, Mary Mehrnoosh Eshaghian-Wilner, Nikila Goli, Arushi Gupta, Shiva Navab, Alekhya Sai Nuduru Pati, Kodiak Ravicz, Gaurav Sarkar, and Ben Shiroma\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e2.1 Introduction, 17\u003c\/p\u003e \u003cp\u003e2.2 Nanocomputing, 18\u003c\/p\u003e \u003cp\u003e2.3 Cloud Computing, 30\u003c\/p\u003e \u003cp\u003e2.4 Conclusion, 37\u003c\/p\u003e \u003cp\u003eAcknowledgment, 37\u003c\/p\u003e \u003cp\u003eReferences, 37\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePART II PERVASIVE WIRELESS COMPUTING IN MEDICINE 41\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003e3 Pervasive Computing in Hospitals 43\u003c\/b\u003e\u003cbr\u003e\u003ci\u003eJanet Meiling Wang-Roveda, Linda Powers, and Kui Ren\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e3.1 Introduction, 43\u003c\/p\u003e \u003cp\u003e3.2 Architecture of Pervasive Computing in Hospitals, 45\u003c\/p\u003e \u003cp\u003e3.3 Sensors, Devices, Instruments, and Embedded Systems, 49\u003c\/p\u003e \u003cp\u003e3.4 Data Acquisition in Pervasive Computing, 59\u003c\/p\u003e \u003cp\u003e3.5 Software Support for Context-Aware and Activity Sharing Services, 63\u003c\/p\u003e \u003cp\u003e3.6 Data and Information Security, 66\u003c\/p\u003e \u003cp\u003e3.7 Conclusion, 71\u003c\/p\u003e \u003cp\u003eAcknowledgment, 71\u003c\/p\u003e \u003cp\u003eReferences, 72\u003c\/p\u003e \u003cp\u003e\u003cb\u003e4 Diagnostic Improvements: Treatment and Care 79\u003c\/b\u003e\u003cbr\u003e\u003ci\u003eXiaojun Xian\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e4.1 Introduction, 79\u003c\/p\u003e \u003cp\u003e4.2 System Design, 81\u003c\/p\u003e \u003cp\u003e4.3 Body Sensor Network, 82\u003c\/p\u003e \u003cp\u003e4.4 Portable Sensors, 84\u003c\/p\u003e \u003cp\u003e4.5 Wearable Sensors, 88\u003c\/p\u003e \u003cp\u003e4.6 Implantable Sensors, 94\u003c\/p\u003e \u003cp\u003e4.7 Wireless Communication, 95\u003c\/p\u003e \u003cp\u003e4.8 Mobile Base Unit, 97\u003c\/p\u003e \u003cp\u003e4.9 Conclusion and Challenges, 98\u003c\/p\u003e \u003cp\u003eAcknowledgment, 99\u003c\/p\u003e \u003cp\u003eReferences, 99\u003c\/p\u003e \u003cp\u003e\u003cb\u003e5 Collaborative Opportunistic Sensing of Human Behavior with Mobile Phones 107\u003c\/b\u003e\u003cbr\u003e\u003ci\u003eLuis A. Castro, Jessica Beltran-Marquez, Jesus Favela, Edgar Chavez, Moises Perez, Marcela Rodriguez, Rene Navarro, and Eduardo Quintana\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e5.1 Health and Mobile Sensing, 107\u003c\/p\u003e \u003cp\u003e5.2 The InCense Sensing Toolkit, 110\u003c\/p\u003e \u003cp\u003e5.3 Sensing Campaign 1: Detecting Behaviors Associated with the Frailty Syndrome Among Older Adults, 119\u003c\/p\u003e \u003cp\u003e5.4 Sensing Campaign 2: Detecting Problematic Behaviors among Elders with Dementia, 123\u003c\/p\u003e \u003cp\u003e5.5 Discussion, 131\u003c\/p\u003e \u003cp\u003e5.6 Conclusions and Future Work, 132\u003c\/p\u003e \u003cp\u003eReferences, 133\u003c\/p\u003e \u003cp\u003e\u003cb\u003e6 Pervasive Computing to Support Individuals with Cognitive Disabilities 137\u003c\/b\u003e\u003cbr\u003e\u003ci\u003eMonica Tentori, José Mercado, Franceli L. Cibrian, and Lizbeth Escobedo\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e6.1 Introduction, 137\u003c\/p\u003e \u003cp\u003e6.2 Wearable and Mobile Sensing Platforms to Ease the Recording of Data Relevant to Clinical Case Assessment, 144\u003c\/p\u003e \u003cp\u003e6.3 Augmented Reality and Mobile and Tangible Computing to Support Cognition, 151\u003c\/p\u003e \u003cp\u003e6.4 Serious Games and Exergames to Support Motor Impairments, 158\u003c\/p\u003e \u003cp\u003e6.5 Conclusions, 168\u003c\/p\u003e \u003cp\u003eAcknowledgments, 172\u003c\/p\u003e \u003cp\u003eReferences, 172\u003c\/p\u003e \u003cp\u003e\u003cb\u003e7 Wireless Power for Implantable Devices: A Technical Review 187\u003c\/b\u003e\u003cbr\u003e\u003ci\u003eNikita Ahuja, Mary Mehrnoosh Eshaghian-Wilner, Zhuochen Ge, Renjun Liu, Alekhya Sai Nuduru Pati, Kodiak Ravicz, Mike Schlesinger, Shu Han Wu, and Kai Xie\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e7.1 Introduction, 187\u003c\/p\u003e \u003cp\u003e7.2 History of Wireless Power, 189\u003c\/p\u003e \u003cp\u003e7.3 Approach of Wireless Power Transmission, 191\u003c\/p\u003e \u003cp\u003e7.4 A Detailed Example of Magnetic Coupling Resonance, 194\u003c\/p\u003e \u003cp\u003e7.5 Popular Standards, 199\u003c\/p\u003e \u003cp\u003e7.6 Wireless Power Transmission in Medical use, 201\u003c\/p\u003e \u003cp\u003e7.7 Conclusion, 204\u003c\/p\u003e \u003cp\u003eAcknowledgments, 205\u003c\/p\u003e \u003cp\u003eReferences, 205\u003c\/p\u003e \u003cp\u003e\u003cb\u003e8 Energy-Efficient Physical Activity Detection in Wireless Body Area Networks 211\u003c\/b\u003e\u003cbr\u003e\u003ci\u003eDaphney-Stavroula Zois, Sangwon Lee, Murali Annavaram, and Urbashi Mitra\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e8.1 Introduction, 211\u003c\/p\u003e \u003cp\u003e8.2 Knowme Platform, 215\u003c\/p\u003e \u003cp\u003e8.3 Energy Impact of Design Choices, 217\u003c\/p\u003e \u003cp\u003e8.4 Problem Formulation, 228\u003c\/p\u003e \u003cp\u003e8.5 Sensor Selection Strategies, 232\u003c\/p\u003e \u003cp\u003e8.6 Alternative Problem Formulation, 237\u003c\/p\u003e \u003cp\u003e8.7 Sensor Selection Strategies for the Alternative Formulation, 241\u003c\/p\u003e \u003cp\u003e8.8 Experiments, 244\u003c\/p\u003e \u003cp\u003e8.9 Related Work, 254\u003c\/p\u003e \u003cp\u003e8.10 Conclusion, 256\u003c\/p\u003e \u003cp\u003eAcknowledgments, 257\u003c\/p\u003e \u003cp\u003eReferences, 257\u003c\/p\u003e \u003cp\u003e\u003cb\u003e9 Markov Decision Process for Adaptive Control of Distributed Body Sensor Networks 263\u003c\/b\u003e\u003cbr\u003e\u003ci\u003eShuping Liu, Anand Panangadan, Ashit Talukder, and Cauligi S. Raghavendra\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e9.1 Introduction, 263\u003c\/p\u003e \u003cp\u003e9.2 Rationale for MDP Formulation, 265\u003c\/p\u003e \u003cp\u003e9.3 Related Work, 268\u003c\/p\u003e \u003cp\u003e9.4 Problem Statement, Assumptions, and Approach, 269\u003c\/p\u003e \u003cp\u003e9.5 MDP Model for Multiple Sensor Nodes, 272\u003c\/p\u003e \u003cp\u003e9.6 Communication, 274\u003c\/p\u003e \u003cp\u003e9.7 Simulation Results, 276\u003c\/p\u003e \u003cp\u003e9.8 Conclusions, 292\u003c\/p\u003e \u003cp\u003eAcknowledgment, 294\u003c\/p\u003e \u003cp\u003eReferences, 294\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePART III NANOSCALE WIRELESS COMPUTING IN MEDICINE 297\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003e10 An Introduction to Nanomedicine 299\u003c\/b\u003e\u003cbr\u003e\u003ci\u003eAmber Bhargava, Janet Cheung, Mary Mehrnoosh Eshaghian-Wilner, Wan Lee, Kodiak Ravicz, Mike Schlesinger, Yesha Shah, and Abhishek Uppal\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e10.1 Introduction, 299\u003c\/p\u003e \u003cp\u003e10.2 Nanomedical Technology, 301\u003c\/p\u003e \u003cp\u003e10.3 Detection, 303\u003c\/p\u003e \u003cp\u003e10.4 Treatment, 305\u003c\/p\u003e \u003cp\u003e10.5 Biocompatibility, 309\u003c\/p\u003e \u003cp\u003e10.6 Power, 311\u003c\/p\u003e \u003cp\u003e10.7 Computer Modeling, 313\u003c\/p\u003e \u003cp\u003e10.8 Research Institutions, 315\u003c\/p\u003e \u003cp\u003e10.9 Conclusion, 317\u003c\/p\u003e \u003cp\u003eAcknowledgments, 317\u003c\/p\u003e \u003cp\u003eReferences, 317\u003c\/p\u003e \u003cp\u003e\u003cb\u003e11 Nanomedicine Using Magneto-Electric Nanoparticles 323\u003c\/b\u003e\u003cbr\u003e\u003ci\u003eMary Mehrnoosh Eshaghian-Wilner, Andrew Prajogi, Kodiak Ravicz, Gaurav Sarkar, Umang Sharma, Rakesh Guduru, and Sakhrat Khizroev\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e11.1 Introduction, 323\u003c\/p\u003e \u003cp\u003e11.2 Overview of MENs, 324\u003c\/p\u003e \u003cp\u003e11.3 Experiment 1: Externally Controlled On-Demand Release of Anti-HIV Drug Azttp Using Mens as Carriers, 325\u003c\/p\u003e \u003cp\u003e11.4 Experiment 2: Mens to Enable Field-Controlled High-Specificity Drug Delivery to Eradicate Ovarian Cancer Cells, 331\u003c\/p\u003e \u003cp\u003e11.5 Experiment 3: Magnetoelectric “Spin” on Stimulating the Brain, 339\u003c\/p\u003e \u003cp\u003e11.6 Bioceramics: Bone Regeneration and MNS, 348\u003c\/p\u003e \u003cp\u003e11.7 Conclusion, 351\u003c\/p\u003e \u003cp\u003eReferences, 353\u003c\/p\u003e \u003cp\u003e\u003cb\u003e12 DNA Computation in Medicine 359\u003c\/b\u003e\u003cbr\u003e\u003ci\u003eNoam Mamet and Ido Bachelet\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e12.1 Background for the Non-Biologist, 359\u003c\/p\u003e \u003cp\u003e12.2 Introduction, 362\u003c\/p\u003e \u003cp\u003e12.3 In Vitro Computing, 364\u003c\/p\u003e \u003cp\u003e12.4 Computation in Vivo, 370\u003c\/p\u003e \u003cp\u003e12.5 Challenges, 373\u003c\/p\u003e \u003cp\u003e12.6 Glimpse into the Future, 373\u003c\/p\u003e \u003cp\u003eReferences, 374\u003c\/p\u003e \u003cp\u003e\u003cb\u003e13 Graphene-Based Nanosystems for the Detection of Proteinic Biomarkers of Disease: Implication in Translational Medicine 377\u003c\/b\u003e\u003cbr\u003e\u003ci\u003eFarid Menaa, Sandeep Kumar Vashist, Adnane Abdelghani, and Bouzid Menaa\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e13.1 Introduction, 377\u003c\/p\u003e \u003cp\u003e13.2 Structural and Physicochemical Properties of Graphene and Main Derivatives, 379\u003c\/p\u003e \u003cp\u003e13.3 Graphene and Derivatives-Based Biosensing Nanosystems and Applications, 382\u003c\/p\u003e \u003cp\u003e13.4 Conclusion and Perspectives, 389\u003c\/p\u003e \u003cp\u003eConflict of Interest, 390\u003c\/p\u003e \u003cp\u003eAbbreviations, 390\u003c\/p\u003e \u003cp\u003eReferences, 391\u003c\/p\u003e \u003cp\u003e\u003cb\u003e14 Modeling Brain Disorders in Silicon Nanotechnologies 401\u003c\/b\u003e\u003cbr\u003e\u003ci\u003eAlice C. Parker, Saeid Barzegarjalali, Kun Yue, Rebecca Lee, and Sukanya Patil\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e14.1 Introduction, 401\u003c\/p\u003e \u003cp\u003e14.2 The BioRC Project, 402\u003c\/p\u003e \u003cp\u003e14.3 Background: BioRC Neural Circuits, 404\u003c\/p\u003e \u003cp\u003e14.4 Modeling Synapses with CNT Transistors, 408\u003c\/p\u003e \u003cp\u003e14.5 Modeling OCD with Hybrid CMOS\/Nano Circuits, 410\u003c\/p\u003e \u003cp\u003e14.6 The Biological Cortical Neuron and Hybrid Electronic Cortical Neuron, 411\u003c\/p\u003e \u003cp\u003e14.7 Biological OCD Circuit and Biomimetic Model, 412\u003c\/p\u003e \u003cp\u003e14.8 Indirect Pathway: The Braking Mechanism, 413\u003c\/p\u003e \u003cp\u003e14.9 Direct Pathway: The Accelerator, 414\u003c\/p\u003e \u003cp\u003e14.10 Typical and Atypical Responses, 415\u003c\/p\u003e \u003cp\u003e14.11 Modeling Schizophrenic Hallucinations with Hybrid CMOS\/Nano Circuits, 416\u003c\/p\u003e \u003cp\u003e14.12 Explanation for Schizophrenia Symptoms, 416\u003c\/p\u003e \u003cp\u003e14.13 Disinhibition due to Miswiring, 418\u003c\/p\u003e \u003cp\u003e14.14 Our Hybrid Neuromorphic Prediction Network, 418\u003c\/p\u003e \u003cp\u003e14.15 Simulation Results, 419\u003c\/p\u003e \u003cp\u003e14.16 Numerical Analysis of False Firing, 421\u003c\/p\u003e \u003cp\u003e14.17 Modeling PD with CMOS Circuits, 422\u003c\/p\u003e \u003cp\u003e14.18 Modeling MS with CMOS Circuits, 424\u003c\/p\u003e \u003cp\u003e14.19 Demyelination Circuit, 425\u003c\/p\u003e \u003cp\u003e14.20 Conclusions and Future Trends, 426\u003c\/p\u003e \u003cp\u003eReferences, 428\u003c\/p\u003e \u003cp\u003e\u003cb\u003e15 Linking Medical Nanorobots to Pervasive Computing 431\u003c\/b\u003e\u003cbr\u003e\u003ci\u003eSylvain Martel\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e15.1 Introduction, 431\u003c\/p\u003e \u003cp\u003e15.2 Complementary Functionalities, 432\u003c\/p\u003e \u003cp\u003e15.3 Main Specifications for such Nanorobotic Agents (Nanorobots), 433\u003c\/p\u003e \u003cp\u003e15.4 Medical Nanorobotic Agents—An Example, 436\u003c\/p\u003e \u003cp\u003e15.5 Nanorobotic Communication Links Allowing Pervasive Computing, 438\u003c\/p\u003e \u003cp\u003e15.6 Types of Information, 439\u003c\/p\u003e \u003cp\u003e15.7 Medical Nanorobotic Agents for Monitoring and Early Detection, 440\u003c\/p\u003e \u003cp\u003e15.8 Medical Nanorobotics and Pervasive Computing—Main Conditions that must be met for its Feasibility, 442\u003c\/p\u003e \u003cp\u003e15.9 Conclusion, 443\u003c\/p\u003e \u003cp\u003eReferences, 444\u003c\/p\u003e \u003cp\u003e\u003cb\u003e16 Nanomedicine’s Transversality: Some Implications of the Nanomedical Paradigm 447\u003c\/b\u003e\u003cbr\u003e\u003ci\u003eJosé J. López and Mathieu Noury\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e16.1 Introduction, 447\u003c\/p\u003e \u003cp\u003e16.2 Nanomedicine’s Promises, 448\u003c\/p\u003e \u003cp\u003e16.3 Analysing Implications of the Nanomedicine Paradigm, 451\u003c\/p\u003e \u003cp\u003e16.4 The Molecular Underpinnings of Nanomedicine’s Transversality, 456\u003c\/p\u003e \u003cp\u003e16.5 Nanomedicine as Predictive Medicine, 457\u003c\/p\u003e \u003cp\u003e16.6 Nanomedicine as Personalized Medicine, 460\u003c\/p\u003e \u003cp\u003e16.7 Nanomedicine as Regenerative Medicine, 465\u003c\/p\u003e \u003cp\u003e16.8 Conclusion, 466\u003c\/p\u003e \u003cp\u003eReferences, 468\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePART IV ETHICAL AND LEGAL ASPECTS OF WIRELESS COMPUTING IN MEDICINE 473\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003e17 Ethical Challenges of Ubiquitous Health Care 475\u003c\/b\u003e\u003cbr\u003e\u003ci\u003eWilliam Sims Bainbridge\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e17.1 Introduction, 475\u003c\/p\u003e \u003cp\u003e17.2 A Philosophical Framework, 478\u003c\/p\u003e \u003cp\u003e17.3 Information Deviance, 480\u003c\/p\u003e \u003cp\u003e17.4 The Current Frenzy, 482\u003c\/p\u003e \u003cp\u003e17.5 Genetic Informatics, 485\u003c\/p\u003e \u003cp\u003e17.6 Ubiquitous Information Technology, 489\u003c\/p\u003e \u003cp\u003e17.7 Stasis versus Progress, 492\u003c\/p\u003e \u003cp\u003e17.8 Problematic Ethics, 494\u003c\/p\u003e \u003cp\u003e17.9 Leadership in Science and Engineering Ethics, 496\u003c\/p\u003e \u003cp\u003e17.10 Conclusion, 498\u003c\/p\u003e \u003cp\u003eReferences, 499\u003c\/p\u003e \u003cp\u003e\u003cb\u003e18 The Ethics of Ubiquitous Computing in Health Care 507\u003c\/b\u003e\u003cbr\u003e\u003ci\u003eClark A. Miller, Heather M. Ross, Gaymon Bennett, and J. Benjamin Hurlbut\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e18.1 Introduction, 507\u003c\/p\u003e \u003cp\u003e18.2 Ubiquitous Computing and the Transformation of Health Care: Three Visions, 511\u003c\/p\u003e \u003cp\u003e18.3 Case Study: Cardiac Implanted Electrical Devices, 516\u003c\/p\u003e \u003cp\u003e18.4 Ethical Reflections, 521\u003c\/p\u003e \u003cp\u003e18.5 Conclusions: The Need for Socio-Technical Design, 534\u003c\/p\u003e \u003cp\u003eReferences, 537\u003c\/p\u003e \u003cp\u003e\u003cb\u003e19 Privacy Protection of Electronic Healthcare Records in e-Healthcare Systems 541\u003c\/b\u003e\u003cbr\u003e\u003ci\u003eFredrick Japhet Mtenzi\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e19.1 Introduction, 541\u003c\/p\u003e \u003cp\u003e19.2 Security and Privacy Concerns of EHR in e-Healthcare Systems, 545\u003c\/p\u003e \u003cp\u003e19.3 Privacy Laws and Regulations of EHRs, 547\u003c\/p\u003e \u003cp\u003e19.4 Privacy of EHRs in e-Healthcare Systems, 552\u003c\/p\u003e \u003cp\u003e19.5 Discussion and Conclusion, 558\u003c\/p\u003e \u003cp\u003e19.6 Contributions and Future Research, 559\u003c\/p\u003e \u003cp\u003eReferences, 561\u003c\/p\u003e \u003cp\u003e\u003cb\u003e20 Ethical, Privacy, and Intellectual Property Issues in Nanomedicine 567\u003c\/b\u003e\u003cbr\u003e\u003ci\u003eKatie Atalla, Ayush Chaudhary, Mary Mehrnoosh Eshaghian-Wilner, Arushi Gupta, Raj Mehta, Adarsh Nayak, Andrew Prajogi, Kodiak Ravicz, Ben Shiroma, and Pujal Trivedi\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e20.1 Introduction, 567\u003c\/p\u003e \u003cp\u003e20.2 Ethical Issues, 568\u003c\/p\u003e \u003cp\u003e20.3 Privacy Issues, 579\u003c\/p\u003e \u003cp\u003e20.4 IP Issues, 590\u003c\/p\u003e \u003cp\u003e20.5 Conclusion, 596\u003c\/p\u003e \u003cp\u003eAcknowledgments, 596\u003c\/p\u003e \u003cp\u003eReferences, 596\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePART V CONCLUSION 601\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003e21 Concluding Remarks 603\u003c\/b\u003e\u003cbr\u003e\u003ci\u003eZhaoqi Chen, Mary Mehrnoosh Eshaghian-Wilner, Kalyani Gonde, Kodiak Ravicz, Rakshith Saligram and Mike Schlesinger\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e21.1 Wireless Computing in Health Care, 603\u003c\/p\u003e \u003cp\u003e21.2 Nanomedicine, 606\u003c\/p\u003e \u003cp\u003e21.3 Ethical, Privacy, and Intellectual Property Issues of Nanomedicine and Wireless Computing, 609\u003c\/p\u003e \u003cp\u003e21.4 Conclusions, 610\u003c\/p\u003e \u003cp\u003eAcknowledgments, 610\u003c\/p\u003e \u003cp\u003eReferences, 610\u003c\/p\u003e \u003cp\u003eIndex 613\u003c\/p\u003e","brand":"John Wiley \u0026 Sons Inc","offers":[{"title":"Default Title","offer_id":48738355675479,"sku":"9781118993590","price":117.85,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0817\/1739\/5799\/files\/9781118993590.jpg?v=1723811966"},{"product_id":"hugo-and-russells-pharmaceutical-microbiology-9781119434498","title":"Hugo and Russells Pharmaceutical Microbiology","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003e\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTable of Contents\u003c\/b\u003e\u003cbr\u003e\u003cp\u003eNotes on Contributors vii\u003c\/p\u003e \u003cp\u003ePreface to the First Edition ix\u003c\/p\u003e \u003cp\u003ePreface to the Ninth Edition x\u003c\/p\u003e \u003cp\u003eAbout the Companion Website xi\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart 1 Introducing Pharmaceutical Microbiology 1\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e1 Introduction to Pharmaceutical Microbiology 3\u003cbr\u003e \u003ci\u003eBrendan F. Gilmore and Stephen P. Denyer\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart 2 Biology of Microorganisms 11\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e2 Fundamental Features of Microbiology 13\u003cbr\u003e \u003ci\u003eNorman Hodges and Stephen P. Denyer\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e3 Bacteria 27\u003cbr\u003e \u003ci\u003eDavid Allison\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e4 Fungi 47\u003cbr\u003e \u003ci\u003eKevin Kavanagh\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e5 Viruses and Other Acellular Infectious Agents: Characteristics and Control 63\u003cbr\u003e \u003ci\u003eTimofey Skvortsov and Jean-Yves Maillard\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e6 Protozoa 98\u003cbr\u003e \u003ci\u003eTim Paget\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart 3 Pathogens and Host Response 121\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e7 Principles of Microbial Pathogenicity and Epidemiology 123\u003cbr\u003e \u003ci\u003eDavid Allison and Andrew J. McBain\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e8 Microbial Biofilms: Consequences for Health 135\u003cbr\u003e \u003ci\u003eBrendan F. Gilmore\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e9 Immunology 147\u003cbr\u003e \u003ci\u003eMark Gumbleton and Mathew W. Smith\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e10 Vaccination and Immunisation 174\u003cbr\u003e \u003ci\u003eGavin J. Humphreys and Andrew J. McBain\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart 4 Prescribing Therapeutics and Infection Control 191\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e11 Antibiotics and Synthetic Antimicrobial Agents: Their Properties and Uses 193\u003cbr\u003e \u003ci\u003eBrendan F. Gilmore\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e12 Mechanisms of Action of Antibiotics and Synthetic Anti-infective Agents 232\u003cbr\u003e \u003ci\u003ePeter Lambert\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e13 Bacterial Resistance to Antibiotics 249\u003cbr\u003e \u003ci\u003eBrendan F. Gilmore and Stephen P. Denyer\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e14 Clinical Uses of Antimicrobial Drugs 272\u003cbr\u003e \u003ci\u003eHayley Wickens and Conor Jamieson\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e15 Antibiotic Prescribing and Antimicrobial Stewardship 289\u003cbr\u003e \u003ci\u003eRebecca Craig\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e16 Infection Prevention and Control: Healthcare-associated Infection 304\u003cbr\u003e \u003ci\u003eElaine Cloutman-Green\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart 5 Contamination and Contamination Control 321\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e17 Microbial Spoilage, Infection Risk and Contamination Control 323\u003cbr\u003e \u003ci\u003eRosamund M. Baird\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e18 Chemical Disinfectants,Antiseptics and Preservatives 343\u003cbr\u003e \u003ci\u003eSean P. Gorman and Brendan F. Gilmore\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e19 Laboratory Evaluation of Antimicrobial Agents 365\u003cbr\u003e \u003ci\u003eBrendan F. Gilmore and Sean P. Gorman\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e20 Microbicides: Mode of Action and Resistance 385\u003cbr\u003e \u003ci\u003eStephen P. Denyer and Jean-Yves Maillard\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e21 Sterilisation Procedures and Sterility Assurance 403\u003cbr\u003e \u003ci\u003eAlistair K. Brown and Stephen P. Denyer\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart 6 Pharmaceutical Production 433\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e22 Sterile Pharmaceutical Products and Principles of Good Manufacturing Practice 435\u003cbr\u003e \u003ci\u003eTim Sandle\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e23 The Manufacture and Quality Control of Immunological Products 462\u003cbr\u003e \u003ci\u003eTim Sandle \u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e24 Recombinant DNA Technology 480\u003cbr\u003e \u003ci\u003eMiguel Cámara and Stephan Heeb\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart 7 Current Trends and New Directions 507\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e25 The Wider Contribution of Microbiology to the Pharmaceutical Sciences 509\u003cbr\u003e \u003ci\u003eMathew W. Smith, James C. Birchall and Sion A. Coulman\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e26 Alternative Strategies to Antibiotics: Priorities for Development 529\u003cbr\u003e \u003ci\u003eBrendan F. Gilmore\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIndex 544\u003c\/p\u003e","brand":"John Wiley and Sons Ltd","offers":[{"title":"Default Title","offer_id":48738359247191,"sku":"9781119434498","price":52.24,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0817\/1739\/5799\/files\/9781119434498.jpg?v=1723811972"},{"product_id":"stress-less-sell-more-9781394153398","title":"Stress Less Sell More","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003e\u003cp\u003e\u003cb\u003eImprove your sales performance and avoid burnout with Mental Health, resilience, and stress-management strategies.\u003c\/b\u003e \u003c\/p\u003e\u003cp\u003eIn\u003ci\u003e Stress Less, Sell More: 220 Strategies to Prevent Sales Burnout and Maximize Mental Performance\u003c\/i\u003e, celebrated sales leader and founder of the Sales Health Alliance, Jeff Riseley, delivers a practical and impactful handbook that makes it easy for sales teams to perform better and build mental health conversations consistently into their busy selling days. \u003c\/p\u003e\u003cp\u003eIn the book, you'll explore ways to navigate the pressures and stressors faced by every sales professional. Its pages can be read day-by-day or all at once, and a companion website supplements the material found in the book with free articles, , and videos. You'll also discover: \u003c\/p\u003e\u003cul\u003e \u003cli\u003eHow to build an individual Mental Health and stress-management toolkit to improve mental resilience and sales performance. \u003c\/li\u003e \u003cli\u003eWays to overcome stressors in sales like lost deals, missed targets and buyers gho\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTable of Contents\u003c\/b\u003e\u003cbr\u003e\u003cp\u003eHow to Use This Book xv\u003c\/p\u003e \u003cp\u003e\u003cb\u003eJanuary 1\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eQuota Relief 2\u003c\/p\u003e \u003cp\u003eCompounding Health 3\u003c\/p\u003e \u003cp\u003ePIP 2.0 4\u003c\/p\u003e \u003cp\u003eSales Sabbaticals 5\u003c\/p\u003e \u003cp\u003eIntrinsic Motivation 6\u003c\/p\u003e \u003cp\u003eWork Hard, Play Hard 7\u003c\/p\u003e \u003cp\u003eKobe 9\u003c\/p\u003e \u003cp\u003eThe Problem with Slack 10\u003c\/p\u003e \u003cp\u003eSlack Hygiene 11\u003c\/p\u003e \u003cp\u003eEight Rules to Live By 12\u003c\/p\u003e \u003cp\u003eTake Your Breaks 13\u003c\/p\u003e \u003cp\u003eThe Problem with Process 14\u003c\/p\u003e \u003cp\u003eVP Sales Enablement 15\u003c\/p\u003e \u003cp\u003eInterview Questions 16\u003c\/p\u003e \u003cp\u003eLeBron James 17\u003c\/p\u003e \u003cp\u003eDaily Vitamins 18\u003c\/p\u003e \u003cp\u003eAdvice from a Friend 20\u003c\/p\u003e \u003cp\u003eRemove Your Blockers 21\u003c\/p\u003e \u003cp\u003eHiring Process Burnout 22\u003c\/p\u003e \u003cp\u003eSharing Bad Habits 23\u003c\/p\u003e \u003cp\u003eEndnotes 23\u003c\/p\u003e \u003cp\u003e\u003cb\u003eFebruary 25\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eListen to Your Body 26\u003c\/p\u003e \u003cp\u003eStop the Hamster Wheels 27\u003c\/p\u003e \u003cp\u003eBeing Present 28\u003c\/p\u003e \u003cp\u003eSales Role Models 29\u003c\/p\u003e \u003cp\u003eRecognition vs Praise 31\u003c\/p\u003e \u003cp\u003eTreat Them like Family 32\u003c\/p\u003e \u003cp\u003eWho Will Be More Motivated? 33\u003c\/p\u003e \u003cp\u003eTwo Tennis Balls and a Sock 34\u003c\/p\u003e \u003cp\u003eWhen You’re Not 100% 36\u003c\/p\u003e \u003cp\u003eHow to End Stigmas 37\u003c\/p\u003e \u003cp\u003eThe Date Jar 39\u003c\/p\u003e \u003cp\u003eWho’s More Responsible? 40\u003c\/p\u003e \u003cp\u003eDavid vs Goliath 41\u003c\/p\u003e \u003cp\u003eRejection Handle 42\u003c\/p\u003e \u003cp\u003eDangerous Expectations 43\u003c\/p\u003e \u003cp\u003eYou Need a Hobby 44\u003c\/p\u003e \u003cp\u003eDo Wellness Initiatives Work? 45\u003c\/p\u003e \u003cp\u003eSave Past Experiences 47\u003c\/p\u003e \u003cp\u003eResponding to Good News 48\u003c\/p\u003e \u003cp\u003eChanging Jobs 49\u003c\/p\u003e \u003cp\u003eEndnotes 50\u003c\/p\u003e \u003cp\u003e\u003cb\u003eMarch 51\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e“Grinding” in Sales 52\u003c\/p\u003e \u003cp\u003eFight Together, Not Alone 53\u003c\/p\u003e \u003cp\u003eMotivation Bucket Checklist 54\u003c\/p\u003e \u003cp\u003eMeaningful Work in Sales 55\u003c\/p\u003e \u003cp\u003eConnecting through Failure 56\u003c\/p\u003e \u003cp\u003eThe Problem with Rewards 57\u003c\/p\u003e \u003cp\u003ePattern Interrupts 58\u003c\/p\u003e \u003cp\u003eSteve Kerr 59\u003c\/p\u003e \u003cp\u003eAm I Experiencing Burnout? 60\u003c\/p\u003e \u003cp\u003eWhat Are We Doing? 61\u003c\/p\u003e \u003cp\u003eVulnerability Paradox 62\u003c\/p\u003e \u003cp\u003eRevenge Bedtime Procrastination 63\u003c\/p\u003e \u003cp\u003eNot Programmed to Exercise 64\u003c\/p\u003e \u003cp\u003eSales Is a Marathon 65\u003c\/p\u003e \u003cp\u003eStoicism and Resilience 66\u003c\/p\u003e \u003cp\u003eBurnout and Control 67\u003c\/p\u003e \u003cp\u003e“Squeezing” Salespeople 69\u003c\/p\u003e \u003cp\u003eFormula 1 70\u003c\/p\u003e \u003cp\u003eMy Team “Looks” Healthy 71\u003c\/p\u003e \u003cp\u003eMindful Eating 72\u003c\/p\u003e \u003cp\u003eEndnotes 72\u003c\/p\u003e \u003cp\u003e\u003cb\u003eApril 73\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eMessy Humans 74\u003c\/p\u003e \u003cp\u003eExercise for $25,000? 75\u003c\/p\u003e \u003cp\u003eDrinking Culture in Sales 76\u003c\/p\u003e \u003cp\u003ePrioritize Mental Health 77\u003c\/p\u003e \u003cp\u003eCollaboration in Sales 78\u003c\/p\u003e \u003cp\u003eSales Training Confusion 79\u003c\/p\u003e \u003cp\u003eLark or Owl? 80\u003c\/p\u003e \u003cp\u003eHave or Have Not 81\u003c\/p\u003e \u003cp\u003eGetting Mental Health Wrong 82\u003c\/p\u003e \u003cp\u003eLanguishing 83\u003c\/p\u003e \u003cp\u003eEmotional Experiences 84\u003c\/p\u003e \u003cp\u003eNapping in Sales 85\u003c\/p\u003e \u003cp\u003e20 Extra Days 86\u003c\/p\u003e \u003cp\u003eDon’t Be a Homer 87\u003c\/p\u003e \u003cp\u003eTake a Mental Health Day 88\u003c\/p\u003e \u003cp\u003eControl What You Can Control 89\u003c\/p\u003e \u003cp\u003eGet Involved 90\u003c\/p\u003e \u003cp\u003eProtect Your Players 91\u003c\/p\u003e \u003cp\u003eYour To-Do List 92\u003c\/p\u003e \u003cp\u003eProactive Sales Onboarding 93\u003c\/p\u003e \u003cp\u003eEndnotes 93\u003c\/p\u003e \u003cp\u003e\u003cb\u003eMay 95\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eSay NO More 96\u003c\/p\u003e \u003cp\u003eRecovery Metrics 97\u003c\/p\u003e \u003cp\u003ePersonal Growth 98\u003c\/p\u003e \u003cp\u003eUnlimited PTO Is Not Enough 99\u003c\/p\u003e \u003cp\u003eContents ix\u003c\/p\u003e \u003cp\u003eClimb Down into the Hole 100\u003c\/p\u003e \u003cp\u003eMental Health Cost Calculator 101\u003c\/p\u003e \u003cp\u003eUncle Ben 103\u003c\/p\u003e \u003cp\u003eStop and Check 104\u003c\/p\u003e \u003cp\u003eThe Wim Hof Method 105\u003c\/p\u003e \u003cp\u003eThe Power of “Yet” 106\u003c\/p\u003e \u003cp\u003eVisualizing Sleep 107\u003c\/p\u003e \u003cp\u003eWhere Is the Off-Ramp? 108\u003c\/p\u003e \u003cp\u003eToxic Sales Dashboards 109\u003c\/p\u003e \u003cp\u003eSharing Openly 110\u003c\/p\u003e \u003cp\u003eWhy Are You Angry? 111\u003c\/p\u003e \u003cp\u003eComponents of Hope 113\u003c\/p\u003e \u003cp\u003eNot Feeling Motivated? Read This 114\u003c\/p\u003e \u003cp\u003eImpact of Job Security 115\u003c\/p\u003e \u003cp\u003eBeing Supportive 116\u003c\/p\u003e \u003cp\u003eChoosing the Right Type of Meditation 117\u003c\/p\u003e \u003cp\u003eEndnotes 117\u003c\/p\u003e \u003cp\u003e\u003cb\u003eJune 119\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eCraft, Mind, and Body 120\u003c\/p\u003e \u003cp\u003eWho Do You Want to Be? 121\u003c\/p\u003e \u003cp\u003eThe NFL and Sales 122\u003c\/p\u003e \u003cp\u003eIt’s Showtime! 123\u003c\/p\u003e \u003cp\u003eThe Power of Appreciation 124\u003c\/p\u003e \u003cp\u003eGrab an Umbrella 125\u003c\/p\u003e \u003cp\u003eCorporate Greed 126\u003c\/p\u003e \u003cp\u003eLearning a New Skill 127\u003c\/p\u003e \u003cp\u003eBe Like Mike 128\u003c\/p\u003e \u003cp\u003eWhat Are You Feeling? 129\u003c\/p\u003e \u003cp\u003eEndnotes 129\u003c\/p\u003e \u003cp\u003e\u003cb\u003eJuly 131\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eBack from Vacation 132\u003c\/p\u003e \u003cp\u003eYour Signature Move 133\u003c\/p\u003e \u003cp\u003eEmpowering Sales Teams 135\u003c\/p\u003e \u003cp\u003eTop-Down, Bottom-Up 136\u003c\/p\u003e \u003cp\u003eEustress vs Distress 138\u003c\/p\u003e \u003cp\u003eBenefits of Meditation 139\u003c\/p\u003e \u003cp\u003eEmotional Literacy 140\u003c\/p\u003e \u003cp\u003eCompound Resilience 141\u003c\/p\u003e \u003cp\u003eBlock the Sales Dashboard 143\u003c\/p\u003e \u003cp\u003eUpper Limit Happiness 144\u003c\/p\u003e \u003cp\u003eThe Right Action 145\u003c\/p\u003e \u003cp\u003eHearing vs Listening 146\u003c\/p\u003e \u003cp\u003eDistanced from Work 147\u003c\/p\u003e \u003cp\u003eCompeting Perspectives in Sales 148\u003c\/p\u003e \u003cp\u003eTop Performers 149\u003c\/p\u003e \u003cp\u003eThe Bus Stop 150\u003c\/p\u003e \u003cp\u003eOvertraining 151\u003c\/p\u003e \u003cp\u003eAfternoon Coffee 152\u003c\/p\u003e \u003cp\u003eEmail Apnea 153\u003c\/p\u003e \u003cp\u003eTheory X or Theory Y 154\u003c\/p\u003e \u003cp\u003eEndnotes 154\u003c\/p\u003e \u003cp\u003e\u003cb\u003eAugust 155\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eUncoupling from Fear 156\u003c\/p\u003e \u003cp\u003eCourageous Vulnerability 157\u003c\/p\u003e \u003cp\u003eMindset Matters 158\u003c\/p\u003e \u003cp\u003ePraising Effort and Learning 159\u003c\/p\u003e \u003cp\u003ePerception and Targets 160\u003c\/p\u003e \u003cp\u003eBecoming a CEO 161\u003c\/p\u003e \u003cp\u003eABCs of Anxiety 162\u003c\/p\u003e \u003cp\u003eSales and Masks 163\u003c\/p\u003e \u003cp\u003eFive Dysfunctions of Mental Health 164\u003c\/p\u003e \u003cp\u003eYour Voice Matters 165\u003c\/p\u003e \u003cp\u003eMindset and Algorithms 166\u003c\/p\u003e \u003cp\u003eThe Anxiety Cure 167\u003c\/p\u003e \u003cp\u003eAction Thinking 168\u003c\/p\u003e \u003cp\u003eInterview Candidates 169\u003c\/p\u003e \u003cp\u003eDark Horses 170\u003c\/p\u003e \u003cp\u003eWellness Day Problems 171\u003c\/p\u003e \u003cp\u003eSocial Impact 172\u003c\/p\u003e \u003cp\u003eGet in Touch 173\u003c\/p\u003e \u003cp\u003eDelivering Bad News 175\u003c\/p\u003e \u003cp\u003eStop Making Excuses 176\u003c\/p\u003e \u003cp\u003eEndnotes 176\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSeptember 177\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eStop Wasting Time 178\u003c\/p\u003e \u003cp\u003eSuicide Prevention 179\u003c\/p\u003e \u003cp\u003ePush-Ups and Sales Burnout 180\u003c\/p\u003e \u003cp\u003eSales Biases 181\u003c\/p\u003e \u003cp\u003eTypes of Sales Stressors 182\u003c\/p\u003e \u003cp\u003eSwing Votes 183\u003c\/p\u003e \u003cp\u003eFear of Loss 184\u003c\/p\u003e \u003cp\u003eDoing the Dishes 185\u003c\/p\u003e \u003cp\u003eControl Your Information 186\u003c\/p\u003e \u003cp\u003eBad Outcomes of Success 187\u003c\/p\u003e \u003cp\u003eThe Pre-call Ritual 188\u003c\/p\u003e \u003cp\u003eNeeds vs Wants 189\u003c\/p\u003e \u003cp\u003eSales Needs Emotion 190\u003c\/p\u003e \u003cp\u003eDrinking on the Job 191\u003c\/p\u003e \u003cp\u003ePlaying the Long Game 193\u003c\/p\u003e \u003cp\u003eNo One Is Wearing Shoes! 194\u003c\/p\u003e \u003cp\u003eHigh Strain Activities 195\u003c\/p\u003e \u003cp\u003eStop Aiming for Perfect 196\u003c\/p\u003e \u003cp\u003eIntermittent Fasting 197\u003c\/p\u003e \u003cp\u003eInput-Focused Mindset 198\u003c\/p\u003e \u003cp\u003eEndnotes 199\u003c\/p\u003e \u003cp\u003e\u003cb\u003eOctober 201\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eYou Don’t Need Years of Experience 202\u003c\/p\u003e \u003cp\u003eStarting the Conversation 203\u003c\/p\u003e \u003cp\u003eNo Brakes 204\u003c\/p\u003e \u003cp\u003eWhat Is Empathy Really? 205\u003c\/p\u003e \u003cp\u003e30 Days of Sweat 206\u003c\/p\u003e \u003cp\u003eRyan Reynolds 207\u003c\/p\u003e \u003cp\u003eRATT 208\u003c\/p\u003e \u003cp\u003eWorking for Workers Act 209\u003c\/p\u003e \u003cp\u003eStop Comparing 210\u003c\/p\u003e \u003cp\u003eYour “Spidey-Sense” 211\u003c\/p\u003e \u003cp\u003eMore Sleep = More Sales 212\u003c\/p\u003e \u003cp\u003e“I’m a Failure” 213\u003c\/p\u003e \u003cp\u003eSeasonal Changes 214\u003c\/p\u003e \u003cp\u003eMaybe They 215\u003c\/p\u003e \u003cp\u003eTrust Recession 217\u003c\/p\u003e \u003cp\u003eHALT 218\u003c\/p\u003e \u003cp\u003eBe Kind to Each Other 219\u003c\/p\u003e \u003cp\u003eDid I Matter? 220\u003c\/p\u003e \u003cp\u003eFix Yourself First 221\u003c\/p\u003e \u003cp\u003eHope in Sales 222\u003c\/p\u003e \u003cp\u003eEndnotes 222\u003c\/p\u003e \u003cp\u003e\u003cb\u003eNovember 223\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eBuyer Mental Health 224\u003c\/p\u003e \u003cp\u003eMastery Manipulation 225\u003c\/p\u003e \u003cp\u003eSuper Mario 226\u003c\/p\u003e \u003cp\u003eFailure in Sales 228\u003c\/p\u003e \u003cp\u003e“Feeling Lucky” 229\u003c\/p\u003e \u003cp\u003eThe Drivers 230\u003c\/p\u003e \u003cp\u003eSeeds of Growth 231\u003c\/p\u003e \u003cp\u003ePlanning to Miss 232\u003c\/p\u003e \u003cp\u003eStory Editing 233\u003c\/p\u003e \u003cp\u003eInstant Gratification 234\u003c\/p\u003e \u003cp\u003eDon’t Speak Up 235\u003c\/p\u003e \u003cp\u003eRehearsal Loop 236\u003c\/p\u003e \u003cp\u003eSmall Actions Matter Most 237\u003c\/p\u003e \u003cp\u003eBuyer Ghosting 239\u003c\/p\u003e \u003cp\u003eChallenging Experiences 240\u003c\/p\u003e \u003cp\u003eThe PIP 241\u003c\/p\u003e \u003cp\u003eBecoming a Chameleon 242\u003c\/p\u003e \u003cp\u003eThe First Call 243\u003c\/p\u003e \u003cp\u003eJeff Goldblum 244\u003c\/p\u003e \u003cp\u003eThe Off-Season 245\u003c\/p\u003e \u003cp\u003eEndnotes 245\u003c\/p\u003e \u003cp\u003e\u003cb\u003eDecember 247\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eYour Inner Citadel 248\u003c\/p\u003e \u003cp\u003eBuilding Empathy 249\u003c\/p\u003e \u003cp\u003eLaw of the Lever 250\u003c\/p\u003e \u003cp\u003eBad Is Stronger than Good 252\u003c\/p\u003e \u003cp\u003eKeeping It Objective 253\u003c\/p\u003e \u003cp\u003eFinding the Present 254\u003c\/p\u003e \u003cp\u003eHow Supported Do You Feel? 255\u003c\/p\u003e \u003cp\u003eNaïve Realism 256\u003c\/p\u003e \u003cp\u003eStress-Enhancing Mindset 257\u003c\/p\u003e \u003cp\u003eSleep Best Practices 259\u003c\/p\u003e \u003cp\u003eEndnotes 260\u003c\/p\u003e \u003cp\u003eAfterword: Salience Bias 261\u003c\/p\u003e \u003cp\u003eAbout the Author 263\u003c\/p\u003e \u003cp\u003eIndex 265\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"John Wiley \u0026 Sons Inc","offers":[{"title":"Default Title","offer_id":48738656289111,"sku":"9781394153398","price":17.84,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0817\/1739\/5799\/files\/9781394153398.jpg?v=1720049796"},{"product_id":"bipolar-disorder-for-dummies-9781394168675","title":"Bipolar Disorder For Dummies","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003e\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTable of Contents\u003c\/b\u003e\u003cbr\u003e\u003cp\u003eIntroduction 1\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart 1: Getting Started on Your Bipolar Journey 5\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eChapter 1: Grasping Bipolar Disorder: Symptoms and Diagnosis 7\u003c\/p\u003e \u003cp\u003eChapter 2: Exploring Possible Causes: The Brain and Body Science of Bipolar Disorder 29\u003c\/p\u003e \u003cp\u003eChapter 3: Reining in Bipolar Disorder: Prognosis and Treatments 49\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart 2: Obtaining a Diagnosis, Developing a Treatment Plan, and Building a Team 61\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eChapter 4: Getting an Accurate Diagnosis 63\u003c\/p\u003e \u003cp\u003eChapter 5: Building Your Treatment Plan 91\u003c\/p\u003e \u003cp\u003eChapter 6: Building a Winning Mood-Management Team 103\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart 3: Managing the Biology of Bipolar Disorder 119\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eChapter 7: Leveling Moods with Medication 121\u003c\/p\u003e \u003cp\u003eChapter 8: Coming to Terms with Medications and Their Side Effects 149\u003c\/p\u003e \u003cp\u003eChapter 9: Expanding Your Biological Treatment Options 169\u003c\/p\u003e \u003cp\u003eChapter 10: Addressing Bipolar Disorder Across Diverse Communities 185\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart 4: Developing Essential Survival Skills 205\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eChapter 11: Exploring Self Help and Professional Therapies 207\u003c\/p\u003e \u003cp\u003eChapter 12: Making Lifestyle Adjustments 227\u003c\/p\u003e \u003cp\u003eChapter 13: Communicating Effectively 245\u003c\/p\u003e \u003cp\u003eChapter 14: Solving Problems and Resolving Conflict 259\u003c\/p\u003e \u003cp\u003eChapter 15: Planning Ahead for a Mood Episode 271\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart 5: Dealing with the Fallout 283\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eChapter 16: From Hospitalization to Recovery 285\u003c\/p\u003e \u003cp\u003eChapter 17: Returning to Work or Not 301\u003c\/p\u003e \u003cp\u003eChapter 18: Overcoming Financial Setbacks 315\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart 6: Assisting a Friend or Relative with Bipolar Disorder 329\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eChapter 19: Supporting Your Loved One 331\u003c\/p\u003e \u003cp\u003eChapter 20: Dealing with Crisis Situations 345\u003c\/p\u003e \u003cp\u003eChapter 21: Supporting Your Bipolar Child or Teen 361\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart 7: The Part of Tens 389\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eChapter 22: Ten Tips for Managing Bipolar 391\u003c\/p\u003e \u003cp\u003eChapter 23: Ten Ways to Help a Loved One with Bipolar Disorder 399\u003c\/p\u003e \u003cp\u003eIndex 405\u003c\/p\u003e","brand":"John Wiley \u0026 Sons Inc","offers":[{"title":"Default Title","offer_id":48738660188503,"sku":"9781394168675","price":17.09,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0817\/1739\/5799\/files\/9781394168675.jpg?v=1720049805"},{"product_id":"acquired-speech-and-language-disorders-9780470025673","title":"Acquired Speech and Language Disorders","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003eIt is vital to have knowledge of the neuroanatomical structures and functional neurological mechanisms, which are disrupted in neurogenic speech\/language, disordered persons in order to understand the speech\/language deficits themselves.  \u003cp\u003eThis book provides a comprehensive coverage of the neurological basis of both the clinically recognised forms of aphasia and the various motor speech disorders, in both children and adults. It also covers more recently recognised language disorders, such as Parkinsons and related diseases, right hemisphere damage, closed-head injury, dementia, etc. This is a perfect text for practitioners who need to understand the integration of neuroanatomy and functional neurology with the practice of speech-language pathology.\u003c\/p\u003e\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTable of Contents\u003c\/b\u003e\u003cbr\u003e\u003cp\u003e1 Neuroanatomical and neuropathological framework of speech and language 1\u003c\/p\u003e \u003cp\u003e2 Aphasia syndromes 47\u003c\/p\u003e \u003cp\u003e3 Subcortical aphasia syndromes 78\u003c\/p\u003e \u003cp\u003e4 Speech-language disorders associated with traumatic brain injury 118\u003c\/p\u003e \u003cp\u003e5 Language disorders subsequent to right-hemisphere lesions 153\u003c\/p\u003e \u003cp\u003e6 Language disturbances in dementia syndromes 176\u003c\/p\u003e \u003cp\u003e7 Language disorders associated with diseases of the cerebral white matter 202\u003c\/p\u003e \u003cp\u003e8 Neurological disturbances associated with aphasia 226\u003c\/p\u003e \u003cp\u003e9 Dysarthrias associated with upper and lower motor neurone lesions 244\u003c\/p\u003e \u003cp\u003e10 Dysarthrias associated with extrapyramidal syndromes 271\u003c\/p\u003e \u003cp\u003e11 Dysarthrias associated with lesions in other motor systems 303\u003c\/p\u003e \u003cp\u003e12 Acquired childhood speech-language disorders 333\u003c\/p\u003e \u003cp\u003eIndex 370\u003c\/p\u003e","brand":"John Wiley \u0026 Sons Inc","offers":[{"title":"Default Title","offer_id":48864621330775,"sku":"9780470025673","price":55.05,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0817\/1739\/5799\/files\/9780470025673.jpg?v=1722272765"},{"product_id":"cognitive-therapy-for-delusions-voices-and-paranoia-93-wiley-series-in-clinical-psychology-9780471961734","title":"Cognitive Therapy for Delusions Voices and","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003eInternationally respected authors, actively working in this area, establish theoretical reasons for extending cognitive therapy to these symptoms.\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTrade Review\u003c\/b\u003e\u003cbr\u003e\"…on my last visit [to Amazon] the recommendations were [this book]…\" (The Independent {Review}, 8 October 2003)\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTable of Contents\u003c\/b\u003e\u003cbr\u003eA Cognitive View of Delusions and Voices.\u003cbr\u003e \u003cbr\u003e The Practice of Therapy and the Problem of Engagement.\u003cbr\u003e \u003cbr\u003e Delusions: Assessment and Formulation.\u003cbr\u003e \u003cbr\u003e Challenging Delusions.\u003cbr\u003e \u003cbr\u003e Voices: Engagement and Assessment.\u003cbr\u003e \u003cbr\u003e Disputing and Testing Beliefs about Voices.\u003cbr\u003e \u003cbr\u003e Cognitive Therapy for Paranoia.\u003cbr\u003e \u003cbr\u003e Challenging Cases and Issues.\u003cbr\u003e \u003cbr\u003e From a Symptom Model to a Person Model.\u003cbr\u003e \u003cbr\u003e References.\u003cbr\u003e \u003cbr\u003e Appendices.\u003cbr\u003e \u003cbr\u003e Index.","brand":"John Wiley \u0026 Sons Inc","offers":[{"title":"Default Title","offer_id":48864653640023,"sku":"9780471961734","price":44.6,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0817\/1739\/5799\/files\/9780471961734.jpg?v=1722272913"},{"product_id":"the-evolution-of-the-human-head-9780674046368","title":"The Evolution of the Human Head","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003eExplains how the human head works, and why our heads evolved in this peculiarly human way. This book documents how the many components of the head function, how they evolved since we diverged from the apes, and how they interact in diverse ways both functionally and developmentally, causing them to be highly integrated.\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTrade Review\u003c\/b\u003e\u003cbr\u003eLieberman's integrated approach will make his book a forum for a way of thinking in human evolution that has not yet found its equal in print. -- Christopher Dean, University College London\u003cbr\u003eThis is an outstanding book. Lieberman draws from a wide variety of disciplines, including bone biology, embryology, morphometrics, functional anatomy, and paleontology to forge a masterful synthesis of the evolution of the human head. It will be the definitive reference for decades. * John G. Fleagle, Department of Anatomical Sciences, Stony Brook University *\u003cbr\u003eLieberman offers acute descriptions of anatomy, embryology, physiology, and hominid fossils, while providing an exciting way to observe the relationships among structures, functions, and evolutionary variance. -- Scott Vieira * Library Journal *\u003cbr\u003eLieberman dives deep into the cranium, showing just how much of what we consider to be human is connected to what happens above the neck. -- Carolyn Y. Johnson * Boston Globe *\u003cbr\u003eDaniel Lieberman has written a wonderful and inspiring book about the human head's evolution...One stands in awe at the work that has gone into it...This encyclopedic book is transformative...The morphological details in Lieberman's book make it a direct descendant of \u003ci\u003eGray's Anatomy\u003c\/i\u003e...If a single word describes this book, it is integrative. The author integrates material from anatomy, physiology, physics, biomechanics, molecular and developmental biology, but brings all under the umbrella of evolutionary theory. -- Chris McManus * Times Higher Education *\u003cbr\u003eThis [is an] impressive book...This hefty and well-written book offers a scholarly breadth and attention to detail that are certainly laudable. The book is quite unusual in that it includes a comprehensive review of the soft tissues associated with cranial features and discusses them within the context of evolutionary morphology and the fossil record of the human skull. I can think of no other volume that packages the anatomy of the human head in this fashion...Lieberman's big book definitely moves us ahead in effectively synthesizing so much of what is currently understood about the structure, function and evolution of the human head. -- Brian T. Shea * American Scientist *\u003cbr\u003eBy rooting his study in the basics of tissue mechanics and functional morphology, Lieberman does the spadework to which all such studies aspire but few achieve--and makes that task seem elegant and effortless. -- Henry Gee * Nature *\u003cbr\u003eDaniel Lieberman marshals diverse evidence to provide a comprehensive framework for understanding patterns of variation and covariation in the form, function, and phylogeny of the human head...The breadth and diversity of subject matter the volume will impart to the reader is particularly laudable. Lieberman's holistic approach is a welcome, if not requisite, strategy for addressing a multifarious biological system such as the human head. The book's focus on both hard- and soft-tissue components, consideration of how such elements correspond to one another, and comprehensive overview of external and internal influences on patterns of morphological variation and covariation clearly set the tone for how one might profitably investigate cranial evolution across all vertebrates. The introductions to myriad biological concepts, surveys of some modern approaches to outstanding paleoanthropological questions, and review of fossil evidence regarding evolutionary transformations in human skull form will enlighten readers of all backgrounds. \u003ci\u003eThe Evolution of the Human Head\u003c\/i\u003e is an entertaining read...It contains a wealth of information relevant to human evolution. In doing so, it offers a wonderful entrée into many of the outstanding issues that will undoubtedly remain at the center of debates regarding human origins for years to come. -- Matthew J. Ravosa * Science *","brand":"Harvard University Press","offers":[{"title":"Default Title","offer_id":48865477722455,"sku":"9780674046368","price":43.16,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0817\/1739\/5799\/files\/9780674046368.jpg?v=1722274157"},{"product_id":"betrayal-trauma-the-logic-of-forgetting-childhood-abuse-paper-9780674068063","title":"Betrayal Trauma  The Logic of Forgetting","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003eThis book lays bare the logic of forgotten abuse. Psychologist Jennifer Freyd's breakthrough theory explaining this phenomenon shows how psychogenic amnesia not only happens but also, if the abuse occurred at the hands of a parent or caregiver, is often necessary for survival.\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTrade Review\u003c\/b\u003e\u003cbr\u003eA century of observation leaves no doubt that some traumatized people develop amnesia for the event and may not recall their experiences. How can we understand this?...Freyd calls attention...to the social context in which the trauma occurs. The relationship between the victim and the perpetrator is central to her theory. \"In order to survive in cases of core betrayals (abuse by a trusted caregiver on a dependent victim) some amount of information blockage is required.\"...In one of the most ingenious and original sections of the book, Freyd puts her hypothesis to the test by reanalyzing data from four recently published studies of adults with histories of childhood sexual abuse. In each case, she finds that those who were abused by close relatives were more likely to have forgotten the abuse...[This book is] a thoughtful and impassioned treatise by a survivor who has transformed her own betrayal trauma into an investigation of the psychology of memory. -- Judith Lewis Herman * American Journal of Psychiatry *\u003cbr\u003eA powerful work dealing with the often forgotten element of betrayal in the paradigm of traumatic (non)experience...Freyd's work places itself squarely against a segment of American medical community that stresses the shortcomings of \"false memory syndrome\"...A survivor of betrayal trauma herself...Freyd should be commended for standing up to a (distinct) typos of traditional psychiatry...[that discounts] an individual's experience by naming it as indicative of false memory syndrome. -- William Aljandro Martin * Metapsychology *\u003cbr\u003e[Freyd has set] out on an ambitious mission: to review the scientific evidence relevant to the hypothesis that child abuse is most likely to be forgotten when the perpetrator is a trusted caregiver. The result is a book of stunning clarity and objectivity that contributes a great deal to the literature on psychological trauma...Dr. Freyd marshals an impressive array of scientific evidence...and she does so in a way that is accessible to a broad audience. This book sheds light on some of the thorniest questions about the delayed recall of childhood abuse without resorting to emotional pleas or sanctimonious grandstanding. Dr. Freyd lets the data speak for themselves, which results in one of the finest integrative reviews of traumatic-memory research to come along in the past decade...Ultimately, \u003ci\u003eBetrayal Trauma\u003c\/i\u003e is a triumph of objective evidence over impassioned pleas, politics, and media sound-bites. This book is a must-read for anyone who has a personal or professional stage in how our society deals with the issue of childhood abuse and its treatment. -- Aaron E. Black, Ph.D. * Psychiatric Services *\u003cbr\u003e\u003ci\u003eBetrayal Trauma\u003c\/i\u003e stands apart and claims our serious attention on several counts. It systematically presents a plausible theory to account for amnesia for childhood abuse and evidence to back up that theory; it makes sophisticated use of contemporary cognitive science; it is well written and avoids...descent into hyperbole and belittlement; and, finally, it notes alternative interpretations of the assembled data...Because it is a cogent, well written, and informative presentation of a way of understanding and accepting the validity of lost and refound memories of trauma, \u003ci\u003eBetrayal Trauma\u003c\/i\u003e is highly recommended reading. -- C. Brooks Brenneis, Ph.D. * Psychoanalytic Books *\u003cbr\u003eJennifer Freyd describes a logical, often elegant theory of forgetting childhood abuse experiences and other upsetting events...[She] addresses the politics of the recovered memory\/false memory debate in a sober and rational way that encourages thinking over affect. She does this despite her own painful experience with both the topics of abuse, itself, and the impact of the False Memory movement on those who report recovered memories...I found this book to be refreshing, intelligent, and challenging. I recommend it to the mental health community, cognitive scientists, and the interested layperson. -- John Briere * Contemporary Psychology *\u003cbr\u003eThis book clearly goes beyond the previous texts [on recovered memory]...Freyd has provided a book that is interesting and informative for the layperson, practitioner, and researcher. By the end of \u003ci\u003eBetrayal Trauma\u003c\/i\u003e, the reader will have a solid understanding of the issue and controversies related to forgotten child abuse. More important, the reader will understand that there is a logic to this forgetting that could be conceptualized within a particular model. -- Jonathan M. Golding * Child Maltreatment *\u003cbr\u003eRational views of the available evidence [surrounding recovered memory] are rather uncommon...That, in addition to the intrinsic merit of the book, is what makes Jennifer Freyd's \u003ci\u003eBetrayal Trauma\u003c\/i\u003e, such an exceptional document and raises it to the level of a landmark contribution. \u003ci\u003eBetrayal Trauma\u003c\/i\u003e is a feat of superb scholarship and remarkable objectivity and integrity...Adroitly employing everyday experiences to make potentially complex processes and concepts immediately accessible, Freyd reviews the literature on both the distortion of memory and the preservation of memory with admirable evenhandedness...Freyd's own theory is simple and elegant...For the scholar, the mental health professional, and the intelligent lay reader, Freyd's rich and rewarding work offers powerful testimony that a scholar with integrity and compassionate rationality can withstand the onslaught of impassioned hysteria and redirect a field's attention to its basic concerns. She has set a new standard for responsible scholarship in this frequently troubled and troublesome area of study. Let us hope her example proves influential. -- Dr. Richard P. Kluft * Pennsylvania Gazette *\u003cbr\u003eJennifer Freyd has written an incredibly powerful and moving book, the kind where her thinking gets yours going and you start to jot notes in the margins as you tear through it...Dr. Freyd has risen above the fray about repressed memories. -- Patience Mason * Post-Traumatic Gazette *\u003cbr\u003eFreyd's book is elegantly and economically written, argued with clarity and precision and presenting testable predictions...[It is] the best book on motivated amnesia for childhood abuse. -- Phil Mollon * Clinical Psychology Forum *\u003cbr\u003eOne may easily predict that this book, and the theory it proposes, will be considered as a central milestone in the research of human psychology in the next decade...There are certain books, and they are not many, which reading is equal to a successful psychotherapy, and which inner truth penetrates the heart. This book most certainly belongs among them. Freyd's writing combines experience, sincerity, and courage with professional capability. -- Irit Y. Yaar, Attorney * Mar'ariv Daily Newspaper *\u003cbr\u003eIn this well-researched book, Freyd has articulated a theory of memory loss and recall surrounding childhood abuse that is both grounded in cognitive science and immensely validating of and accessible to feminist therapists...She covers a tremendous amount of ground, all the while articulating complex processes in clear, relevant terms. She made memory research exciting and relevant to me as a therapist while satisfying my researcher's need for evidence...Freyd has taken a courageous huge step in bringing both sanity and clarity to the field of child sexual abuse therapy. -- Susan L. Morrow, Ph.D. * Women and Therapy *\u003cbr\u003e\u003ci\u003eBetrayal Trauma\u003c\/i\u003e is not a polemic tract but a knowledgeable treatise on the subject of memory formation, and forgetting. In covers in scholarly, yet clear detail the formation and logic of memory and its retrieval…The book is highly recommended for all those interested in the field, for it encapsulates the research whilst clearly showing the plausibility of what Freyd calls the \"logic of forgetting childhood abuse.\" -- Dawn Baker * ANZJFT *\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTable of Contents\u003c\/b\u003e\u003cbr\u003e1. Betrayal Blindness   2. Conceptual Knots   3. Context and Controversy   4. Why Forget?   5. Ways of Forgetting   6. Testable Predictions   7. Creating Connections   Afterword   References   Acknowledgments   Index","brand":"Harvard University Press","offers":[{"title":"Default Title","offer_id":48865480671575,"sku":"9780674068063","price":29.66,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0817\/1739\/5799\/files\/9780674068063.jpg?v=1722274171"},{"product_id":"family-therapy-techniques-9780674294103","title":"Family Therapy Techniques","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003eMinuchin traces for the first time the minute operations of day-to-day practice. Having achieved renown for his theoretical breakthroughs and his success at treatment, he now explains those precise and difficult maneuvers that constitute his art. The book thus codifies the method of one of the country's most successful practitioners.\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTrade Review\u003c\/b\u003e\u003cbr\u003eAmong family therapists, Minuchin is recognized as a most original innovator, a superb clinician, and an outstanding teacher. He has been able to transmit all of his background and experience into this excellent book. Anyone who has a serious interest in family therapy today will want to have and to know this book. * Journal of Psychotherapy *\u003cbr\u003eFor the individual therapist searching for a better family model, \u003ci\u003eFamilies and Family Therapy\u003c\/i\u003e is recommended at the top of any list of acquisitions. It is doubtful whether any other family therapy publication today can match it. * Contemporary Psychology *\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTable of Contents\u003c\/b\u003e\u003cbr\u003e1. Spontaneity   2. Families   3. Joining   4. Planning   5. Change   6. Reframing   7. Enactment   8. Focus   9. Intensity   10. Restructuring   11. Boundaries   12. Unbalancing   13. Complementarity   14. Realities   15. Constructions   16. Paradoxes, by Peggy Papp   17. Strengths   18. Beyond Technique      Notes   Case Index   General Index","brand":"Harvard University Press","offers":[{"title":"Default Title","offer_id":48865486831959,"sku":"9780674294103","price":55.21,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0817\/1739\/5799\/files\/9780674294103.jpg?v=1722274203"},{"product_id":"the-mind-of-a-mnemonist-a-little-books-a-bouta-vast-memory-with-a-new-foreword-by-jerome-s-bruner-9780674576223","title":"The Mind of a Mnemonist  A Little Books a Bouta","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003e\u003ci\u003eThe Mind of a Mnemonist\u003c\/i\u003e is a rare phenomenon—a scientific study that transcends its data and, in the manner of the best fictional literature, fashions a portrait of an unforgettable human being.\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTrade Review\u003c\/b\u003e\u003cbr\u003eA distinguished Soviet psychologist’s study…[of a] young man who was discovered to have a literally limitless memory and eventually became a professional mnemonist. Experiments and interviews over the years showed that his memory was based on synesthesia (turning sounds into vivid visual imagery), that he could forget anything only by an act of will, that he solved problems in a peculiar crablike fashion that worked, and that he was handicapped intellectually because he could not make discriminations, and because every abstraction and idea immediately dissolved into an image for him. It is all fascinating and delightful. * New Yorker *\u003cbr\u003eLuria’s essay is a model of lucid presentation and is an altogether convincing description of a man whose whole personality and fate was conditioned by an intellectual idiosyncrasy. * Times Literary Supplement *\u003cbr\u003eThese two books [\u003ci\u003eThe Man with a Shattered World\u003c\/i\u003e and \u003ci\u003eThe Mind of a Mnemonist\u003c\/i\u003e] are compassionate and vivid portraits—he called them ‘neurological novels’—though they are in fact case histories of two patients whom Luria observed for 30 years. * Los Angeles Times *\u003cbr\u003eA welcome re-issue of an English translation of Alexander Luria’s famous case-history of hypermnestic man. The study remains the classic paradigm of what Luria called ‘romantic science,’ a genre characterized by individual portraiture based on an assessment of operative psychological processes. The opening section analyses in some detail the subject’s extraordinary capacity for recall and demonstrates the association between the persistence of iconic memory and a highly developed synaesthesia. The remainder of the book deals with the subject’s construction of the world, his mental strengths and weaknesses, his control of behaviour and his personality. The result is a contribution to literature as well as to science. * Psychological Medicine *\u003cbr\u003eThe richness of clinical insight, the acuity of the observations, and the fullness of the overall picture of [Luria’s] mnemonist are all extraordinary… A perceptive study not only of memory organization but also of the manner in which memory is imbedded in a pattern of life. -- Jerome S. Bruner, from the Foreword to the First Edition (1967)\u003cbr\u003eOriginally published almost two decades ago, these fascinating and enormously informative case histories are now classics, each the product of almost 30 years of research by the late Soviet neuropsychologist Aleksandr Romanovich Luria… \u003ci\u003eThe Man with a Shattered World\u003c\/i\u003e describes the heroic struggle of a young soldier trying to recover the memory and other mental capacities lost when a bullet entered his brain. Although different facets of mind are discussed in each [\u003ci\u003eThe Man with a Shattered World\u003c\/i\u003e and \u003ci\u003eThe Mind of a Mnemonist\u003c\/i\u003e], in a sense the two books are complementary, as memory is exaggerated in one and impaired in the other. What we know about the brain and mind is greatly enriched by either book. -- Elliot Valenstein * Boston Globe *\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTable of Contents\u003c\/b\u003e\u003cbr\u003eForeword to the 1987 Edition    Foreword to the First Edition    Preface     1. Introduction    2. The Beginning of the Research    3. His Memory    The Initial Facts    Synesthesia    Words and Images    Difficulties    Eidotechnique    The Art Of Forgetting   4. His World   People and Things   Words   5. His Mind   His Strong Points   His Weak Points   6. His Control of Behavior   The Objective Data   A Pew Words About Magic   7. His Personality","brand":"Harvard University Press","offers":[{"title":"Default Title","offer_id":48865488830807,"sku":"9780674576223","price":25.16,"currency_code":"GBP","in_stock":true}]},{"product_id":"the-nature-of-fear-9780674916487","title":"The Nature of Fear","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003eAnimal behavior expert Daniel T. Blumstein delves into the evolutionary origins and diverse ecological contexts of fear. Fear protects organisms from threats, but at a cost in health and productivity. The various species manage these costs differently, providing lessons for humans as we seek to benefit from fear without succumbing to panic.\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTrade Review\u003c\/b\u003e\u003cbr\u003eClearly, \u003ci\u003eThe Nature of Fear\u003c\/i\u003e is a book for this moment. Dread is all around, manifold and constant during the coronavirus pandemic, of course. But a particular theme of our escalating anxieties comes to the fore with Blumstein’s book in hand: the fear of belonging to nature…As the pandemic brings into focus our biological fragility, the time seems apt to examine the nature of human fear through the lens of, well, nature. * The Atlantic *\u003cbr\u003eA revelatory and masterful work by the world’s authority on fear in animal societies. Blumstein focuses the lenses of animal behavior and evolution on very human anxieties and fears. The result is a beautifully written book rich in crucial insights, with salience for scientists, students, policy makers, and every human being navigating their way through our sometimes frightening world. -- Barbara Natterson-Horowitz, coauthor of \u003ci\u003eWildhood\u003c\/i\u003e and \u003ci\u003eZoobiquity\u003c\/i\u003e\u003cbr\u003eBlumstein has studied fear in the animal kingdom for more than 30 years. In this highly readable book, he explains how related insights can help us do everything from composing scary music to managing biodiversity and imposing effective public health measures…Embrace your fears, and give it a read! * BBC Wildlife *\u003cbr\u003e\u003ci\u003eThe Nature of Fear\u003c\/i\u003e’s main province is the fluttering pulse-rates of the broader animal kingdom, and that makes for mind-changing reading. -- Steve Donoghue * Open Letters Review *\u003cbr\u003eThis terrific book is a reminder that when we are afraid, we are not alone. Lizards have fear. Mice have fear. Marmots have fear. This feeling is ancient, and for many millions of years, it has guided animals’ actions. If you want to understand the roots of fear, and also make more sense of your own life, read this book. -- Rob Dunn, author of \u003ci\u003eNever Home Alone\u003c\/i\u003e\u003cbr\u003eBlumstein shows us how fear can be a positive force. When equipped with the knowledge of fear’s origin, we have a blueprint for conquering it. Informed by animals and evolution, \u003ci\u003eThe Nature of Fear\u003c\/i\u003e is a biological thriller that everyone needs to read. -- Brian Hare, coauthor of \u003ci\u003eThe Genius of Dogs\u003c\/i\u003e\u003cbr\u003eIn this lively and informative book, Blumstein takes the study of fear from the laboratory into the wild to emphasize the costs and benefits of fear responses and their evolution. This novel approach has much to offer as we try to understand the origin of our own fears. -- Guy Beauchamp, author of \u003ci\u003eAnimal Vigilance: Monitoring Predators and Competitors\u003c\/i\u003e\u003cbr\u003eIn this fascinating book, Daniel Blumstein explores the causes and consequences of fear for human and nonhuman animals, providing important insights into the ways that we all recognize and cope with risks in the course of our daily lives. -- Tim Clutton-Brock, author of \u003ci\u003eMammal Societies\u003c\/i\u003e\u003cbr\u003eThe feature making this project most compelling is the thesis that fear can be chronic, inappropriate, and very costly…An enjoyable book. -- James Chadwick Johnson * Quarterly Review of Biology *\u003cbr\u003eIn this slim but packed book, Daniel Blumstein explores many facets of an emotion all animals feel: fear in all its different faces, broadening the discussion in ways that will challenge readers to re-examine the values of a trauma nobody likes. -- Steve Donoghue * Open Letters Review *","brand":"Harvard University Press","offers":[{"title":"Default Title","offer_id":48865494139223,"sku":"9780674916487","price":19.76,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0817\/1739\/5799\/files\/9780674916487.jpg?v=1722274232"},{"product_id":"mri-9781119013051","title":"MRI","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003e\u003cb\u003eThis fifth edition of the most accessible introduction to MRI principles and applications from renowned teachers in the field provides an understandable yet comprehensive update.\u003c\/b\u003e\u003cbr\u003e \u003cul\u003e \u003cli\u003eAccessible introductory guide from renowned teachers in the field\u003c\/li\u003e \u003cli\u003eProvides a concise yet thorough introduction for MRI focusing on fundamental physics, pulse sequences, and clinical applications without presenting advanced math\u003c\/li\u003e \u003cli\u003eTakes a practical approach, including up-to-date protocols, and supports technical concepts with thorough explanations and illustrations\u003c\/li\u003e \u003cli\u003eHighlights sections that are directly relevant to radiology board exams\u003c\/li\u003e \u003cli\u003ePresents new information on the latest scan techniques and applications including 3 Tesla whole body scanners, safety issues, and the nephrotoxic effects of gadolinium-based contrast media\u003c\/li\u003e \u003c\/ul\u003e\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTable of Contents\u003c\/b\u003e\u003cbr\u003e\u003cp\u003ePreface, ix\u003c\/p\u003e \u003cp\u003eABR study guide topics, xi\u003c\/p\u003e \u003cp\u003e\u003cb\u003e1 Production of net magnetization 1\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e1.1 Magnetic fields 1\u003c\/p\u003e \u003cp\u003e1.2 Nuclear spin 2\u003c\/p\u003e \u003cp\u003e1.3 Nuclear magnetic moments 4\u003c\/p\u003e \u003cp\u003e1.4 Larmor precession 4\u003c\/p\u003e \u003cp\u003e1.5 Net magnetization 6\u003c\/p\u003e \u003cp\u003e1.6 Susceptibility and magnetic materials 8\u003c\/p\u003e \u003cp\u003e\u003cb\u003e2 Concepts of magnetic resonance 10\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e2.1 Radiofrequency excitation 10\u003c\/p\u003e \u003cp\u003e2.2 Radiofrequency signal detection 12\u003c\/p\u003e \u003cp\u003e2.3 Chemical shift 14\u003c\/p\u003e \u003cp\u003e\u003cb\u003e3 Relaxation 17\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e3.1 T1 relaxation and saturation 17\u003c\/p\u003e \u003cp\u003e3.2 T2 relaxation, T2* relaxation, and spin echoes 21\u003c\/p\u003e \u003cp\u003e\u003cb\u003e4 Principles of magnetic resonance imaging – 1 26\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e4.1 Gradient fields 26\u003c\/p\u003e \u003cp\u003e4.2 Slice selection 28\u003c\/p\u003e \u003cp\u003e4.3 Readout or frequency encoding 30\u003c\/p\u003e \u003cp\u003e4.4 Phase encoding 33\u003c\/p\u003e \u003cp\u003e4.5 Sequence looping 35\u003c\/p\u003e \u003cp\u003e\u003cb\u003e5 Principles of magnetic resonance imaging – 2 39\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e5.1 Frequency selective excitation 39\u003c\/p\u003e \u003cp\u003e5.2 Composite pulses 44\u003c\/p\u003e \u003cp\u003e5.3 Raw data and image data matrices 46\u003c\/p\u003e \u003cp\u003e5.4 Signal-to-noise ratio and tradeoffs 47\u003c\/p\u003e \u003cp\u003e5.5 Raw data and k-space 48\u003c\/p\u003e \u003cp\u003e5.6 Reduced k-space techniques 51\u003c\/p\u003e \u003cp\u003e5.7 Reordered k-space filling techniques 54\u003c\/p\u003e \u003cp\u003e5.8 Other k-space filling techniques 56\u003c\/p\u003e \u003cp\u003e5.9 Phased-array coils 58\u003c\/p\u003e \u003cp\u003e5.10 Parallel acquisition methods 60\u003c\/p\u003e \u003cp\u003e\u003cb\u003e6 Pulse sequences 65\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e6.1 Spin echo sequences 67\u003c\/p\u003e \u003cp\u003e6.2 Gradient echo sequences 70\u003c\/p\u003e \u003cp\u003e6.3 Echo planar imaging sequences 75\u003c\/p\u003e \u003cp\u003e6.4 Magnetization-prepared sequences 77\u003c\/p\u003e \u003cp\u003e\u003cb\u003e7 Measurement parameters and image contrast 86\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e7.1 Intrinsic parameters 87\u003c\/p\u003e \u003cp\u003e7.2 Extrinsic parameters 89\u003c\/p\u003e \u003cp\u003e7.3 Parameter tradeoffs 91\u003c\/p\u003e \u003cp\u003e\u003cb\u003e8 Signal suppression techniques 94\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e8.1 Spatial presaturation 94\u003c\/p\u003e \u003cp\u003e8.2 Magnetization transfer suppression 96\u003c\/p\u003e \u003cp\u003e8.3 Frequency-selective saturation 99\u003c\/p\u003e \u003cp\u003e8.4 Nonsaturation methods 101\u003c\/p\u003e \u003cp\u003e\u003cb\u003e9 Artifacts 103\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e9.1 Motion artifacts 103\u003c\/p\u003e \u003cp\u003e9.2 Sequence\/Protocol-related artifacts 105\u003c\/p\u003e \u003cp\u003e9.3 External artifacts 119\u003c\/p\u003e \u003cp\u003e\u003cb\u003e10 Motion artifact reduction techniques 126\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e10.1 Acquisition parameter modification 126\u003c\/p\u003e \u003cp\u003e10.2 Triggering\/Gating 127\u003c\/p\u003e \u003cp\u003e10.3 Flow compensation 132\u003c\/p\u003e \u003cp\u003e10.4 Radial-based motion compensation 134\u003c\/p\u003e \u003cp\u003e\u003cb\u003e11 Magnetic resonance angiography 135\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e11.1 Time-of-flight MRA 137\u003c\/p\u003e \u003cp\u003e11.2 Phase contrast MRA 141\u003c\/p\u003e \u003cp\u003e11.3 Maximum intensity projection 144\u003c\/p\u003e \u003cp\u003e12 Advanced imaging applications 147\u003c\/p\u003e \u003cp\u003e12.1 Diffusion 147\u003c\/p\u003e \u003cp\u003e\u003cb\u003e12.2 Perfusion 153\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e12.3 Functional brain imaging 156\u003c\/p\u003e \u003cp\u003e12.4 Ultra-high field imaging 158\u003c\/p\u003e \u003cp\u003e12.5 Noble gas imaging 159\u003c\/p\u003e \u003cp\u003e\u003cb\u003e13 Magnetic resonance spectroscopy 162\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e13.1 Additional concepts 162\u003c\/p\u003e \u003cp\u003e13.2 Localization techniques 167\u003c\/p\u003e \u003cp\u003e13.3 Spectral analysis and postprocessing 169\u003c\/p\u003e \u003cp\u003e13.4 Ultra-high field spectroscopy 173\u003c\/p\u003e \u003cp\u003e\u003cb\u003e14 Instrumentation 177\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e14.1 Computer systems 177\u003c\/p\u003e \u003cp\u003e14.2 Magnet system 180\u003c\/p\u003e \u003cp\u003e14.3 Gradient system 182\u003c\/p\u003e \u003cp\u003e14.4 Radiofrequency system 184\u003c\/p\u003e \u003cp\u003e14.5 Data acquisition system 186\u003c\/p\u003e \u003cp\u003e14.6 Summary of system components 187\u003c\/p\u003e \u003cp\u003e\u003cb\u003e15 Contrast agents 189\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e15.1 Intravenous agents 190\u003c\/p\u003e \u003cp\u003e15.2 Oral agents 195\u003c\/p\u003e \u003cp\u003e\u003cb\u003e16 Safety 196\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e16.1 Base magnetic field 197\u003c\/p\u003e \u003cp\u003e16.2 Cryogens 197\u003c\/p\u003e \u003cp\u003e16.3 Gradients 198\u003c\/p\u003e \u003cp\u003e16.4 RF power deposition 198\u003c\/p\u003e \u003cp\u003e16.5 Contrast media 199\u003c\/p\u003e \u003cp\u003e\u003cb\u003e17 Clinical applications 200\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e17.1 General principles of clinical MR imaging 200\u003c\/p\u003e \u003cp\u003e17.2 Examination design considerations 202\u003c\/p\u003e \u003cp\u003e17.3 Protocol considerations for anatomical regions 203\u003c\/p\u003e \u003cp\u003e17.4 Recommendations for specific sequences and clinical situations 218\u003c\/p\u003e \u003cp\u003eReferences and suggested readings 222\u003c\/p\u003e \u003cp\u003eIndex 225\u003c\/p\u003e","brand":"John Wiley and Sons Ltd","offers":[{"title":"Default Title","offer_id":48866384347479,"sku":"9781119013051","price":51.25,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0817\/1739\/5799\/files\/9781119013051.jpg?v=1722278393"},{"product_id":"interpretation-basics-of-cone-beam-computed-tomography-9781119685845","title":"Interpretation Basics of Cone Beam Computed","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003e\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTable of Contents\u003c\/b\u003e\u003cbr\u003e\u003cp\u003ePreface to the Second Edition ix\u003c\/p\u003e \u003cp\u003eAcknowledgments xi\u003c\/p\u003e \u003cp\u003eAbout the Companion Website xiii\u003c\/p\u003e \u003cp\u003e\u003cb\u003e1. Introduction to Cone Beam Computed Tomography 1\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eShawneen M. Gonzalez\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 1\u003c\/p\u003e \u003cp\u003eConventional Computed Tomography 1\u003c\/p\u003e \u003cp\u003eCone Beam Computed Tomography 2\u003c\/p\u003e \u003cp\u003eConventional CT versus Cone Beam CT 2\u003c\/p\u003e \u003cp\u003eViewing CBCT Data 4\u003c\/p\u003e \u003cp\u003eArtifacts 7\u003c\/p\u003e \u003cp\u003eReferences 11\u003c\/p\u003e \u003cp\u003e\u003cb\u003e2. Cone Beam Computed Tomography Recommendations 13\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eShawneen M. Gonzalez\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 13\u003c\/p\u003e \u003cp\u003eEndodontics 13\u003c\/p\u003e \u003cp\u003eOrthodontics 18\u003c\/p\u003e \u003cp\u003ePeriodontics 24\u003c\/p\u003e \u003cp\u003eReferences 30\u003c\/p\u003e \u003cp\u003e\u003cb\u003e3. Legal Issues Concerning Cone Beam Computed Tomography 33\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eShawneen M. Gonzalez\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 33\u003c\/p\u003e \u003cp\u003eStandard of Care 33\u003c\/p\u003e \u003cp\u003eRecommendations 34\u003c\/p\u003e \u003cp\u003eSummary 36\u003c\/p\u003e \u003cp\u003eReferences 37\u003c\/p\u003e \u003cp\u003e\u003cb\u003e4. Paranasal Sinuses and Mastoid Air Cells 39\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eGayle Tieszen Reardon\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 39\u003c\/p\u003e \u003cp\u003eAnatomy 39\u003c\/p\u003e \u003cp\u003eInflammatory Disease of the Paranasal Sinuses 56\u003c\/p\u003e \u003cp\u003eIntrinsic Disease of the Paranasal Sinuses 60\u003c\/p\u003e \u003cp\u003ePostsurgical Changes of Paranasal Sinuses 69\u003c\/p\u003e \u003cp\u003eReferences 70\u003c\/p\u003e \u003cp\u003e\u003cb\u003e5. The Sinonasal Cavity and Airway 73\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eGayle Tieszen Reardon\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 73\u003c\/p\u003e \u003cp\u003eAnatomy 73\u003c\/p\u003e \u003cp\u003eSurgical Variations 87\u003c\/p\u003e \u003cp\u003eInflammatory Diseases 89\u003c\/p\u003e \u003cp\u003eThe Pharynx 91\u003c\/p\u003e \u003cp\u003eThe Nasopharynx 92\u003c\/p\u003e \u003cp\u003eThe Oropharynx 93\u003c\/p\u003e \u003cp\u003eThe Hypopharynx (Also Called Laryngopharynx) 95\u003c\/p\u003e \u003cp\u003eThe Parapharyngeal Space 95\u003c\/p\u003e \u003cp\u003eReferences 96\u003c\/p\u003e \u003cp\u003e\u003cb\u003e6. Cranial Skull Base and Orbits 97\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eShawneen M. Gonzalez\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 97\u003c\/p\u003e \u003cp\u003eAnatomy 97\u003c\/p\u003e \u003cp\u003eAnatomic Variants\/Developmental Anomalies 106\u003c\/p\u003e \u003cp\u003eIncidental Findings 111\u003c\/p\u003e \u003cp\u003eReferences 113\u003c\/p\u003e \u003cp\u003e\u003cb\u003e7. Soft Tissues 115\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eShawneen M. Gonzalez\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 115\u003c\/p\u003e \u003cp\u003ePathosis—Arterial Calcifications 115\u003c\/p\u003e \u003cp\u003ePathosis—Other Calcifications 122\u003c\/p\u003e \u003cp\u003eIncidental Findings—Soft Tissue of the Brain 126\u003c\/p\u003e \u003cp\u003eIncidental Findings—Orbital Cavity 133\u003c\/p\u003e \u003cp\u003eIncidental Findings—Face 136\u003c\/p\u003e \u003cp\u003eReferences 138\u003c\/p\u003e \u003cp\u003e\u003cb\u003e8. Cervical Spine 141\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eShawneen M. Gonzalez\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 141\u003c\/p\u003e \u003cp\u003eAnatomy 141\u003c\/p\u003e \u003cp\u003eAnatomic Variants\/Developmental Anomalies 147\u003c\/p\u003e \u003cp\u003ePathosis 153\u003c\/p\u003e \u003cp\u003eReferences 158\u003c\/p\u003e \u003cp\u003e\u003cb\u003e9. Maxilla and Mandible (excluding TMJs) 161\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eShawneen M. Gonzalez\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 161\u003c\/p\u003e \u003cp\u003eAnatomy 161\u003c\/p\u003e \u003cp\u003eAnatomic Variants\/Developmental Anomalies 167\u003c\/p\u003e \u003cp\u003ePathosis 169\u003c\/p\u003e \u003cp\u003eIncidental Findings 178\u003c\/p\u003e \u003cp\u003eReferences 182\u003c\/p\u003e \u003cp\u003e\u003cb\u003e10. Temporomandibular Joints 183\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eGayle Tieszen Reardon\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 183\u003c\/p\u003e \u003cp\u003eNormal Anatomy and Function 183\u003c\/p\u003e \u003cp\u003eDevelopmental Abnormalities 187\u003c\/p\u003e \u003cp\u003eSoft‐Tissue Abnormalities 192\u003c\/p\u003e \u003cp\u003eRemodeling and Arthritis 194\u003c\/p\u003e \u003cp\u003eTrauma 204\u003c\/p\u003e \u003cp\u003eTumors 206\u003c\/p\u003e \u003cp\u003eReferences 207\u003c\/p\u003e \u003cp\u003e\u003cb\u003e11. Implants 209\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eGayle Tieszen Reardon and Shawneen M. Gonzalez\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 209\u003c\/p\u003e \u003cp\u003eImaging for Implant Purposes 210\u003c\/p\u003e \u003cp\u003eCBCT Image Development 214\u003c\/p\u003e \u003cp\u003eGray Values and Hounsfield Units 214\u003c\/p\u003e \u003cp\u003eBone Density: A Key Determinant for Treatment Planning 215\u003c\/p\u003e \u003cp\u003eLinear Measurement Accuracy 216\u003c\/p\u003e \u003cp\u003eMandibular Canal 217\u003c\/p\u003e \u003cp\u003eVirtual Implant Placement Software 218\u003c\/p\u003e \u003cp\u003eReferences 221\u003c\/p\u003e \u003cp\u003e\u003cb\u003eAppendix Sample Reports 223\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eShawneen M. Gonzalez\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 223\u003c\/p\u003e \u003cp\u003eGeneral Health Report 224\u003c\/p\u003e \u003cp\u003ePathology Report 226\u003c\/p\u003e \u003cp\u003eEndodontic Report 231\u003c\/p\u003e \u003cp\u003eIndex 237\u003c\/p\u003e","brand":"John Wiley and Sons Ltd","offers":[{"title":"Default Title","offer_id":48866411151703,"sku":"9781119685845","price":106.16,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0817\/1739\/5799\/files\/9781119685845.jpg?v=1722278510"},{"product_id":"the-maudsley-deprescribing-guidelines-9781119822981","title":"The Maudsley Deprescribing Guidelines","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003e\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTable of Contents\u003c\/b\u003e\u003cbr\u003e\u003cp\u003ePreface ix\u003c\/p\u003e \u003cp\u003eAcknowledgements xii\u003c\/p\u003e \u003cp\u003eNotes on Using the Maudsley® Deprescribing Guidelines xiii\u003c\/p\u003e \u003cp\u003eAbbreviations List xv\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 1 Introduction to Deprescribing Psychiatric Medications 1\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eDeprescribing as an Intervention 1\u003c\/p\u003e \u003cp\u003eThe context for deprescribing 2\u003c\/p\u003e \u003cp\u003eWhy deprescribe? 7\u003c\/p\u003e \u003cp\u003eBarriers and facilitators to deprescribing 11\u003c\/p\u003e \u003cp\u003eWithdrawal Effects from Psychiatric Medications 13\u003c\/p\u003e \u003cp\u003eMis-diagnosis of withdrawal effects as relapse 13\u003c\/p\u003e \u003cp\u003ePathophysiology of psychiatric drug withdrawal symptoms 16\u003c\/p\u003e \u003cp\u003eClinical aspects of psychiatric drug withdrawal 19\u003c\/p\u003e \u003cp\u003eSpecific issues in psychiatric drug withdrawal 23\u003c\/p\u003e \u003cp\u003eHow to Deprescribe Psychiatric Medications Safely 27\u003c\/p\u003e \u003cp\u003eThe neurobiology of tapering 28\u003c\/p\u003e \u003cp\u003ePractical options for prescribing gradually tapering doses 36\u003c\/p\u003e \u003cp\u003ePsychological aspects of tapering 43\u003c\/p\u003e \u003cp\u003eTapering psychiatric drugs in practice 45\u003c\/p\u003e \u003cp\u003eFurther topics 52\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 2 Safe Deprescribing of Antidepressants 57\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eWhen and Why to Stop Antidepressants 57\u003c\/p\u003e \u003cp\u003eAdverse effects of antidepressants 66\u003c\/p\u003e \u003cp\u003eDiscussing deprescribing antidepressants with patients 72\u003c\/p\u003e \u003cp\u003eWithdrawal Effects from Antidepressants 76\u003c\/p\u003e \u003cp\u003eRecent developments in the understanding of antidepressant withdrawal 76\u003c\/p\u003e \u003cp\u003ePathophysiology of antidepressant withdrawal symptoms 80\u003c\/p\u003e \u003cp\u003eClinical aspects of antidepressant withdrawal 87\u003c\/p\u003e \u003cp\u003eHow common, severe and long‐ lasting are withdrawal symptoms from antidepressants? 92\u003c\/p\u003e \u003cp\u003eProtracted antidepressant withdrawal syndrome 96\u003c\/p\u003e \u003cp\u003ePost‐ SSRI sexual dysfunction 98\u003c\/p\u003e \u003cp\u003eFactors influencing development of withdrawal effects 99\u003c\/p\u003e \u003cp\u003eStratfiying risk of antidepressant withdrawal 105\u003c\/p\u003e \u003cp\u003eDistinguishing antidepressant withdrawal symptoms from relapse 107\u003c\/p\u003e \u003cp\u003eDistinguishing antidepressant withdrawal symptoms from new onset of a physical or mental health condition 111\u003c\/p\u003e \u003cp\u003eWithdrawal symptoms during antidepressant maintenance treatment or switching medication 113\u003c\/p\u003e \u003cp\u003eHow to Deprescribe Antidepressants Safely 115\u003c\/p\u003e \u003cp\u003eTapering antidepressants gradually 119\u003c\/p\u003e \u003cp\u003eHyperbolic tapering of antidepressants 125\u003c\/p\u003e \u003cp\u003ePractical options in prescribing gradually tapering doses of antidepressants 131\u003c\/p\u003e \u003cp\u003ePsychological aspects of antidepressant tapering 140\u003c\/p\u003e \u003cp\u003eTapering antidepressants in practice 143\u003c\/p\u003e \u003cp\u003eManaging complications of antidepressant discontinuation 153\u003c\/p\u003e \u003cp\u003eTapering Guidance for Specific Antidepressants 158\u003c\/p\u003e \u003cp\u003eAgomelatine 159\u003c\/p\u003e \u003cp\u003eAmitriptyline 163\u003c\/p\u003e \u003cp\u003eBupropion 168\u003c\/p\u003e \u003cp\u003eCitalopram 174\u003c\/p\u003e \u003cp\u003eClomipramine 183\u003c\/p\u003e \u003cp\u003eDesvenlafaxine 188\u003c\/p\u003e \u003cp\u003eDosulepin 193\u003c\/p\u003e \u003cp\u003eDoxepin 198\u003c\/p\u003e \u003cp\u003eDuloxetine 203\u003c\/p\u003e \u003cp\u003eEscitalopram 209\u003c\/p\u003e \u003cp\u003eFluoxetine 216\u003c\/p\u003e \u003cp\u003eFluvoxamine 223\u003c\/p\u003e \u003cp\u003eImipramine 228\u003c\/p\u003e \u003cp\u003eLofepramine 233\u003c\/p\u003e \u003cp\u003eMirtazapine 238\u003c\/p\u003e \u003cp\u003eMoclobemide 243\u003c\/p\u003e \u003cp\u003eNortriptyline 248\u003c\/p\u003e \u003cp\u003eParoxetine 253\u003c\/p\u003e \u003cp\u003ePhenelzine 259\u003c\/p\u003e \u003cp\u003eSertraline 264\u003c\/p\u003e \u003cp\u003eTranylcypromine 270\u003c\/p\u003e \u003cp\u003eTrazodone 275\u003c\/p\u003e \u003cp\u003eVenlafaxine 280\u003c\/p\u003e \u003cp\u003eVilazodone 288\u003c\/p\u003e \u003cp\u003eVortioxetine 292\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 3 Safe Deprescribing of Benzodiazepines and Z-drugs 297\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eWhen and Why to Stop Benzodiazepines and Z-drugs 297\u003c\/p\u003e \u003cp\u003eDiscussing deprescribing benzodiazepines and z-drugs 304\u003c\/p\u003e \u003cp\u003eWithdrawal Symptoms from Benzodiazepines and Z-drugs 309\u003c\/p\u003e \u003cp\u003ePhysical dependence vs addiction in use of benzodiazepines and z-drugs 311\u003c\/p\u003e \u003cp\u003ePathophysiology of benzodiazepine withdrawal syndrome 313\u003c\/p\u003e \u003cp\u003eVariety of withdrawal symptoms from benzodiazepines and z-drugs 316\u003c\/p\u003e \u003cp\u003eProtracted benzodiazepine withdrawal syndrome 320\u003c\/p\u003e \u003cp\u003eDistinguishing benzodiazepine withdrawal symptoms from return of an underlying condition 323\u003c\/p\u003e \u003cp\u003eWithdrawal symptoms during benzodiazepine maintenance treatment 326\u003c\/p\u003e \u003cp\u003eHow to Deprescribe Benzodiazepines and Z-drugs Safely 327\u003c\/p\u003e \u003cp\u003eTapering benzodiazepines and z-drugs gradually 330\u003c\/p\u003e \u003cp\u003eHyperbolic tapering of benzodiazepines and z-drugs 332\u003c\/p\u003e \u003cp\u003eSwitching to longer-acting benzodiazepines to taper 335\u003c\/p\u003e \u003cp\u003eMaking up smaller doses of benzodiazepines and z-drugs practically 338\u003c\/p\u003e \u003cp\u003eOther considerations in tapering benzodiazepines and z-drugs 342\u003c\/p\u003e \u003cp\u003ePsychological aspects of tapering benzodiazepines and z-drugs 345\u003c\/p\u003e \u003cp\u003eTapering benzodiazepines and z-drugs in practice 348\u003c\/p\u003e \u003cp\u003eManagement of complications of benzodiazepine and z-drug discontinuation 358\u003c\/p\u003e \u003cp\u003eTapering Guidance for Specific Benzodiazepines and Z-drugs 362\u003c\/p\u003e \u003cp\u003eAlprazolam 364\u003c\/p\u003e \u003cp\u003eBuspirone 375\u003c\/p\u003e \u003cp\u003eChlordiazepoxide 380\u003c\/p\u003e \u003cp\u003eClonazepam 388\u003c\/p\u003e \u003cp\u003eClorazepate 396\u003c\/p\u003e \u003cp\u003eDiazepam 404\u003c\/p\u003e \u003cp\u003eEstazolam 412\u003c\/p\u003e \u003cp\u003eEszopiclone 418\u003c\/p\u003e \u003cp\u003eFlurazepam 423\u003c\/p\u003e \u003cp\u003eLorazepam 429\u003c\/p\u003e \u003cp\u003eLormetazepam 440\u003c\/p\u003e \u003cp\u003eNitrazepam 446\u003c\/p\u003e \u003cp\u003eOxazepam 452\u003c\/p\u003e \u003cp\u003eQuazepam 461\u003c\/p\u003e \u003cp\u003eTemazepam 467\u003c\/p\u003e \u003cp\u003eTriazolam 474\u003c\/p\u003e \u003cp\u003eZaleplon 480\u003c\/p\u003e \u003cp\u003eZolpidem 485\u003c\/p\u003e \u003cp\u003eZopiclone 490\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 4 Safe Deprescribing of Gabapentinoids 495\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eWhen and Why to Stop Gabapentinoids 495\u003c\/p\u003e \u003cp\u003eDiscussing deprescribing gabapentinoids 504\u003c\/p\u003e \u003cp\u003eOverview of Gabapentinoid Withdrawal Effects 507\u003c\/p\u003e \u003cp\u003ePhysical dependence vs addiction in use of gabapentinoids 510\u003c\/p\u003e \u003cp\u003eHow to Deprescribe Gabapentinoids Safely 512\u003c\/p\u003e \u003cp\u003ePrinciples for tapering gabapentinoids 512\u003c\/p\u003e \u003cp\u003eMaking up smaller doses of gabapentinoids practically 516\u003c\/p\u003e \u003cp\u003eOther considerations in tapering gabapentinoids 520\u003c\/p\u003e \u003cp\u003ePsychological aspects of tapering gabapentinoids 523\u003c\/p\u003e \u003cp\u003eTapering gabapentinoids in practice 525\u003c\/p\u003e \u003cp\u003eManagement of complications of gabapentinoid discontinuation 532\u003c\/p\u003e \u003cp\u003eTapering Guidance for Specific Gabapentinoids 537\u003c\/p\u003e \u003cp\u003eGabapentin 538\u003c\/p\u003e \u003cp\u003ePregabalin 546\u003c\/p\u003e \u003cp\u003eIndex 553\u003c\/p\u003e","brand":"John Wiley and Sons Ltd","offers":[{"title":"Default Title","offer_id":48866418360663,"sku":"9781119822981","price":47.49,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0817\/1739\/5799\/files\/9781119822981.jpg?v=1722278550"},{"product_id":"child-and-adolescent-psychiatry-9781119979685","title":"Child and Adolescent Psychiatry","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003eAn introduction to child psychiatry which draws on clinical experience as well as the latest research findings.   Child Psychiatry includes many practical tips on successful assessment and treatment techniques.\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTrade Review\u003c\/b\u003e\u003cbr\u003e\u003cp\u003e“Overall, this is a great introduction to child and adolescent psychiatry. It provides a general overview and looks at specific diagnoses and treatments, without getting bogged down in too many details, or going beyond the level necessary for the target audience. It is up to date and accurate, and is a helpful update to the previous edition.”  (\u003ci\u003eDoody’s\u003c\/i\u003e, 29 March 2013)\u003c\/p\u003e\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTable of Contents\u003c\/b\u003e\u003cbr\u003e\u003cp\u003eForeword to First Edition vii\u003c\/p\u003e \u003cp\u003eForeword to Third Edition ix\u003c\/p\u003e \u003cp\u003ePreface xi\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart 1 Assessment Classification and Epidemiology  1\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e1 Assessment 1\u003c\/p\u003e \u003cp\u003e2 Classification 22\u003c\/p\u003e \u003cp\u003e3 Epidemiology 31\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart 2 Specific Disorders and Presentations  43\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e4 Autistic Spectrum Disorders 45\u003c\/p\u003e \u003cp\u003e5 Disorders of Attention and Activity 56\u003c\/p\u003e \u003cp\u003e6 Disruptive Behaviour 65\u003c\/p\u003e \u003cp\u003e7 Juvenile Delinquency 79\u003c\/p\u003e \u003cp\u003e8 School Refusal 89\u003c\/p\u003e \u003cp\u003e9 Anxiety Disorders 95\u003c\/p\u003e \u003cp\u003e10 Depression 102\u003c\/p\u003e \u003cp\u003e11 Mania 109\u003c\/p\u003e \u003cp\u003e12 Suicide and Deliberate Self-harm 116\u003c\/p\u003e \u003cp\u003e13 Stress Disorders 123\u003c\/p\u003e \u003cp\u003e14 Obsessive-compulsive Disorder 131\u003c\/p\u003e \u003cp\u003e15 Tourette Syndrome and Other Tic Disorders 136\u003c\/p\u003e \u003cp\u003e16 Selective Mutism 141\u003c\/p\u003e \u003cp\u003e17 Attachment Disorders 145\u003c\/p\u003e \u003cp\u003e18 Enuresis 151\u003c\/p\u003e \u003cp\u003e19 Faecal Soiling 159\u003c\/p\u003e \u003cp\u003e20 Sleep Disorders 163\u003c\/p\u003e \u003cp\u003e21 Psychosomatics 171\u003c\/p\u003e \u003cp\u003e22 Preschool Problems 182\u003c\/p\u003e \u003cp\u003e23 Introduction to Adolescence and Its Disorders 187\u003c\/p\u003e \u003cp\u003e24 Schizophrenia 193\u003c\/p\u003e \u003cp\u003e25 Eating Disorders 199\u003c\/p\u003e \u003cp\u003e26 Substance Use and Abuse 204\u003c\/p\u003e \u003cp\u003e27 Maltreatment 210\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart 3 Risk Factors  227\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e28 Intellectual Disability 229\u003c\/p\u003e \u003cp\u003e29 Brain Disorders 239\u003c\/p\u003e \u003cp\u003e30 Language Disorders 244\u003c\/p\u003e \u003cp\u003e31 Reading Difficulties 250\u003c\/p\u003e \u003cp\u003e32 Insecure Attachment 259\u003c\/p\u003e \u003cp\u003e33 Nature and Nurture 270\u003c\/p\u003e \u003cp\u003e34 Coping with Adversity 282\u003c\/p\u003e \u003cp\u003e35 School and Peer Factors 292\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart 4 Treatment and Services  299\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e36 Intervention: First Principles 301\u003c\/p\u003e \u003cp\u003e37 Prevention 310\u003c\/p\u003e \u003cp\u003e38 Medication and Diet 319\u003c\/p\u003e \u003cp\u003e39 Behaviourally-based Treatments 328\u003c\/p\u003e \u003cp\u003e40 Cognitive Interpersonal and Other Individual Therapies 336\u003c\/p\u003e \u003cp\u003e41 Family and Systemic Therapies 344\u003c\/p\u003e \u003cp\u003e42 Fostering and Adoption 361\u003c\/p\u003e \u003cp\u003e43 Organisation of Services 370\u003c\/p\u003e \u003cp\u003eIndex 381\u003c\/p\u003e","brand":"John Wiley and Sons Ltd","offers":[{"title":"Default Title","offer_id":48866426814807,"sku":"9781119979685","price":44.6,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0817\/1739\/5799\/files\/9781119979685.jpg?v=1722278593"},{"product_id":"pocket-tutor-psychiatry-second-edition-9781909836730","title":"Pocket Tutor Psychiatry: Second Edition","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003e\u003cp\u003eTitles in the \u003cem\u003ePocket Tutor\u003c\/em\u003e series give practical guidance on subjects that medical students and foundation doctors need help with ‘on the go’, at a highly-affordable price that puts them within reach of those rotating through modular courses or working on attachment.  \u003c\/p\u003e  \u003cp\u003e \u003c\/p\u003e  \u003cp\u003eTopics reflect information needs stemming from today’s integrated undergraduate and foundation courses:\u003c\/p\u003e  \u003cul\u003e\n\u003cli\u003eCommon presentations\u003c\/li\u003e\n\u003cli\u003eInvestigation options (e.g. ECG, imaging)\u003c\/li\u003e\n\u003cli\u003eClinical and patient-orientated skills (e.g. examinations, history-taking)\u003c\/li\u003e\n\u003c\/ul\u003e \u003cp\u003e \u003c\/p\u003e  \u003cp\u003eThe highly-structured, bite-size content helps novices combat the ‘fear factor’ associated with day-to-day clinical training, and provides a detailed resource that students and junior doctors can carry in their pocket.   \u003c\/p\u003e  \u003cp\u003e \u003c\/p\u003e  \u003cp\u003e\u003cstrong\u003eKey points\u003c\/strong\u003e\u003c\/p\u003e  \u003cul\u003e\n\u003cli\u003eLogical, sequential content: an introduction to the clinical essentials of psychiatric practice, then chapters devoted to common groups of disorders and clinical issues, e.g. mood disorders, anxiety disorders, child and adolescent psychiatry\u003c\/li\u003e\n\u003cli\u003eFully updated to reflect the new DSM V\u003c\/li\u003e\n\u003cli\u003eAdditional content on old age psychiatry and social care. New chapter on mental health services and legislation\u003c\/li\u003e\n\u003c\/ul\u003e\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTable of Contents\u003c\/b\u003e\u003cbr\u003e\u003cp\u003e\u003cstrong\u003eChapter 1 \u003c\/strong\u003ePsychiatric assessment \u003c\/p\u003e  \u003cp\u003e\u003cstrong\u003eChapter 2 \u003c\/strong\u003eMental health services and legislation\u003c\/p\u003e  \u003cp\u003e\u003cstrong\u003eChapter 3 \u003c\/strong\u003eManagement\u003c\/p\u003e  \u003cp\u003e\u003cstrong\u003eChapter 4 \u003c\/strong\u003eSchizophrenia and other psychoses \u003c\/p\u003e  \u003cp\u003e\u003cstrong\u003eChapter 5 \u003c\/strong\u003eMood disorders and perinatal psychiatric conditions\u003c\/p\u003e  \u003cp\u003e\u003cstrong\u003eChapter 6 \u003c\/strong\u003eSuicide and self-harm \u003c\/p\u003e  \u003cp\u003e\u003cstrong\u003eChapter 7 \u003c\/strong\u003ePersonality disorders \u003c\/p\u003e  \u003cp\u003e\u003cstrong\u003eChapter 8 \u003c\/strong\u003eAnxiety disorders and medically unexplained symptoms \u003c\/p\u003e  \u003cp\u003e\u003cstrong\u003eChapter 9 \u003c\/strong\u003eSubstance misuse \u003c\/p\u003e  \u003cp\u003e\u003cstrong\u003eChapter 10 \u003c\/strong\u003eOld age psychiatry: delirium and dementia \u003c\/p\u003e  \u003cp\u003e\u003cstrong\u003eChapter 11 \u003c\/strong\u003eEating, sleep and sexual disorders \u003c\/p\u003e  \u003cp\u003e\u003cstrong\u003eChapter 12 \u003c\/strong\u003ePsychiatry of intellectual disability \u003c\/p\u003e  \u003cp\u003e\u003cstrong\u003eChapter 13 \u003c\/strong\u003eChild and adolescent psychiatry \u003c\/p\u003e","brand":"JP Medical Ltd","offers":[{"title":"Default Title","offer_id":48868942479703,"sku":"9781909836730","price":999.99,"currency_code":"GBP","in_stock":false}]},{"product_id":"the-traditional-sakkiya-practice-a-public-health-issue-in-northern-nigeria-9781536147636","title":"The Traditional Sakkiya Practice: A Public Health","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003eSakkiya is a Hausa word, which has its origin from the Hausa culture, and it means the act of using hot pointed metallic tip to puncture bodily swelling with the aim of achieving a curative effect. The Hausa culture is one of the three most popular cultures in Nigeria. The Hausas are predominantly located in the northwestern geopolitical zone of Nigeria, predominantly working as farmers. The majority of the Hausa people practice the Islamic religion. Encounters from the medical setting with cases of complications arising from failure of Sakkiya treatment, where some patients did not survive this treatment made investigation into this form of alternative medicine a paramount issue. In order to fill the void of information and literature on Sakkiya treatment, the authors embarked on a literature search and field studies resulting in this book. The authors found a lack of historical evidence concerning the old traditional Sakkiya practice, and therefore urge archaeologists, anthropologists, sociologists and historians to investigate into the historical evolution of Sakkiya practice in northern Nigeria.Kehinde Kanmodi, BDS, ACIPM, AISQEM is a dental surgeon, lecturer, multidisciplinary researcher, and manager affiliated with Cephas Health Research Initiative Inc, Ibadan (head office), Community Health Officers Training Programme, Usmanu Danfodiyo University Teaching Hospital, Sokoto, National Teachers Institute, Department of Political Science of the National Open University of Nigeria, Abuja, Nigerian Institute of Management, Abuja, Chartered Institute of Project Management, Lagos, and Dental Clinic, Kebbi Medical Centre, Kalgo, Nigeria.Joav Merrick, MD, MMedSci, DMSc, born and educated in Denmark is professor of pediatrics, child health and human development affiliated with the Division of Pediatrics, Hadassah Hebrew University Medical Center, Mt Scopus Campus, Jerusalem, Israel, Kentucky Childrens Hospital, University of Kentucky, Lexington, United States and professor of public health at the Center for Healthy Development, School of Public Health, Georgia State University, Atlanta, United States, the former medical director of the Division for Intellectual and Developmental Disabilities, Ministry of Social Affairs and Social Services, Jerusalem and the founder and director of the National Institute of Child Health and Human Development in Israel.","brand":"Nova Science Publishers Inc","offers":[{"title":"Default Title","offer_id":48886110978391,"sku":"9781536147636","price":62.04,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0817\/1739\/5799\/files\/9781536147636.jpg?v=1722538856"},{"product_id":"binge-eating-psychological-factors-symptoms-treatment-9781606922422","title":"Binge Eating: Psychological Factors, Symptoms \u0026","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003eBinge eating disorder (BED) is the most common eating disorder among men and women. This book centres on binge eating, which consists of episodes of uncontrollable overeating, followed by compensatory behaviour (ie: purging, fasting, heavy exercising). People who suffer from this disease often try to hide their binge-eating episodes from others, and often feel ashamed or depressed about their overeating. Many factors may contribute to binge-eating, such as dissociation, which may undermine an individual''s body image, and impulsivity. This book focuses on such factors as well as the frequency with which such behaviours occur in multi-ethnic populations, and the differences in frequency rates as a function of gender and identity. The differences in binge eating and bulimia nervosa behaviours are also explained, as well as the theory that binging on some palatable foods, such as sugar, can result in addictive-like behaviour. The association between emotional abuse in childhood and future binge eating episodes are explained as well as the prevalence of BE episodes in overweight or obese children or adolescents. The effectiveness of certain treatments for binge-eating are described, including cognitive behavioural therapy (CBT), motivational enhancement therapy (MET) and combined treatment.","brand":"Nova Science Publishers Inc","offers":[{"title":"Default Title","offer_id":48886687138135,"sku":"9781606922422","price":999.99,"currency_code":"GBP","in_stock":false}]},{"product_id":"alternative-medicine-yearbook-2010-9781621001324","title":"Alternative Medicine Yearbook 2010","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003e","brand":"Nova Science Publishers Inc","offers":[{"title":"Default Title","offer_id":48886967140695,"sku":"9781621001324","price":212.99,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0817\/1739\/5799\/files\/9781621001324.jpg?v=1722542406"},{"product_id":"abrams-urodynamics-9781118844717","title":"Abrams Urodynamics","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003e\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTable of Contents\u003c\/b\u003e\u003cbr\u003e\u003cp\u003eAbbreviations ix\u003c\/p\u003e \u003cp\u003eContributors xi\u003c\/p\u003e \u003cp\u003ePreface xv\u003c\/p\u003e \u003cp\u003eFirst Foreword xvii\u003c\/p\u003e \u003cp\u003eSecond Foreword xix\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart I Basic Principles 1\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e1. Basic Urodynamics and Fundamental Issues 3\u003cbr\u003e\u003ci\u003eMarcus Drake, Andrew Gammie, Laura Thomas, Arturo García-Mora, and Hashim Hashim\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e2. Applied Anatomy and Physiology 24\u003cbr\u003e\u003ci\u003eChendrimada Madhu and Marcus Drake\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e3. The Physics of Urodynamic Measurements 45\u003cbr\u003e\u003ci\u003eAndrew Gammie\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart II Functional Urology \u003c\/b\u003e\u003cb\u003e53\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e4. Patient Assessment 55\u003cbr\u003e\u003ci\u003eMusaab Yassin, Alan Uren, and Nikki Cotterill\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e5. Treatments for Lower Urinary Tract Dysfunction 73\u003cbr\u003e\u003ci\u003eSharon Yeo and Hashim Hashim\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart III Urodynamic Techniques \u003c\/b\u003e\u003cb\u003e93\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e6. Uroflowmetry 95\u003cbr\u003e\u003ci\u003eAmit Mevcha and Richard Napier-Hemy\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e7. Cystometry and Pressure-Flow Studies 109\u003cbr\u003e\u003ci\u003eMarcus Drake, Rachel Tindle, and Su-Min Lee\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e8. Video Urodynamics 158\u003cbr\u003e\u003ci\u003eMarcus Drake, Michelle Ong, Devang Desai, Michel Wyndaele, Mark Woodward, and Hashim Hashim\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e9. Ambulatory Urodynamics 193\u003cbr\u003e\u003ci\u003eJulie Ellis-Jones and Wendy Bevan\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e10. Studies Assessing Urethral Pressures 199\u003cbr\u003e\u003ci\u003eDharmesh Kapoor and Marcus Drake\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e11. Non-invasive Urodynamics 217\u003cbr\u003e\u003ci\u003eAlison Bray, Christopher Blake, and Christopher Harding\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart IV Urodynamics in Clinical Practice \u003c\/b\u003e\u003cb\u003e227\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e12. Urodynamics in Children 229\u003cbr\u003e\u003ci\u003eJonathan S. Ellison, Guy Nicholls, and Mark Woodward\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e13. Urodynamics in Women 242\u003cbr\u003e\u003ci\u003eWael Agur, Ruben Trochez, Antonin Prouza, George Kasyan, and Abdelmageed Abdelrahman\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e14. Urodynamics in Men 273\u003cbr\u003e\u003ci\u003eArturo García-Mora, Connie Chew, and Marcus Drake\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e15. Structural Changes of the Bladder Outlet 301\u003cbr\u003e\u003ci\u003eMichelle Ong, Marcus Drake, and Devang Desai\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e16. Neurological Disease and LUTS 313\u003cbr\u003e\u003ci\u003eMarcus Drake, Jeremy Nettleton, and Mohammed Belal\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e17. Urodynamics in Older People 360\u003cbr\u003e\u003ci\u003eSu-Min Lee and Emily Henderson\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart V Running a Urodynamics Unit \u003c\/b\u003e\u003cb\u003e369\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e18. Troubleshooting During Urodynamics 371\u003cbr\u003e\u003ci\u003eLaura Thomas, Rachel Tindle, and Andrew Gammie\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e19. Artefacts in Urodynamics 383\u003cbr\u003e\u003ci\u003eAndrew Gammie\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e20. Anorectal Physiology 394\u003cbr\u003e\u003ci\u003eLaura Thomas and Kathryn McCarthy\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e21. Organisation of the Urodynamic Unit 406\u003cbr\u003e\u003ci\u003eLaura Thomas, Alexandra Bacon, Joanne Sheen, and Andrew Gammie\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e22. Equipment 412\u003cbr\u003e\u003ci\u003eAndrew Gammie\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e23. Working with Limited Resources 415\u003cbr\u003e\u003ci\u003eAndrew Gammie, Laura Thomas, Marcus Drake, and Eskinder Solomon\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e24. Research Evidence on the Clinical Role of Urodynamics 420\u003cbr\u003e\u003ci\u003eAndrew Gammie, Marcus Drake, and Hashim Hashim\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eAppendices\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eKey Patient Assessment Tools from the International Consultation on Incontinence Questionnaires (ICIQ) \u003c\/b\u003e\u003cb\u003e423\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eICIQ-FLUTS 423\u003c\/p\u003e \u003cp\u003eICIQ-MLUTS 427\u003c\/p\u003e \u003cp\u003eICIQ-BD 432\u003c\/p\u003e \u003cp\u003e\u003cb\u003eFundamentals Documents from the International Continence Society \u003c\/b\u003e\u003cb\u003e434\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eN\u0026amp;U 2018 Volume 37 Supplement 6 434\u003c\/p\u003e \u003cp\u003eEditorial Comment 439\u003c\/p\u003e \u003cp\u003eA Commentary on Expectations of Healthcare Professionals When Applying the International Continence Society Standards to Basic Assessment of Lower Urinary Tract Function 440\u003c\/p\u003e \u003cp\u003eFundamentals of Terminology in Lower Urinary Tract Function 446\u003c\/p\u003e \u003cp\u003eBasic Concepts in Nocturia, Based on International Continence Society Standards in Nocturnal Lower Urinary Tract Function 453\u003c\/p\u003e \u003cp\u003eNeurological Lower Urinary Tract Dysfunction Essential Terminology 458\u003c\/p\u003e \u003cp\u003eThe Fundamentals of Chronic Pelvic Pain Assessment, Based on International Continence Society Recommendations 465\u003c\/p\u003e \u003cp\u003eHow to Use the Pelvic Organ Prolapse Quantification (POP-Q) system? 472\u003c\/p\u003e \u003cp\u003eThe Fundamentals of Uroflowmetry Practice, Based on International Continence Society Good Urodynamic Practices Recommendations 477\u003c\/p\u003e \u003cp\u003eFundamentals of Urodynamic Practice, Based on International Continence Society Good Urodynamic Practices Recommendations 483\u003c\/p\u003e \u003cp\u003eBasics of Videourodynamics for Adult Patients With Lower Urinary Tract Dysfunction 494\u003c\/p\u003e \u003cp\u003eWhy ICS Standardization of Lower Urinary Tract Symptoms Matters 500\u003c\/p\u003e \u003cp\u003eCritical Steps in Developing Professional Standards for the International Continence Society 502\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePatient Information Leaflets from the Bristol Urological Institute \u003c\/b\u003e\u003cb\u003e508\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eFree Flow Rate Testing 508\u003c\/p\u003e \u003cp\u003eUrodynamics 515\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePractice, Standards, and Equipment Recommendations \u003c\/b\u003e\u003cb\u003e530\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eInternational Consultation on Incontinence 2016; Executive Summary: Urodynamic Testing 531\u003c\/p\u003e \u003cp\u003eUnited Kingdom Continence Society: Minimum Standards for Urodynamic Studies, 2018 539\u003c\/p\u003e \u003cp\u003eUK Centre for Evidence-Based Purchasing; Buyers’ Guide Urodynamics Systems 571\u003c\/p\u003e \u003cp\u003eInternational Continence Society Good Urodynamic Practices and Terms 2016: Urodynamics, uroflowmertry, cystometry, and pressure-flow study 578\u003c\/p\u003e \u003cp\u003eGood Urodynamic Practices Documents from the International Continence Society 595\u003c\/p\u003e \u003cp\u003eGood Urodynamic Practices: Uroflowmetry, Filling Cystometry, and Pressure-Flow Studies 596\u003c\/p\u003e \u003cp\u003eIndex 610\u003c\/p\u003e","brand":"John Wiley and Sons Ltd","offers":[{"title":"Default Title","offer_id":49083839381847,"sku":"9781118844717","price":49.35,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0817\/1739\/5799\/files\/9781118844717.jpg?v=1725550179"},{"product_id":"professional-responsibility-in-dentistry-9781119830061","title":"Professional Responsibility in Dentistry","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003ePROFESSIONAL RESPONSIBILITY IN DENTISTRY Concise guide to practical information on dental law, ethics, and practice management, all tailored to any dental practice  Professional Responsibility in Dentistry, Second Edition is a clinically oriented guide to legal and ethical requirements in a dental practice. This thoroughly revised new edition takes a practical approach, providing examples and case studies of situations that dentists may face, with discussions of dental law, risk management, professionalism, and ethics as they relate to each situation.  Divided into four sections to allow for comprehensive and accessible coverage of the subject, the Second Edition adds new chapters on taking practices to the next level and how to read a profit and loss statement, as well as offering updates and new information throughout.  Professional Responsibility in Dentistry provides key information on:   Lawsuits, including the effects of losing one, the regulation of dentistry, and definitions of\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTable of Contents\u003c\/b\u003e\u003cbr\u003e\u003cp\u003eContents\u003c\/p\u003e \u003cp\u003ePreface xi\u003c\/p\u003e \u003cp\u003eAcknowledgments xiii\u003c\/p\u003e \u003cp\u003eAbout the Author xiv\u003c\/p\u003e \u003cp\u003ePart I Legal Concepts 1\u003c\/p\u003e \u003cp\u003e1 The Lawsuit 3\u003c\/p\u003e \u003cp\u003eTrue Case 1: Miscarriage due to endodontics 3\u003c\/p\u003e \u003cp\u003eThe Complaint 3\u003c\/p\u003e \u003cp\u003eTrue Case 2: Changing the chart 4\u003c\/p\u003e \u003cp\u003eTrue Case 3: Saving the case for trial 5\u003c\/p\u003e \u003cp\u003eExamination before Trial 5\u003c\/p\u003e \u003cp\u003eThe Results 6\u003c\/p\u003e \u003cp\u003eReferences 7\u003c\/p\u003e \u003cp\u003e2 The Regulation of Dentistry 8\u003c\/p\u003e \u003cp\u003eTrue Case 4: Dental state board case of fractured porcelain 9\u003c\/p\u003e \u003cp\u003eFederal Oversight 10\u003c\/p\u003e \u003cp\u003eOSHA 10\u003c\/p\u003e \u003cp\u003eTrue Case 5: OSHA 12\u003c\/p\u003e \u003cp\u003eFDA\/DEA\/EPA 12\u003c\/p\u003e \u003cp\u003eNPDB 13\u003c\/p\u003e \u003cp\u003eHIPAA 13\u003c\/p\u003e \u003cp\u003eTrue Case 6: Ransomware 15\u003c\/p\u003e \u003cp\u003eTCPA 16\u003c\/p\u003e \u003cp\u003eTrue Case 7: Unsolicited texts 16\u003c\/p\u003e \u003cp\u003eLicensure 17\u003c\/p\u003e \u003cp\u003eContinuing Education 17\u003c\/p\u003e \u003cp\u003eI-Stop (Internet System for Tracking Over-Prescribing) 18\u003c\/p\u003e \u003cp\u003ePermits 18\u003c\/p\u003e \u003cp\u003eProfessional Misconduct and Unprofessional Conduct 19\u003c\/p\u003e \u003cp\u003eTrue Case 8: Forfeit of license 20\u003c\/p\u003e \u003cp\u003eTrue Case 9: Lost his license 20\u003c\/p\u003e \u003cp\u003eAuxiliary Personnel 20\u003c\/p\u003e \u003cp\u003eTrue Case 10: Assistant extracted tooth 21\u003c\/p\u003e \u003cp\u003eAdvertising 22\u003c\/p\u003e \u003cp\u003eTrue Case 11: Dental society denial 23\u003c\/p\u003e \u003cp\u003eFederal False Claims Act 23\u003c\/p\u003e \u003cp\u003eTrue Case 12: Fraudulent billing 24\u003c\/p\u003e \u003cp\u003eReferences 25\u003c\/p\u003e \u003cp\u003e3 Definitions and Legal Concepts 27\u003c\/p\u003e \u003cp\u003eNegligence 27\u003c\/p\u003e \u003cp\u003eTrue Case 13: Amalgam tattoo – melanoma 28\u003c\/p\u003e \u003cp\u003eTrue Case 14: Divorce due to paresthesia 29\u003c\/p\u003e \u003cp\u003eTrue Case 15 (True Case 1 Revisited): Lawsuit due to dentist’s criticism 29\u003c\/p\u003e \u003cp\u003eDefinitions 29\u003c\/p\u003e \u003cp\u003eTrue Case 16: Tennessee case Tolliver v. Gamble 32\u003c\/p\u003e \u003cp\u003eReferences 32\u003c\/p\u003e \u003cp\u003ePart II The Practice of Dentistry 33\u003c\/p\u003e \u003cp\u003e4 The Doctor–Patient Relationship 35\u003c\/p\u003e \u003cp\u003eBasis for Relationship 35\u003c\/p\u003e \u003cp\u003eTrue Case 17: Food for fillings 35\u003c\/p\u003e \u003cp\u003eFiduciary Duty 36\u003c\/p\u003e \u003cp\u003eTypes of Realtionships 36\u003c\/p\u003e \u003cp\u003eWhen Does It Begin 37\u003c\/p\u003e \u003cp\u003eDuties of Doctor and Patient 37\u003c\/p\u003e \u003cp\u003ePatient Relationships 38\u003c\/p\u003e \u003cp\u003eWhen Does It End 39\u003c\/p\u003e \u003cp\u003eTrue Case 18: No pay, no crown 39\u003c\/p\u003e \u003cp\u003eReferences 39\u003c\/p\u003e \u003cp\u003e5 May You Refuse to Treat? 40\u003c\/p\u003e \u003cp\u003ePandemics (COVID-19) 41\u003c\/p\u003e \u003cp\u003eTrue Case 19: Patient demand 41\u003c\/p\u003e \u003cp\u003eReferences 41\u003c\/p\u003e \u003cp\u003e6 The Medical–Dental History 42\u003c\/p\u003e \u003cp\u003eTrue Case 20: Only Boniva 42\u003c\/p\u003e \u003cp\u003eOther Needed Information 43\u003c\/p\u003e \u003cp\u003eTrue Case 21: Only heart surgery 44\u003c\/p\u003e \u003cp\u003eBarriers 44\u003c\/p\u003e \u003cp\u003eReference 44\u003c\/p\u003e \u003cp\u003e7 Patient Abuse 45\u003c\/p\u003e \u003cp\u003eDefinitions 45\u003c\/p\u003e \u003cp\u003eReporting Child Abuse 46\u003c\/p\u003e \u003cp\u003eTrue Case 22: Child neglect 47\u003c\/p\u003e \u003cp\u003eElder Abuse 47\u003c\/p\u003e \u003cp\u003eSigns of Abuse 48\u003c\/p\u003e \u003cp\u003eFailure to Report Patient Abuse 48\u003c\/p\u003e \u003cp\u003eDomestic Partner Abuse 49\u003c\/p\u003e \u003cp\u003eReferences 49\u003c\/p\u003e \u003cp\u003e8 Informed Consent 50\u003c\/p\u003e \u003cp\u003eWhat Needs to Be Done 50\u003c\/p\u003e \u003cp\u003eTrue Case 23: Implants include the teeth 51\u003c\/p\u003e \u003cp\u003eInformation Needed 51\u003c\/p\u003e \u003cp\u003eConsent 52\u003c\/p\u003e \u003cp\u003eTrue Case 24: Signed consent? Forgery 53\u003c\/p\u003e \u003cp\u003eCompetency 53\u003c\/p\u003e \u003cp\u003eTrue Case 25: Two for one 54\u003c\/p\u003e \u003cp\u003eExceptions 55\u003c\/p\u003e \u003cp\u003eTrue Case 26: Teenage pregnancy 55\u003c\/p\u003e \u003cp\u003eTypes of Consent 55\u003c\/p\u003e \u003cp\u003eTrue Case 27: Lawyer threatens: write off patient’s balance or be sued 56\u003c\/p\u003e \u003cp\u003eReferences 57\u003c\/p\u003e \u003cp\u003e9 Records 58\u003c\/p\u003e \u003cp\u003eTrue Case 28: $300,000 Night Guard 58\u003c\/p\u003e \u003cp\u003eRecord Entries 59\u003c\/p\u003e \u003cp\u003eElectronic Records 60\u003c\/p\u003e \u003cp\u003eTrue Case 29: Corporate greed 61\u003c\/p\u003e \u003cp\u003eRelease of Records 62\u003c\/p\u003e \u003cp\u003eTexting 63\u003c\/p\u003e \u003cp\u003eTeledentistry 64\u003c\/p\u003e \u003cp\u003eHIPAA 64\u003c\/p\u003e \u003cp\u003eRetention of Records 65\u003c\/p\u003e \u003cp\u003eReferences 65\u003c\/p\u003e \u003cp\u003e10 Statute of Limitations 67\u003c\/p\u003e \u003cp\u003eWhen to Tell the Patient 67\u003c\/p\u003e \u003cp\u003eExceptions 68\u003c\/p\u003e \u003cp\u003eTrue Case 30: Never fitting denture 68\u003c\/p\u003e \u003cp\u003eReference 69\u003c\/p\u003e \u003cp\u003e11 Abandonment 70\u003c\/p\u003e \u003cp\u003eTypes of Abandonment 70\u003c\/p\u003e \u003cp\u003eAvoiding Abandonment 71\u003c\/p\u003e \u003cp\u003eTrue Case 31: No Money – No Teeth 71\u003c\/p\u003e \u003cp\u003eProper Termination 72\u003c\/p\u003e \u003cp\u003eRelease of All Claims\/Anti-defamation Clauses 73\u003c\/p\u003e \u003cp\u003eTrue Case 32: Patient outsmarts dentist 73\u003c\/p\u003e \u003cp\u003eReferences 73\u003c\/p\u003e \u003cp\u003e12 Standard of Care 75\u003c\/p\u003e \u003cp\u003eHow It Began 75\u003c\/p\u003e \u003cp\u003eChallenges 81\u003c\/p\u003e \u003cp\u003eReferences 81\u003c\/p\u003e \u003cp\u003e13 Peer Review 83\u003c\/p\u003e \u003cp\u003eTrue Case 33: Peer review 84\u003c\/p\u003e \u003cp\u003eReferences 84\u003c\/p\u003e \u003cp\u003e14 Risk Management 85\u003c\/p\u003e \u003cp\u003eTrue Case 34: Too many “near misses” 86\u003c\/p\u003e \u003cp\u003eThe Dos and Don’ts of Risk Management 87\u003c\/p\u003e \u003cp\u003eCollections 90\u003c\/p\u003e \u003cp\u003eIf You Are Sued 91\u003c\/p\u003e \u003cp\u003eTrue Case 35: (True Case 6 revisited): Dentist leaves state 91\u003c\/p\u003e \u003cp\u003eTrue Case 36: (True Case 2 revisited): Changing the chart 92\u003c\/p\u003e \u003cp\u003ePractice Enhancement Through Risk Management 93\u003c\/p\u003e \u003cp\u003eTrue Case 37: Who knows what is going on? 94\u003c\/p\u003e \u003cp\u003eThe Examination 94\u003c\/p\u003e \u003cp\u003eReferences 97\u003c\/p\u003e \u003cp\u003e15 Employees and Associates 98\u003c\/p\u003e \u003cp\u003eHiring and Firing 99\u003c\/p\u003e \u003cp\u003eTrue Case 38: Extra-long vacation 99\u003c\/p\u003e \u003cp\u003eUnemployment 100\u003c\/p\u003e \u003cp\u003eTrue Case 39: Just eight hours count 100\u003c\/p\u003e \u003cp\u003eStaff Snafus\/Problems 101\u003c\/p\u003e \u003cp\u003eTrue Case 40: Embezzlement 101\u003c\/p\u003e \u003cp\u003eHarassment 102\u003c\/p\u003e \u003cp\u003eTrue Case 41: Looks too good 102\u003c\/p\u003e \u003cp\u003eReferences 102\u003c\/p\u003e \u003cp\u003ePart III Professionalism and Ethics 103\u003c\/p\u003e \u003cp\u003e16 Professionalism 105\u003c\/p\u003e \u003cp\u003eProfessional Obligations 105\u003c\/p\u003e \u003cp\u003eLearning Professionalism 107\u003c\/p\u003e \u003cp\u003eProfessionalism Boundaries 108\u003c\/p\u003e \u003cp\u003eLeadership 109\u003c\/p\u003e \u003cp\u003eReferences 110\u003c\/p\u003e \u003cp\u003e17 Ethics 112\u003c\/p\u003e \u003cp\u003eCode of Ethics 113\u003c\/p\u003e \u003cp\u003eTrue Case 42: Patient doesn’t want referral 114\u003c\/p\u003e \u003cp\u003eTrue Case 43: I don’t want my teeth 114\u003c\/p\u003e \u003cp\u003eTrue Case 44: Fractured porcelain 117\u003c\/p\u003e \u003cp\u003eTeaching Dental Ethics 117\u003c\/p\u003e \u003cp\u003eTrue Case 45: No pay, no treatment 118\u003c\/p\u003e \u003cp\u003eEthical Challenges 118\u003c\/p\u003e \u003cp\u003eDecision Making 119\u003c\/p\u003e \u003cp\u003eReferences 119\u003c\/p\u003e \u003cp\u003e18 Professional Ethical Situations Based on True Cases 121\u003c\/p\u003e \u003cp\u003ePart IV New Dentist Issues 125\u003c\/p\u003e \u003cp\u003e19 Associateships 127\u003c\/p\u003e \u003cp\u003eNoncompete\/Restrictive Convenants 128\u003c\/p\u003e \u003cp\u003eTrue Case 46: Dentist reopened next door 129\u003c\/p\u003e \u003cp\u003eTrue Case 47: Dentist takes all patient records to new office 129\u003c\/p\u003e \u003cp\u003eTrade Secrets 129\u003c\/p\u003e \u003cp\u003eCompensation 130\u003c\/p\u003e \u003cp\u003eTrue Case 48: Buy what you built? 131\u003c\/p\u003e \u003cp\u003eTrue Case 49: Earn your pay 131\u003c\/p\u003e \u003cp\u003eDental Service Organization (DSO) 132\u003c\/p\u003e \u003cp\u003eReferences 133\u003c\/p\u003e \u003cp\u003e20 Starting or Buying a Practice 134\u003c\/p\u003e \u003cp\u003eTrue Case 50: Do you see me now? 134\u003c\/p\u003e \u003cp\u003eLocation 134\u003c\/p\u003e \u003cp\u003eTrue Case 51: You can run but you can’t hide 135\u003c\/p\u003e \u003cp\u003eTransfer\/Setup Considerations 135\u003c\/p\u003e \u003cp\u003eTrue Case 52: Poof! You’re moving 137\u003c\/p\u003e \u003cp\u003eShow Me the Money 137\u003c\/p\u003e \u003cp\u003eTrue Case 53: Bankrupt 138\u003c\/p\u003e \u003cp\u003eBalance Sheet and Profit and Loss 139\u003c\/p\u003e \u003cp\u003eInsurance Needed 141\u003c\/p\u003e \u003cp\u003eReferences 143\u003c\/p\u003e \u003cp\u003e21 Marketing for a Successful Practice 144\u003c\/p\u003e \u003cp\u003eEthical Advertising 145\u003c\/p\u003e \u003cp\u003eCompetition for Patients 148\u003c\/p\u003e \u003cp\u003eFee Splitting 149\u003c\/p\u003e \u003cp\u003eTrue Case 54: Keeping it in the family 149\u003c\/p\u003e \u003cp\u003eThe Logo 150\u003c\/p\u003e \u003cp\u003eTrue Case 55: Keep the patients coming 150\u003c\/p\u003e \u003cp\u003ePreferred Provider Organization (PPO) 150\u003c\/p\u003e \u003cp\u003eTrue Case 56: Insurance company approves treatment but then doesn’t pay 152\u003c\/p\u003e \u003cp\u003eCollections 153\u003c\/p\u003e \u003cp\u003eReferences 154\u003c\/p\u003e \u003cp\u003e22 Social Media 156\u003c\/p\u003e \u003cp\u003eTypes and Characterizations of Social Media 156\u003c\/p\u003e \u003cp\u003eYou Posted It, You Own It 157\u003c\/p\u003e \u003cp\u003eTrue Case 57: Can’t stop you from posting it 158\u003c\/p\u003e \u003cp\u003eTrue Case 58: Oh yes I can stop you from posting it 158\u003c\/p\u003e \u003cp\u003eIs It Working? 158\u003c\/p\u003e \u003cp\u003eReferences 159\u003c\/p\u003e \u003cp\u003e23 Co-diagnosing and Gaining the Patient’s Trust 160\u003c\/p\u003e \u003cp\u003eTypes of Patients 160\u003c\/p\u003e \u003cp\u003eMaking the Appointment 161\u003c\/p\u003e \u003cp\u003ePatient Motivation 161\u003c\/p\u003e \u003cp\u003eTrue case 59: Denture time 162\u003c\/p\u003e \u003cp\u003eCo-diagnosing With the Patient 162\u003c\/p\u003e \u003cp\u003eReference 164\u003c\/p\u003e \u003cp\u003e24 Employee Management 165\u003c\/p\u003e \u003cp\u003eTrue Case 60: Please believe me 166\u003c\/p\u003e \u003cp\u003eTesting the Waters 166\u003c\/p\u003e \u003cp\u003eOffice Culture Integration 166\u003c\/p\u003e \u003cp\u003eThe Paperwork 168\u003c\/p\u003e \u003cp\u003eTrue Case 61: Dr. Chadwick v. Board of Registration in Dentistry (MASS) 168\u003c\/p\u003e \u003cp\u003eEvaluation and Appreciation 168\u003c\/p\u003e \u003cp\u003eReference 171\u003c\/p\u003e \u003cp\u003e25 Multispecialty Practice 172\u003c\/p\u003e \u003cp\u003eThe Set Up 172\u003c\/p\u003e \u003cp\u003eWho’s Next 173\u003c\/p\u003e \u003cp\u003eTrue Case 62: I want to pay more 174\u003c\/p\u003e \u003cp\u003eShow Me the Money 174\u003c\/p\u003e \u003cp\u003e26 Forms 177\u003c\/p\u003e \u003cp\u003eGeneral Release for Dental Treatment 177\u003c\/p\u003e \u003cp\u003eConsent for Pulpal Debridement and Endodontic Treatment 178\u003c\/p\u003e \u003cp\u003eConsent for Oral Surgery 179\u003c\/p\u003e \u003cp\u003eConsent for Periodontal Surgery 180\u003c\/p\u003e \u003cp\u003eGeneral Consent for Surgical and Invasive Procedures 181\u003c\/p\u003e \u003cp\u003eRefusal of Treatment \/ Referral 182\u003c\/p\u003e \u003cp\u003eTermination Letter 183\u003c\/p\u003e \u003cp\u003eWhat You Should Know about Financing Your Dental Treatment 184\u003c\/p\u003e \u003cp\u003eAuthorization for Release of Dental Records 185\u003c\/p\u003e \u003cp\u003ePhotography Authorization 186\u003c\/p\u003e \u003cp\u003eRelease of All Claims 187\u003c\/p\u003e \u003cp\u003eAnti-defamation Clause 188\u003c\/p\u003e \u003cp\u003eEpidemic\/Pandemic Dental Treatment Information Form 189\u003c\/p\u003e \u003cp\u003eIndex 190\u003c\/p\u003e","brand":"John Wiley and Sons Ltd","offers":[{"title":"Default Title","offer_id":49083840659799,"sku":"9781119830061","price":52.2,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0817\/1739\/5799\/files\/9781119830061.jpg?v=1725550185"},{"product_id":"the-psychiatric-interview-9781119976233","title":"The Psychiatric Interview","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003eThe American Board of Psychiatry and Neurology and the Accrediting Council on Graduate Medical Education identify interviewing skills as a core competency for psychiatric residents. This title offers an approach to this topic that fulfills the need for training in biopsychosocial assessment and diagnosis.\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTrade Review\u003c\/b\u003e\u003cbr\u003e\u003cp\u003e“This book is not only a first rate introduction for psychiatric residents and medical students interested in psychiatry but arguably should be a mandatory reading for all medical students given the importance of general interviewing skills, the prominence of psychiatric issues throughout medicine, and the importance of the techniques presented for building the foundations of the physician-patient relationship.”  (\u003ci\u003eJournal of Nervous and Mental Disease\u003c\/i\u003e, 1 December 2014)\u003c\/p\u003e\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTable of Contents\u003c\/b\u003e\u003cbr\u003e\u003cp\u003e\u003ci\u003eContributors ix\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003ci\u003ePreface xi\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003ci\u003eAcknowledgments xiii\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 1 Listening to the Patient 1\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eListening: The Key Skill in Psychiatry 1\u003c\/p\u003e \u003cp\u003eThe Primary Tools: Words, Analogies, Metaphors, Similes, and Symbols 3\u003c\/p\u003e \u003cp\u003eHow Does One Hear Words in This Way? 4\u003c\/p\u003e \u003cp\u003eListening as More Than Hearing 6\u003c\/p\u003e \u003cp\u003eCommon Blocks to Effective Listening 7\u003c\/p\u003e \u003cp\u003eCrucial Attitudes That Enable Effective Listening 10\u003c\/p\u003e \u003cp\u003eTheoretical Perspectives on Listening 14\u003c\/p\u003e \u003cp\u003eUsing Oneself in Listening 16\u003c\/p\u003e \u003cp\u003eTo Be Found: The Psychological Product of Being Heard 18\u003c\/p\u003e \u003cp\u003eListening to Oneself to Listen Better 20\u003c\/p\u003e \u003cp\u003eListening in Special Clinical Situations 23\u003c\/p\u003e \u003cp\u003eGrowing and Maturing as a Listener 26\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 2 Physician–Patient Relationship 31\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eFormation of the Physician–Patient Relationship 34\u003c\/p\u003e \u003cp\u003eSpecial Issues in the Physician–Patient Relationship 42\u003c\/p\u003e \u003cp\u003eThe Physician–Patient Relationship in Specific Populations of Patients 44\u003c\/p\u003e \u003cp\u003eConclusion 46\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 3 The Cultural Context of Clinical Assessment 47\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eIntroduction: The Cultural Matrix of Psychiatry 47\u003c\/p\u003e \u003cp\u003eWhat Is Culture? 48\u003c\/p\u003e \u003cp\u003eCulture and Gender 50\u003c\/p\u003e \u003cp\u003eThe Cultural Formulation 51\u003c\/p\u003e \u003cp\u003eEthnocultural Identity 52\u003c\/p\u003e \u003cp\u003eIllness Explanations and Help-Seeking 53\u003c\/p\u003e \u003cp\u003ePsychosocial Environment and Levels of Functioning 55\u003c\/p\u003e \u003cp\u003eClinician–Patient Relationship 56\u003c\/p\u003e \u003cp\u003eOverall Assessment 57\u003c\/p\u003e \u003cp\u003eCultural Competence 57\u003c\/p\u003e \u003cp\u003eWorking with Interpreters and Culture-Brokers 60\u003c\/p\u003e \u003cp\u003eConclusion: The Limits of Culture 62\u003c\/p\u003e \u003cp\u003eChapter 4 The Psychiatric Interview: Settings and Techniques 65\u003c\/p\u003e \u003cp\u003eGoals of the Psychiatric Interview 66\u003c\/p\u003e \u003cp\u003eThe Psychiatric Database 75\u003c\/p\u003e \u003cp\u003eDatabase Components 77\u003c\/p\u003e \u003cp\u003eMental Status Examination 81\u003c\/p\u003e \u003cp\u003eConduct of the Interview: Factors That Affect the Interview 83\u003c\/p\u003e \u003cp\u003eGeneral Features of Psychiatric Interviews 85\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 5 Psychiatric Interviews: Special Populations 103\u003c\/b\u003e\u003cbr\u003e \u003ci\u003eRandon Welton and Jerald Kay\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003ePsychiatric Interview in Special Circumstances 104\u003c\/p\u003e \u003cp\u003ePsychiatric Interview in Special Patient Populations 115\u003c\/p\u003e \u003cp\u003eConclusions 131\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 6 Formulation 135\u003c\/b\u003e\u003cbr\u003e \u003ci\u003eAllison Cowan, Randon Welton and Jerald Kay\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eBiological Contributions 136\u003c\/p\u003e \u003cp\u003eSocial Factors 138\u003c\/p\u003e \u003cp\u003ePsychological Factors 140\u003c\/p\u003e \u003cp\u003eSummary 146\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 7 Clinical Evaluation and Treatment Planning: A Multimodal Approach 147\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003ePsychiatric Interview 147\u003c\/p\u003e \u003cp\u003eIdentifying Information 149\u003c\/p\u003e \u003cp\u003eChief Complaint 149\u003c\/p\u003e \u003cp\u003eHistory of Present Illness 150\u003c\/p\u003e \u003cp\u003ePast Psychiatric History 150\u003c\/p\u003e \u003cp\u003ePersonal History 150\u003c\/p\u003e \u003cp\u003eFamily History 151\u003c\/p\u003e \u003cp\u003eMedical History 152\u003c\/p\u003e \u003cp\u003eSubstance Use History 152\u003c\/p\u003e \u003cp\u003eMental Status Examination 153\u003c\/p\u003e \u003cp\u003ePhysical Examination 157\u003c\/p\u003e \u003cp\u003eNeurological Examination 158\u003c\/p\u003e \u003cp\u003ePsychological and Neuropsychological Testing 159\u003c\/p\u003e \u003cp\u003eStructured Clinical Instruments and Rating Scales 159\u003c\/p\u003e \u003cp\u003eLaboratory Assessments 159\u003c\/p\u003e \u003cp\u003eNeurophysiologic Assessment 159\u003c\/p\u003e \u003cp\u003eBrain Imaging 162\u003c\/p\u003e \u003cp\u003eSpecial Assessment Techniques 163\u003c\/p\u003e \u003cp\u003eAssessment of Risk 164\u003c\/p\u003e \u003cp\u003eSuicide Risk 164\u003c\/p\u003e \u003cp\u003eDifferential Diagnosis 167\u003c\/p\u003e \u003cp\u003eInitial Treatment Plan 170\u003c\/p\u003e \u003cp\u003eConclusion 171\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 8 Professional Ethics and Boundaries 173\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 173\u003c\/p\u003e \u003cp\u003eEthical Behavior and Its Relationship to the Professional Attitude 174\u003c\/p\u003e \u003cp\u003eWPA Guidelines on Euthanasia 176\u003c\/p\u003e \u003cp\u003eWPA Guidelines on Torture 177\u003c\/p\u003e \u003cp\u003eWPA Guidelines on Sex Selection 177\u003c\/p\u003e \u003cp\u003eWPA Guidelines on Organ Transplantation 177\u003c\/p\u003e \u003cp\u003eWPA Guidelines on Genetic Research and Counseling in Psychiatric Patients 177\u003c\/p\u003e \u003cp\u003eWPA Guidelines on Ethnic Discrimination and Ethnic Cleansing 178\u003c\/p\u003e \u003cp\u003eWPA Guidelines on Psychiatrists Addressing the Media 178\u003c\/p\u003e \u003cp\u003eThe Coherent Treatment Frame and the Role of Therapeutic Boundaries in Effective Psychiatric Treatment 178\u003c\/p\u003e \u003cp\u003eBoundary Violations 179\u003c\/p\u003e \u003cp\u003eComponents of the Coherent Psychiatric Frame 180\u003c\/p\u003e \u003cp\u003eStability 181\u003c\/p\u003e \u003cp\u003eAvoiding Dual Relationships 182\u003c\/p\u003e \u003cp\u003eAutonomy and Neutrality 183\u003c\/p\u003e \u003cp\u003eCoherent and Noncollusive Compensation 183\u003c\/p\u003e \u003cp\u003eConfidentiality 184\u003c\/p\u003e \u003cp\u003eAnonymity 184\u003c\/p\u003e \u003cp\u003eAbstinence 185\u003c\/p\u003e \u003cp\u003eSelf-respect and Self-protection 186\u003c\/p\u003e \u003cp\u003e\u003ci\u003eSummary 187\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003ci\u003eIndex 191\u003c\/i\u003e\u003c\/p\u003e","brand":"John Wiley and Sons Ltd","offers":[{"title":"Default Title","offer_id":49083841970519,"sku":"9781119976233","price":55.05,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0817\/1739\/5799\/files\/9781119976233.jpg?v=1725550189"},{"product_id":"goaloriented-assessment-of-lifeskills-goal-paper-box-sheet-pad-of-25-w614b-9780749166601","title":"GoalOriented Assessment of Lifeskills GOAL Paper","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003e","brand":"Elsevier Health Sciences","offers":[{"title":"Default Title","offer_id":49396201161047,"sku":"9780749166601","price":64.41,"currency_code":"GBP","in_stock":true}]},{"product_id":"becoming-a-psychotherapist-a-clinical-primer-9780226036366","title":"Becoming a Psychotherapist  A Clinical Primer","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003e","brand":"The University of Chicago Press","offers":[{"title":"Default Title","offer_id":49399920427351,"sku":"9780226036366","price":28.0,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0817\/1739\/5799\/files\/9780226036366.jpg?v=1730469141"},{"product_id":"suffering-made-real-9780226482385","title":"Suffering Made Real","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003eA study of the first attempts to understand how radiation affected the survivors of the atomic bomb and subsequent generations of Japanese, this book argues that Cold War politics and cultural values shaped this research. Using varied sources, it examines how US science was socially constructed.","brand":"The University of Chicago Press","offers":[{"title":"Default Title","offer_id":49400036098391,"sku":"9780226482385","price":30.4,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0817\/1739\/5799\/files\/9780226482385.jpg?v=1730469512"},{"product_id":"mental-health-in-the-war-on-terror-9780231166645","title":"Mental Health in the War on Terror","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003eAn investigation into the unintended cultural and psychological consequences of our fight against terrorism.\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTrade Review\u003c\/b\u003e\u003cbr\u003eVery few people are able to synthesize the disciplines of anthropology, mental health, cultural studies, political theory, religious studies, bioethics, and forensics in the way Neil Krishan Aggarwal does in this book. He offers a balanced and insightful account of the challenges of forensic psychiatry in assessing and managing terrorism suspects. -- Hamada Hamid, Yale University Using concrete clinical cases to anchor sophisticated and thought-provoking analysis, Aggarwal demonstrates that not only ethics but also the very nature of clinical knowledge and practice are at issue in the use, and especially misuse, of mental-health categories in the War on Terror. His book brings a new level of critical self-reflection to the psychology of terrorism. -- James W. Jones, author of Blood That Cries Out from the Earth: The Psychology of Religious Terrorism An indispensable and astute account of the insidious cultural manifestations emerging from the justifying framework that is the War on Terror. In light of the increasingly intolerable actions permissible through deference to notions of national security, Aggarwal's review of bioethics is crucial to understanding the evolution, through politicization, of approaches to mental health. Aggarwal's review of orientalist positions within psychotherapy literature, which underpin this creeping securitization of mental health, reinforces the impact of culturally laden views on Islam and Muslims. An essential read. -- Orla Lynch, Centre for the Study of Terrorism and Political Violence, University of St Andrews Aggarwal has written a theoretically sophisticated, multisided exploration of how the War on Terror and mental health are powerfully connected through the 'culture' of psychiatry, psychoanalysis, hospitals, courts, the military, and Islam. His argument is that science, religion, and moral experience are not just infiltrated with cultural meanings but come to create new cultural forms such as 'trauma,' forensic processes, and 'terrorism,' which in turn remake the world. An important achievement. -- Arthur Kleinman, Harvard University A clear and impassioned discussion of the presence of psychiatrists and mental-health knowledge practices in the micro-functioning of the War on Terror and the impact of each on the other. The book is a compelling portrayal of the way that medicine and its scientific languages and knowledge structures are able to move through and across political domains, being put to use to challenge and undo the very power structures they are meant to serve. Engaging, rigorous, and beautifully written. -- Sarah Pinto, Tufts University In this impressive and provocative volume, Aggarwal reveals many hidden failings of dominant social and political thought on radicalization and terrorism. Bioethics, arabic science, and symptoms in Guantanamo detainees are all debated to present an alternative, rounded, and compelling approach that includes medicine and cultural psychiatry as essential actors. -- Kamaldeep Bhui, Queen Mary University of London The questions it poses are valuable, difficult, and without easy answers - for clinicians, military leaders, or even civilians, all of whom must live with a medical culture deeply marked by the war on terror. Publishers Weekly Should be required reading for psychiatrists and mental health professionals interested in the psychology of Islamist terrorism... It is an exemplar of the manner in which the lens of transcultural psychiatry can clarify our perspective... Psychiatric Services\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTable of Contents\u003c\/b\u003e\u003cbr\u003ePreface Acknowledgments 1. Mental Health, Culture, and Power in the War on Terror 2. Bioethics and the Conduct of Mental Health Professionals in the War on Terror 3. The Meanings of Symptoms and Services for Guantanamo Detainees 4. Depictions of Arabs and Muslims in Psychodynamic Scholarship 5. Depictions of Suicide Bombers in the Mental Health Scholarship 6. Knowledge and Practice in War on Terror Deradicalization Programs Epilogue Notes References Index","brand":"Columbia University Press","offers":[{"title":"Default Title","offer_id":49400279761239,"sku":"9780231166645","price":38.25,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0817\/1739\/5799\/files\/9780231166645.jpg?v=1730470270"},{"product_id":"madhouse-a-tragic-tale-of-megalomania-and-modern-medicine-9780300126709","title":"Madhouse  A Tragic Tale of Megalomania and Modern","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003eConvinced that he had uncovered the single source of psychosis, Henry Cotton, superintendent of the Trenton State Hospital, New Jersey, launched a ruthless campaign to 'eliminate the perils of pus infection'. This book reconstructs a nightmarish, cautionary chapter in modern psychiatry when professionals failed to police themselves.\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTrade Review\u003c\/b\u003e\u003cbr\u003e\"'Scull writes an exemplary narrative - reminding us that today's respected clinician can still easily become tomorrow's mad scientist.' Michael Moorcock, Daily Telegraph 'Madhouse is fascinating. Scull's detection is impressive; it extends over years.' Hugh Freeman, Times Literary Supplement 'A brilliant piece of medical scholarship...' The Irish Times\"","brand":"Yale University Press","offers":[{"title":"Default Title","offer_id":49401506824535,"sku":"9780300126709","price":19.99,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0817\/1739\/5799\/files\/9780300126709.jpg?v=1730477649"},{"product_id":"a-brief-natural-history-of-civilization-9780300245912","title":"A Brief Natural History of Civilization","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003eA compelling evolutionary narrative that reveals how human civilization follows the same ecological rules that shape all life on Earth\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTrade Review\u003c\/b\u003e\u003cbr\u003e“Starting from ecological and evolutionary principles that transcend our own species, Mark Bertness offers a new perspective on the rise of human civilization.”—Judith Bronstein, editor of \u003ci\u003eMutualism\u003c\/i\u003e\u003cbr\u003e\u003cbr\u003e“\u003ci\u003eA Brief Natural History of Civilization\u003c\/i\u003e uses the science of natural history to frame the peril and promise of our times.”—Paul Ewald, author of \u003ci\u003ePlague Time: The New Germ Theory of Disease\u003c\/i\u003e\u003cbr\u003e\u003cbr\u003e“Understanding the ‘big picture’ of the development and trajectory of human civilization is vital as a global society faces collapse. Bertness’ book provides a brilliant short course on what should be the central topic for public education today.”—Paul R. Ehrlich, author of \u003ci\u003eHuman Natures\u003c\/i\u003e\u003cbr\u003e\u003cbr\u003e“A remarkable, far-ranging synthesis with something new and eye-opening on just about every page. Mark Bertness points to the powerful force of cooperation as our best hope.”—James Gustave Speth, author of \u003ci\u003eAmerica the Possible: Manifesto for a New Economy\u003c\/i\u003e\u003cbr\u003e\u003cbr\u003e“Who am I? This book weaves a powerful argument that our sense of self and our culture is very tightly coupled to our sense of place in nature. A remarkable synthesis!”—Paul Dayton, Scripps Institution of Oceanography\u003cbr\u003e\u003cbr\u003e","brand":"Yale University Press","offers":[{"title":"Default Title","offer_id":49401555747159,"sku":"9780300245912","price":21.38,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0817\/1739\/5799\/files\/9780300245912.jpg?v=1730477788"},{"product_id":"severe-dementia-9780470010549","title":"Severe Dementia","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003eSevere Dementia is a clinical text giving clear guidance on the management of all forms of severe dementia. It covers diagnosis, reviews all therapeutic interventions and includes chapters on the ethical, legal and social aspects of care of these patients.\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTrade Review\u003c\/b\u003e\u003cbr\u003e\"This is an excellent book for those interested in the care of patients with sever dementia.\" (\u003ci\u003eDoody's Health Services\u003c\/i\u003e)\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTable of Contents\u003c\/b\u003e\u003cbr\u003eList of contributors.  \u003cp\u003eIntroduction.\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePART 1: INTRODUCTORY.\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eChapter 1: Assessment and Diagnosis of Severe Dementia (\u003ci\u003ePaul Newhouse and Joseph Lasek\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003eChapter 2: Neurochemistry of Severe Dementia (\u003ci\u003eSally I. Sharp, Paul T. Francis and Clive G. Ballard\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003eChapter 3: The Molecular Pathology of Severe Dementia (\u003ci\u003eClive Holmes\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePART 2: CLINICAL FEATURES OF SEVERE DEMENTIA.\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eChapter 4: Cognitive Functions in Severe Dementia (\u003ci\u003eJudith Saxton and François Boller\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003eChapter 5: Behavioural and Psychological Symptons of Dementia – Agitation (\u003ci\u003eE. Jane Byrne and Deborah Collins\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003eChapter 6: Depression in Severe Dementia (\u003ci\u003eKate Bielinski and Brian Lawlor\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003eChapter 7: Physical Aspects of Severe Alzheimer’s Disease (\u003ci\u003eBruno Vellas\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003eChapter 8: Clinical Features of Severe Dementia: Staging (\u003ci\u003eBarry Reisberg, Jerzy Wegiel, Emile Franssen, Sridhar Kadiyala, Stefanie Auer, Liduïn Souren, Marwan Sabbagh and James Golomb\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003eChapter 9: Clinical Features of Severe Dementia: Function (\u003ci\u003eSerge Gauthier\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePART 3: MANAGEMENT.\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eChapter 10: Drug Treatment: Memantine (\u003ci\u003eAnton P. Porsteinsson and Pierre N. Tariot\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003eChapter 11: Drug Treatment: Cholinesterase Inhibitors (\u003ci\u003eMichael Woodward and Howard Feldman\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003eChapter 12: Drug Treatment: Treatment of Behavioural and Psychological Symptoms of Dementia with Neuroleptics (\u003ci\u003ePeter Paul De Deyn\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003eChapter 13: Non-pharmacological Treatment of Severe Dementia: An Overview (\u003ci\u003eRoss Overshott and Alistair Burns\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003eChapter 14: Non-pharmacological Treatment of Severe Dementia: the Seattle Protocols (\u003ci\u003eRebecca G. Logsdon, Linda Teri and Sue M. McCurry\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003eChapter 15: Care by Families for Late Stage Dementia (\u003ci\u003eSteven H. Zarit and Joseph E. Gaugler\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003eChapter 16: Person-centred Care for People with Severe Dementia (\u003ci\u003eMurna Downs, Neil Small and Katherine Froggatt\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003eChapter 17: Palliative Care in Patients with Severe Dementia (\u003ci\u003eRaymond Koopmans, H. Roeline W. Pasman and\u003c\/i\u003e \u003ci\u003eJenny T. van der Steen\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003eChapter 18: Narrative Ethics and Ethical Narratives in Dementia (\u003ci\u003eClive Baldwin\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003eChapter 19: Health Economics of Severe Dementia (\u003ci\u003eAnders Wimo and Bengt Winblad\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003eIndex.\u003c\/p\u003e","brand":"John Wiley \u0026 Sons Inc","offers":[{"title":"Default Title","offer_id":49402250428759,"sku":"9780470010549","price":131.35,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0817\/1739\/5799\/files\/9780470010549.jpg?v=1730479837"},{"product_id":"advanced-manufacturing-technology-for-medical-applications-reverse-engineering-software-conversion-and-rapid-prototyping-engineering-research-series-rep-11-9780470016886","title":"Advanced Manufacturing Technology for Medical","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003eThis book covers a range of applications where advanced manufacturing technology can be applied to medical procedures. Early chapters look at the reverse engineering process, where patient data is converted into a machine-readable format to allow users to create system solutions to medical problems.\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTable of Contents\u003c\/b\u003e\u003cbr\u003e\u003cp\u003eContributors xi\u003c\/p\u003e \u003cp\u003e\u003cb\u003e1 Rapid Prototyping for Medical Applications 1\u003c\/b\u003e\u003cbr\u003e\u003ci\u003eIan Gibson\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e1.1 Overview 1\u003c\/p\u003e \u003cp\u003e1.2 Workshop on Medical Applications for Reverse Engineering and Rapid Prototyping 2\u003c\/p\u003e \u003cp\u003e1.3 Purpose of This Chapter (Overview) 3\u003cbr\u003e\u003cbr\u003e1.4 Background on Rapid Prototyping 3\u003c\/p\u003e \u003cp\u003e1.5 Stereolithography and Other Resin-type Systems 6\u003c\/p\u003e \u003cp\u003e1.6 Fused Deposition Modelling and Selective Laser Sintering 7\u003c\/p\u003e \u003cp\u003e1.7 Droplet\/Binder Systems 9\u003c\/p\u003e \u003cp\u003e1.8 Related Technology: Microsystems and Direct Metal Systems 10\u003c\/p\u003e \u003cp\u003e1.9 File Preparation 11\u003c\/p\u003e \u003cp\u003e1.10 Relationship with Other Technologies 12\u003c\/p\u003e \u003cp\u003e1.11 Disadvantages with RP for Medical Applications 13\u003c\/p\u003e \u003cp\u003e1.12 Summary 14\u003c\/p\u003e \u003cp\u003eBibliography 14\u003c\/p\u003e \u003cp\u003e\u003cb\u003e2 Role of Rapid Digital Manufacture in Planning and Implementation of Complex Medical Treatments 15\u003c\/b\u003e\u003cbr\u003e\u003ci\u003eAndrew M. Christensen and Stephen M. Humphries\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e2.1 Introduction 16\u003c\/p\u003e \u003cp\u003e2.2 Primer on Medical Imaging 16\u003c\/p\u003e \u003cp\u003e2.3 Surgical Planning 18\u003c\/p\u003e \u003cp\u003e2.3.1 Virtual planning 18\u003c\/p\u003e \u003cp\u003e2.3.2 Implementation of the plan 20\u003c\/p\u003e \u003cp\u003e2.4 RDM in Medicine 22\u003c\/p\u003e \u003cp\u003e2.4.1 RP-generated anatomical models 22\u003c\/p\u003e \u003cp\u003e2.4.2 Custom treatment devices with ADM 26\u003c\/p\u003e \u003cp\u003e2.5 The Future 28\u003c\/p\u003e \u003cp\u003e2.6 Conclusion 29\u003c\/p\u003e \u003cp\u003eReferences 29\u003c\/p\u003e \u003cp\u003e\u003cb\u003e3 Biomodelling 31\u003c\/b\u003e\u003cbr\u003e\u003ci\u003eP. D’Urso\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e3.1 Introduction 31\u003c\/p\u003e \u003cp\u003e3.2 Surgical Applications of Real Virtuality 32\u003c\/p\u003e \u003cp\u003e3.2.1 Cranio-maxillofacial biomodelling 33\u003c\/p\u003e \u003cp\u003e3.2.1.1 Integration of biomodels with dental castings 34\u003c\/p\u003e \u003cp\u003e3.2.1.2 Use of biomodels to shape maxillofacial implants 35\u003c\/p\u003e \u003cp\u003e3.2.1.3 Use of biomodels to prefabricate templates and splints 35\u003c\/p\u003e \u003cp\u003e3.2.1.4 Use of biomodels in restorative prosthetics 36\u003c\/p\u003e \u003cp\u003e3.2.2 Use of real virtuality in customized cranio-maxillofacial prosthetics 36\u003c\/p\u003e \u003cp\u003e3.2.2.1 Computer mirroring techniques for the generation of prostheses 38\u003c\/p\u003e \u003cp\u003e3.2.2.2 Results of implantation 39\u003c\/p\u003e \u003cp\u003e3.2.2.3 Advantages of prefabricated customized cranioplastic implants 39\u003c\/p\u003e \u003cp\u003e3.2.3 Biomodel-guided stereotaxy 39\u003c\/p\u003e \u003cp\u003e3.2.3.1 Development of stereotaxy 40\u003c\/p\u003e \u003cp\u003e3.2.3.2 Development of biomodel-guided stereotactic surgery 40\u003c\/p\u003e \u003cp\u003e3.2.3.3 Biomodel-guided stereotactic surgery with a template and markers 41\u003c\/p\u003e \u003cp\u003e3.2.3.4 Biomodel-guided stereotactic surgery using the D’Urso frame 42\u003c\/p\u003e \u003cp\u003e3.2.3.5 Utility of biomodel-guided stereotactic surgery 43\u003c\/p\u003e \u003cp\u003e3.2.4 Vascular biomodelling 44\u003c\/p\u003e \u003cp\u003e3.2.4.1 Biomodelling from CTA 44\u003c\/p\u003e \u003cp\u003e3.2.4.2 Biomodelling from MRA 45\u003c\/p\u003e \u003cp\u003e3.2.4.3 Clinical applications of vascular biomodels 45\u003c\/p\u003e \u003cp\u003e3.2.4.4 Vascular biomodelling: technical note 46\u003c\/p\u003e \u003cp\u003e3.2.5 Skull-base tumour surgery 46\u003c\/p\u003e \u003cp\u003e3.2.6 Spinal surgery 48\u003c\/p\u003e \u003cp\u003e3.2.6.1 Spinal biomodel stereotaxy 48\u003c\/p\u003e \u003cp\u003e3.2.6.2 Technical considerations in spinal biomodelling 50\u003c\/p\u003e \u003cp\u003e3.2.7 Orthopaedic biomodelling 50\u003c\/p\u003e \u003cp\u003e3.3 Case Studies 51\u003c\/p\u003e \u003cp\u003eReferences 55\u003c\/p\u003e \u003cp\u003e\u003cb\u003e4 Three-dimensional Data Capture and Processing 59\u003c\/b\u003e\u003cbr\u003e\u003ci\u003eW. Feng, Y. F. Zhang, Y. F. Wu and Y. S. Wong\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e4.1 Introduction 60\u003c\/p\u003e \u003cp\u003e4.2 3D Medical Scan Process 61\u003c\/p\u003e \u003cp\u003e4.2.1 3D scanning 61\u003c\/p\u003e \u003cp\u003e4.2.1.1 Computed tomography imaging and its applications 61\u003c\/p\u003e \u003cp\u003e4.2.1.2 Magnetic resonance imaging and its applications 63\u003c\/p\u003e \u003cp\u003e4.2.1.3 Ultrasound imaging and its applications 64\u003c\/p\u003e \u003cp\u003e4.2.1.4 3D laser scanning 65\u003c\/p\u003e \u003cp\u003e4.2.2 3D reconstruction 65\u003c\/p\u003e \u003cp\u003e4.3 RE and RP in Medical Application 67\u003c\/p\u003e \u003cp\u003e4.3.1 Proposed method for RP model construction from scanned data 68\u003c\/p\u003e \u003cp\u003e4.3.2 Reconstruction software 69\u003c\/p\u003e \u003cp\u003e4.3.3 Accuracy issues 70\u003c\/p\u003e \u003cp\u003e4.4 Applications of Medical Imaging 71\u003c\/p\u003e \u003cp\u003e4.5 Case Study 72\u003c\/p\u003e \u003cp\u003e4.5.1 Case study with CT\/MR scanned data 72\u003c\/p\u003e \u003cp\u003e4.5.2 Case studies for RE and RP 74\u003c\/p\u003e \u003cp\u003e4.6 Conclusions 76\u003c\/p\u003e \u003cp\u003eReferences 76\u003c\/p\u003e \u003cp\u003eBibliography 76\u003c\/p\u003e \u003cp\u003e\u003cb\u003e5 Software for Medical Data Transfer 79\u003c\/b\u003e\u003cbr\u003e\u003ci\u003eEllen Dhoore\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e5.1 Introduction 79\u003c\/p\u003e \u003cp\u003e5.2 Medical Imaging: from Medical Scanner to 3D Model 79\u003c\/p\u003e \u003cp\u003e5.2.1 Introduction 79\u003c\/p\u003e \u003cp\u003e5.2.2 Mimics® 80\u003c\/p\u003e \u003cp\u003e5.2.2.1 Basic functionality of Mimics 80\u003c\/p\u003e \u003cp\u003e5.2.2.2 Additional modules in Mimics 82\u003c\/p\u003e \u003cp\u003e5.3 Computer Approach in Dental Implantology 92\u003c\/p\u003e \u003cp\u003e5.3.1 Introduction 92\u003c\/p\u003e \u003cp\u003e5.3.2 Virtual 3D planning environment: SimPlant® 92\u003c\/p\u003e \u003cp\u003e5.3.3 Guide to accurate implant treatment: SurgiGuide® 93\u003c\/p\u003e \u003cp\u003e5.3.3.1 General concept of SurgiGuide® 93\u003c\/p\u003e \u003cp\u003e5.3.3.2 Different types of SurgiGuide® 94\u003c\/p\u003e \u003cp\u003e5.3.3.3 Immediate SmileTM: temporary prosthesis for truly ‘immediate’ loading 100\u003c\/p\u003e \u003cp\u003e5.4 Conclusions 102\u003c\/p\u003e \u003cp\u003eBibliography 103\u003c\/p\u003e \u003cp\u003e\u003cb\u003e6 BioBuild Software 105\u003c\/b\u003e\u003cbr\u003e\u003ci\u003eRobert Thompson, Dr Gian Lorenzetto and Dr Paul D'Urso\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e6.1 Introduction 105\u003c\/p\u003e \u003cp\u003e6.2 BioBuild Paradigm 109\u003c\/p\u003e \u003cp\u003e6.2.1 Importing a dataset 110\u003c\/p\u003e \u003cp\u003e6.2.2 Volume reduction 112\u003c\/p\u003e \u003cp\u003e6.2.3 Anatomical orientation confirmation 112\u003c\/p\u003e \u003cp\u003e6.2.4 Volume inspection and intensity thresholding 112\u003c\/p\u003e \u003cp\u003e6.2.4.1 Intensity thresholding 113\u003c\/p\u003e \u003cp\u003e6.2.4.2 Display options 114\u003c\/p\u003e \u003cp\u003e6.2.5 Volume editing 114\u003c\/p\u003e \u003cp\u003e6.2.5.1 Connectivity options 115\u003c\/p\u003e \u003cp\u003e6.2.5.2 Volume morphology 115\u003c\/p\u003e \u003cp\u003e6.2.5.3 Region morphology 116\u003c\/p\u003e \u003cp\u003e6.2.5.4 Volume algebra 116\u003c\/p\u003e \u003cp\u003e6.2.5.5 Labels 117\u003c\/p\u003e \u003cp\u003e6.2.5.6 Volume transformations 117\u003c\/p\u003e \u003cp\u003e6.2.6 Image processing 118\u003c\/p\u003e \u003cp\u003e6.2.7 Build orientation optimization 118\u003c\/p\u003e \u003cp\u003e6.2.8 3D visualization 119\u003c\/p\u003e \u003cp\u003e6.2.9 RP file generation 119\u003c\/p\u003e \u003cp\u003e6.3 Future Enhancements 120\u003c\/p\u003e \u003cp\u003e6.3.1 Direct volume rendering (DVR) 120\u003c\/p\u003e \u003cp\u003e6.4 Conclusion 121\u003c\/p\u003e \u003cp\u003eReferences 121\u003c\/p\u003e \u003cp\u003e\u003cb\u003e7 Generalized Artificial Finger Joint Design Process Employing Reverse Engineering 123\u003c\/b\u003e\u003cbr\u003e\u003ci\u003eI. Gibson and X. P. Wang\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e7.1 Introduction 123\u003c\/p\u003e \u003cp\u003e7.1.1 Structure of a human finger joint 123\u003c\/p\u003e \u003cp\u003e7.1.2 Rheumatoid arthritis disease 123\u003c\/p\u003e \u003cp\u003e7.1.3 Finger joint replacement design 124\u003c\/p\u003e \u003cp\u003e7.1.4 Requirements for new finger joint design 125\u003c\/p\u003e \u003cp\u003e7.1.5 Research objectives 126\u003c\/p\u003e \u003cp\u003e7.2 Supporting Literature 127\u003c\/p\u003e \u003cp\u003e7.2.1 Previous prosthetic designs 127\u003c\/p\u003e \u003cp\u003e7.2.2 More recent designs 128\u003c\/p\u003e \u003cp\u003e7.2.3 Development of a new design 128\u003c\/p\u003e \u003cp\u003e7.2.4 Need for a generalized finger joint prosthesis 129\u003c\/p\u003e \u003cp\u003e7.3 Technological Supports for the Prosthesis Design 130\u003c\/p\u003e \u003cp\u003e7.3.1 Reverse engineering 130\u003c\/p\u003e \u003cp\u003e7.3.2 Comparison of different imaging techniques 131\u003c\/p\u003e \u003cp\u003e7.3.3 Engineering and medical aspects 131\u003c\/p\u003e \u003cp\u003e7.3.4 NURBS design theory 131\u003c\/p\u003e \u003cp\u003e7.4 Proposed Methodology 132\u003c\/p\u003e \u003cp\u003e7.4.1 Finger joint model preparation 132\u003c\/p\u003e \u003cp\u003e7.4.2 Finger joint digitization 133\u003c\/p\u003e \u003cp\u003e7.4.3 Surface reconstruction in paraform 135\u003c\/p\u003e \u003cp\u003e7.4.4 Curve feature extraction 135\u003c\/p\u003e \u003cp\u003e7.4.5 Database construction and surface generalization 135\u003c\/p\u003e \u003cp\u003e7.4.6 Review of the procedure 136\u003c\/p\u003e \u003cp\u003e7.5 Finger Joint Surface Modelling and Feature Extraction 136\u003c\/p\u003e \u003cp\u003e7.5.1 Data acquisition of the bone samples 136\u003c\/p\u003e \u003cp\u003e7.5.2 Finger joint surface reconstruction 137\u003c\/p\u003e \u003cp\u003e7.5.3 NURBS curve and feature extraction 138\u003c\/p\u003e \u003cp\u003e7.5.3.1 NURBS curve extraction from the PP head 138\u003c\/p\u003e \u003cp\u003e7.5.3.2 NURBS curve feature extraction from the PP and MP base 141\u003c\/p\u003e \u003cp\u003e7.5.3.3 Discussion on curve feature extraction 142\u003c\/p\u003e \u003cp\u003e7.5.4 Automatic surface reconstruction and feature extraction 143\u003c\/p\u003e \u003cp\u003e7.5.4.1 Automated identification of the bearing surface 143\u003c\/p\u003e \u003cp\u003e7.5.4.2 Automated feature extraction 143\u003c\/p\u003e \u003cp\u003e7.6 Database Construction and Surface Generalization 145\u003c\/p\u003e \u003cp\u003e7.6.1 Finger joint database construction 145\u003c\/p\u003e \u003cp\u003e7.6.1.1 Statistical dimension analysis 145\u003c\/p\u003e \u003cp\u003e7.6.1.2 PP head geometrical features 150\u003c\/p\u003e \u003cp\u003e7.6.2 Generalized finger joint surface reconstruction 155\u003c\/p\u003e \u003cp\u003e7.7 Conclusions 159\u003c\/p\u003e \u003cp\u003eAcknowledgements 161\u003c\/p\u003e \u003cp\u003eReferences 161\u003c\/p\u003e \u003cp\u003e\u003cb\u003e8 Scaffold-based Tissue Engineering – Design and Fabrication of Matrices Using Solid Freeform Fabrication Techniques 163\u003c\/b\u003e\u003cbr\u003e\u003ci\u003eDietmar W. Hutmacher\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e8.1 Background 164\u003c\/p\u003e \u003cp\u003e8.2 Introduction 167\u003c\/p\u003e \u003cp\u003e8.3 Systems Based on Laser and UV Light Sources 167\u003c\/p\u003e \u003cp\u003e8.3.1 Stereolithography apparatus (SLA) 167\u003c\/p\u003e \u003cp\u003e8.3.2 Selective laser sintering (SLS) 170\u003c\/p\u003e \u003cp\u003e8.3.3 Laminated object manufacturing (LOM) 171\u003c\/p\u003e \u003cp\u003e8.3.4 Solid ground curing (SGC) 171\u003c\/p\u003e \u003cp\u003e8.4 Systems Based on Printing Technology 172\u003c\/p\u003e \u003cp\u003e8.4.1 Three-dimensional printing (3DP) 172\u003c\/p\u003e \u003cp\u003e8.5 Systems Based on Extrusion\/Direct Writing 176\u003c\/p\u003e \u003cp\u003e8.6 Indirect SFF 180\u003c\/p\u003e \u003cp\u003e8.7 Robotic and Mechatronically Controlled Systems 182\u003c\/p\u003e \u003cp\u003e8.8 Conclusions 185\u003c\/p\u003e \u003cp\u003eReferences 186\u003c\/p\u003e \u003cp\u003e\u003cb\u003e9 Direct Fabrication of Custom Orthopedic Implants Using Electron Beam Melting Technology 191\u003c\/b\u003e\u003cbr\u003e\u003ci\u003eOla L. A. Harrysson and Denis R. Cormier\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e9.1 Introduction 191\u003c\/p\u003e \u003cp\u003e9.2 Literature Review 192\u003c\/p\u003e \u003cp\u003e9.2.1 Custom joint replacement implants 192\u003c\/p\u003e \u003cp\u003e9.2.2 Custom bone plates and implants 196\u003c\/p\u003e \u003cp\u003e9.3 Electron Beam Melting Technology 199\u003c\/p\u003e \u003cp\u003e9.4 Direct Fabrication of Titanium Orthopedic Implants 201\u003c\/p\u003e \u003cp\u003e9.4.1 EBM fabrication of custom knee implants 201\u003c\/p\u003e \u003cp\u003e9.4.2 EBM fabrication of custom bone plates 202\u003c\/p\u003e \u003cp\u003e9.4.3 Direct fabrication of bone ingrowth surfaces 203\u003c\/p\u003e \u003cp\u003e9.5 Summary and Conclusions 204\u003c\/p\u003e \u003cp\u003eReferences 205\u003c\/p\u003e \u003cp\u003e\u003cb\u003e10 Modelling, Analysis and Fabrication of Below-knee Prosthetic Sockets Using Rapid Prototyping 207\u003c\/b\u003e\u003cbr\u003e\u003ci\u003eJ. Y. H. Fuh, W. Feng and Y. S. Wong\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e10.1 Introduction 208\u003c\/p\u003e \u003cp\u003e10.1.1 Process of making the below-knee artificial prosthesis 208\u003c\/p\u003e \u003cp\u003e10.1.1.1 Shaping of the positive mould 208\u003c\/p\u003e \u003cp\u003e10.1.1.2 Fabrication of the prosthesis 209\u003c\/p\u003e \u003cp\u003e10.1.2 Modelling, analysis and fabrication 210\u003c\/p\u003e \u003cp\u003e10.2 Computer-Facilitated Approach 211\u003c\/p\u003e \u003cp\u003e10.2.1 CAD modelling 211\u003c\/p\u003e \u003cp\u003e10.2.2 Finite element analysis (FEA) 213\u003c\/p\u003e \u003cp\u003e10.2.2.1 Geometries 213\u003c\/p\u003e \u003cp\u003e10.2.2.2 Boundary conditions 213\u003c\/p\u003e \u003cp\u003e10.2.2.3 Loading conditions 213\u003c\/p\u003e \u003cp\u003e10.2.2.4 Analysis 214\u003c\/p\u003e \u003cp\u003e10.3 Experiments 215\u003c\/p\u003e \u003cp\u003e10.4 Results and Discussions 216\u003c\/p\u003e \u003cp\u003e10.5 Rapid Socket Manufacturing Machine (RSMM) 219\u003c\/p\u003e \u003cp\u003e10.5.1 RSMM design considerations 220\u003c\/p\u003e \u003cp\u003e10.5.1.1 File format 220\u003c\/p\u003e \u003cp\u003e10.5.1.2 Nozzle 220\u003c\/p\u003e \u003cp\u003e10.5.1.3 System accuracy 221\u003c\/p\u003e \u003cp\u003e10.5.2 Overview of the RSMM 221\u003c\/p\u003e \u003cp\u003e10.5.3 Clinical test 223\u003c\/p\u003e \u003cp\u003e10.5.4 Future work 224\u003c\/p\u003e \u003cp\u003e10.6 Conclusions 225\u003c\/p\u003e \u003cp\u003eAcknowledgements 225\u003c\/p\u003e \u003cp\u003eReferences 225\u003c\/p\u003e \u003cp\u003eBibliography 226\u003c\/p\u003e \u003cp\u003e\u003cb\u003e11 Future Development of Medical Applications for Advanced Manufacturing Technology 227\u003c\/b\u003e\u003cbr\u003e\u003ci\u003eIan Gibson\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e11.1 Introduction 227\u003c\/p\u003e \u003cp\u003e11.2 Scanning Technology 228\u003c\/p\u003e \u003cp\u003e11.3 RP Technology 229\u003c\/p\u003e \u003cp\u003e11.4 Direct Manufacture 230\u003c\/p\u003e \u003cp\u003e11.5 Tissue Engineering 231\u003c\/p\u003e \u003cp\u003e11.6 Business 232\u003c\/p\u003e \u003cp\u003eIndex 233\u003c\/p\u003e","brand":"John Wiley \u0026 Sons Inc","offers":[{"title":"Default Title","offer_id":49402255835479,"sku":"9780470016886","price":107.06,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0817\/1739\/5799\/files\/9780470016886.jpg?v=1730479852"},{"product_id":"language-and-social-disadvantage-theory-into-practice-9780470019757","title":"Language and Social Disadvantage Theory into","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003eThis book critically analyses and reviews the development of language in direct relation to social disadvantage in the early years and beyond.   Definitions and descriptions of social disadvantage are addressed and the wider aspects discussed.\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTrade Review\u003c\/b\u003e\u003cbr\u003e\"…a book for all teachers and parents.\" (\u003ci\u003eThe Guardian\u003c\/i\u003e, December 2006) \u003cbr\u003e\u003cbr\u003e\u003cb\u003eTable of Contents\u003c\/b\u003e\u003cbr\u003e\u003cb\u003eList of contributors.\u003c\/b\u003e  \u003cp\u003e\u003cb\u003eIntroduction.\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePART I.\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 1\u003c\/b\u003e Language and social disadvantage: the effects of socio-economic status on children’s language acquisition and use \u003ci\u003e(Jane Ginsborg).\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 2\u003c\/b\u003e The interplay between language and cognition in typical and atypical development \u003ci\u003e(Nicola Botting).\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 3\u003c\/b\u003e Literacy and numeracy \u003ci\u003e(Ivy Doherty and Jenny Landells).\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 4\u003c\/b\u003e Childhood speech and language difficulties and later life chances \u003ci\u003e(Judy Clegg).\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 5\u003c\/b\u003e Language and the development of social and emotional understanding \u003ci\u003e(Marion Farmer).\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 6\u003c\/b\u003e Language, behaviour and social disadvantage \u003ci\u003e(Helen Stringer and Judy Clegg).\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 7\u003c\/b\u003e Language and communication in young people with learning difficulties: stories of social disadvantage (Monica Bray).\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 8\u003c\/b\u003e The effects of intervention on the communication skills of socially disadvantaged children \u003ci\u003e(James Law and Francis Harris).\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePART II: Research reports.\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 9\u003c\/b\u003e Interventions to promote language development in socially disadvantaged children – the devil may be in the detail \u003ci\u003e(James Law).\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e9.1 Participation in Sure Start: lessons from language screening \u003ci\u003e(Caroline Pickstone).\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e9.2 The ‘Teaching Children Talking’ project \u003ci\u003e(Linda Hobbs).\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e9.3 The Talking Table \u003ci\u003e(Marion Farmer and Fleur Griffiths).\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e9.4 Implementing effective oral language interventions in preschool settings: no simple solutions \u003ci\u003e(Julie E. Dockrell, Morag Stuart and Diane King).\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e9.5 Working and learning together: an evaluation of a collaborative approach to intervention with student speech and language therapists and nursery staff \u003ci\u003e(Jenny Leyden and Marcin Szczerbinkski).\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e9.6 Facilitating narrative and social skills in secondary school students with language and behaviour difficulties \u003ci\u003e(Helen Stringer).\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e9.7 Enhancing language and communication in language impaired secondary school-aged children \u003ci\u003e(Victoria Joffe).\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eAfterword\u003c\/b\u003e \u003ci\u003e(Ann Locke).\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eIndex.\u003c\/b\u003e\u003c\/p\u003e","brand":"John Wiley \u0026 Sons Inc","offers":[{"title":"Default Title","offer_id":49402258194775,"sku":"9780470019757","price":52.2,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0817\/1739\/5799\/files\/9780470019757.jpg?v=1730479859"},{"product_id":"disasters-and-mental-health-9780470021231","title":"Disasters and Mental Health","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003eOffers a comprehensive overview of clinical, epidemiological, psychobiological, psychosocial and service organization aspects of disaster psychiatry. This title takes a practical approach and includes a series of reports on significant experiences made in this field in various regions of the world.\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTrade Review\u003c\/b\u003e\u003cbr\u003e\"…will inform mental health care providers and epidemiologists, as well as those that study and plan disaster response worldwide.\" (\u003ci\u003eE-STREAMS\u003c\/i\u003e, April 2006)  \u003cp\u003e\"Highly recommended to all physicians who practice within the realm of psychological medicine…recommended to Health Science libraries as a general reference text…\" (\u003ci\u003eElectric Review\u003c\/i\u003e, November\/December 2005)\u003c\/p\u003e \u003cp\u003e\"This timely book will help us maximize what we are summoned to bear when disaster inevitably strikes next.\" (\u003ci\u003eNew England Journal of Medicine\u003c\/i\u003e, August 25, 2005)\u003c\/p\u003e \u003cp\u003e\"This book offers an excellent source of research in the area…vital for those who prepare prevention and response to local and international crises.\" (\u003ci\u003eDoody's Health Services\u003c\/i\u003e)\u003c\/p\u003e\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTable of Contents\u003c\/b\u003e\u003cbr\u003eList of contributors.  \u003cp\u003ePreface (Lopez-Ibor et al).\u003c\/p\u003e \u003cp\u003e1. What is a Disaster? (Lopez-Ibor).\u003c\/p\u003e \u003cp\u003e2. Psychological and Psychopathological Consequences of Disasters (Fullerton and Ursano).\u003c\/p\u003e \u003cp\u003e3. Psychiatric Morbidity following Disasters: Epidemiology, Risk and Protective Factors (McFarlane).\u003c\/p\u003e \u003cp\u003e4. Reevaluating the Link between Disasters and Psychopathology (Yehuda and Bierer).\u003c\/p\u003e \u003cp\u003e5. Psychological Interventions for People Exposed to Disasters (Benyakar and Collazo).\u003c\/p\u003e \u003cp\u003e6. Organization of Mental Health Services for Disaster Victims (Crocq et al).\u003c\/p\u003e \u003cp\u003eMental Health Consequences of Disasters: Research Reports.\u003c\/p\u003e \u003cp\u003e7. The Experience of the Kobe Earthquake (Shinfuku).\u003c\/p\u003e \u003cp\u003e8. The Experience of the Marmara Earthquake (Gokalp).\u003c\/p\u003e \u003cp\u003e9. The Experience of the Athens Earthquake (Christodoulou et al)\u003c\/p\u003e \u003cp\u003e10. The Experience of the Nairobi US Embassy Bombing (Njeng and Nyamai).\u003c\/p\u003e \u003cp\u003e11. The Experience of the New York September 11 Terroristic Attack (DeLisi et al).\u003c\/p\u003e \u003cp\u003e12. The Experience of the Chernobyl Nuclear Disaster (Havenaar and Bromet).\u003c\/p\u003e \u003cp\u003e13. The Experience of the Bhopal Disaster (Murthy).\u003c\/p\u003e \u003cp\u003e14. The Latin American and Caribbean Experience (Caldas de Ameida and Rodriguez).\u003c\/p\u003e \u003cp\u003e15.  The Israeli Experience (Shalev).\u003c\/p\u003e \u003cp\u003e16. The Palestinian Experience (El Sarraj and Qouta).\u003c\/p\u003e \u003cp\u003e17. The Experience of Bosnia-Herzegovina: Psychosocial Consequences of War Atrocities on Children (Husain).\u003c\/p\u003e \u003cp\u003e18. The Serbian Experience (Lecic-Tosevski and Draganic-Gajic).\u003c\/p\u003e \u003cp\u003e19. The Croatian Experience (Folnegovic Smalc).\u003c\/p\u003e","brand":"John Wiley \u0026 Sons Inc","offers":[{"title":"Default Title","offer_id":49402258522455,"sku":"9780470021231","price":123.26,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0817\/1739\/5799\/files\/9780470021231.jpg?v=1730479860"},{"product_id":"quantitative-methods-for-health-research-9780470022740","title":"Quantitative Methods for Health Research","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003e\u003cb\u003e\u003ci\u003eQuantitative Research Methods for Health Professionals: A Practical Interactive Course\u003c\/i\u003e\u003c\/b\u003eis a superb introduction to epidemiology, biostatistics, and research methodology for the whole health care community.  \u003cp\u003eDrawing examples from a wide range of health research, this practical handbook covers important contemporary health research methods such as survival analysis, Cox regression, and meta-analysis, the understanding of which go beyond introductory concepts.\u003c\/p\u003e \u003cp\u003eThe book includes self-assessment exercises throughout to help students explore and reflect on their understanding and a clear distinction is made between a) knowledge and concepts that all students should ensure they understand and b) those that can be pursued by students who wish to do so.\u003c\/p\u003e \u003cp\u003eThe authors incorporate a program of practical exercises in SPSS using a prepared data set that helps to consolidate the theory and develop skills and confidence in data handling, analysis and interpretation.\u003c\/p\u003e\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTable of Contents\u003c\/b\u003e\u003cbr\u003ePreface.  \u003cp\u003eAcknowledgements.\u003c\/p\u003e \u003cp\u003e\u003cb\u003e1. Philosophy of science and introduction to epidemiology.\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eIntroduction and learning objectives.\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e1.1 Approaches to scientific research.\u003c\/p\u003e \u003cp\u003e1.2 Formulating a research question.\u003c\/p\u003e \u003cp\u003e1.3 Rates: incidence and prevalence.\u003c\/p\u003e \u003cp\u003e1.4 Concepts of prevention.\u003c\/p\u003e \u003cp\u003e1.5 Answers to self-assessment exercises.\u003c\/p\u003e \u003cp\u003e\u003cb\u003e2. Routine data sources and descriptive epidemiology.\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eIntroduction and learning objectives.\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e2.1 Routine collection of health information.\u003c\/p\u003e \u003cp\u003e2.2 Descriptive epidemiology.\u003c\/p\u003e \u003cp\u003e2.3 Information on the environment.\u003c\/p\u003e \u003cp\u003e2.4 Displaying, describing and presenting data.\u003c\/p\u003e \u003cp\u003e2.5 Summary of routinely available data.\u003c\/p\u003e \u003cp\u003e2.6 Descriptive epidemiology in action.\u003c\/p\u003e \u003cp\u003e2.7 Overview of epidemiological study designs.\u003c\/p\u003e \u003cp\u003e2.8 Answers to self-assessment exercises.\u003c\/p\u003e \u003cp\u003e\u003cb\u003e3. Standardisation.\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eIntroduction and learning objectives.\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e3.1 Health inequalities in Merseyside.\u003c\/p\u003e \u003cp\u003e3.2 Indirect standardisation: calculation of the standardised mortality ratio (SMR).\u003c\/p\u003e \u003cp\u003e3.3 Direct standardisation.\u003c\/p\u003e \u003cp\u003e3.4 Standardisation for factors other than age.\u003c\/p\u003e \u003cp\u003e3.5 Answers to self-assessment exercises.\u003c\/p\u003e \u003cp\u003e\u003cb\u003e4. Surveys.\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eIntroduction and learning objectives.\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e4.1 Purpose and context.\u003c\/p\u003e \u003cp\u003e4.2 Sampling methods.\u003c\/p\u003e \u003cp\u003e4.3 The sampling frame.\u003c\/p\u003e \u003cp\u003e4.4 Sampling error, confidence intervals and sample size .\u003c\/p\u003e \u003cp\u003e4.5 Response.\u003c\/p\u003e \u003cp\u003e4.6 Measurement.\u003c\/p\u003e \u003cp\u003e4.7 Data types and presentation.\u003c\/p\u003e \u003cp\u003e4.8 Answers to self-assessment exercises.\u003c\/p\u003e \u003cp\u003e\u003cb\u003e5. Cohort studies.\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eIntroduction and learning objectives.\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e5.1 Why do a cohort study?.\u003c\/p\u003e \u003cp\u003e5.2 Obtaining the sample.\u003c\/p\u003e \u003cp\u003e5.3 Measurement.\u003c\/p\u003e \u003cp\u003e5.4 Follow-up.\u003c\/p\u003e \u003cp\u003e5.5 Basic presentation and analysis of results.\u003c\/p\u003e \u003cp\u003e5.6 How large should a cohort study be?.\u003c\/p\u003e \u003cp\u003e5.7 Confounding.\u003c\/p\u003e \u003cp\u003e5.8 Simple linear regression.\u003c\/p\u003e \u003cp\u003e5.9 Introduction to multiple linear regression.\u003c\/p\u003e \u003cp\u003e5.10 Answers to self-assessment exercises.\u003c\/p\u003e \u003cp\u003e\u003cb\u003e6. Case-control studies.\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eIntroduction and learning objectives.\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e6.1 Why do a case-control study?.\u003c\/p\u003e \u003cp\u003e6.2 Key elements of study design.\u003c\/p\u003e \u003cp\u003e6.3 Basic unmatched and matched analysis.\u003c\/p\u003e \u003cp\u003e6.4 Sample size for a case-control study.\u003c\/p\u003e \u003cp\u003e6.5 Confounding and logistic regression.\u003c\/p\u003e \u003cp\u003e6.6 Answers to self-assessment exercises.\u003c\/p\u003e \u003cp\u003e\u003cb\u003e7. Intervention studies.\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eIntroduction and learning objectives.\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e7.1 Why do an intervention study?.\u003c\/p\u003e \u003cp\u003e7.2 Key elements of intervention study design.\u003c\/p\u003e \u003cp\u003e7.3 The analysis of intervention studies.\u003c\/p\u003e \u003cp\u003e7.4 Testing more complex interventions.\u003c\/p\u003e \u003cp\u003e7.5 How big should the trial be?.\u003c\/p\u003e \u003cp\u003e7.6 Further aspects of intervention study design and analysis.\u003c\/p\u003e \u003cp\u003e7.7 Answers to self-assessment exercises.\u003c\/p\u003e \u003cp\u003e\u003cb\u003e8. Life tables, survival analysis and Cox regression.\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eIntroduction and learning objectives.\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e8.1 Survival analysis.\u003c\/p\u003e \u003cp\u003e8.2 Cox regression.\u003c\/p\u003e \u003cp\u003e8.3 Current life tables.\u003c\/p\u003e \u003cp\u003e8.4 Answers to self-assessment exercises.\u003c\/p\u003e \u003cp\u003e\u003cb\u003e9. Systematic reviews and meta analysis.\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eIntroduction and learning objectives.\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e9.1 The why and how of systematic reviews.\u003c\/p\u003e \u003cp\u003e9.2 The methodology of meta-analysis.\u003c\/p\u003e \u003cp\u003e9.3 Systematic reviews and meta-analyses of observational studies.\u003c\/p\u003e \u003cp\u003e9.4 The Cochrane Collaboration.\u003c\/p\u003e \u003cp\u003e9.5 Answers to self-assessment exercises.\u003c\/p\u003e \u003cp\u003e\u003cb\u003e10. Prevention strategies and evaluation of screening .\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eIntroduction and learning objectives.\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e10.1 Concepts of risk.\u003c\/p\u003e \u003cp\u003e10.2 Strategies of prevention.\u003c\/p\u003e \u003cp\u003e10.3 Evaluation of screening programmes.\u003c\/p\u003e \u003cp\u003e10.4 Cohort and period effects.\u003c\/p\u003e \u003cp\u003e10.5 Answers to self-assessment exercises.\u003c\/p\u003e \u003cp\u003e\u003cb\u003e11. Probability distributions, hypothesis testing and Bayesian methods.\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eIntroduction and learning objectives.\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e11.1 Probability distributions.\u003c\/p\u003e \u003cp\u003e11.2 Data that do not ‘fit’ a probability distribution.\u003c\/p\u003e \u003cp\u003e11.3 Hypothesis testing.\u003c\/p\u003e \u003cp\u003e11.4 Choosing an appropriate hypothesis test.\u003c\/p\u003e \u003cp\u003e11.5 Bayesian methods.\u003c\/p\u003e \u003cp\u003e11.6 Answers to self-assessment exercises.\u003c\/p\u003e \u003cp\u003eBibliography.\u003c\/p\u003e \u003cp\u003eIndex.\u003c\/p\u003e","brand":"John Wiley \u0026 Sons Inc","offers":[{"title":"Default Title","offer_id":49402259865943,"sku":"9780470022740","price":119.65,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0817\/1739\/5799\/files\/9780470022740.jpg?v=1730479864"},{"product_id":"speech-and-language-disorders-associated-with-subcortical-pathology-9780470025734","title":"Speech and Language Disorders Associated with","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003eThis book provides comprehensive coverage of speech and language disorders arising from pathological processes involving the subcortical structures of the brain. It gives an understanding of these disorders in terms of their neuropathological basis, clinical symptomatology and prognosis.\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTable of Contents\u003c\/b\u003e\u003cbr\u003e\u003cb\u003eSECTION A: INTRODUCTION.\u003c\/b\u003e  \u003cp\u003e1. Subcortical Involvement in Speech and Language: An Introduction and Historical Perspective.\u003c\/p\u003e \u003cp\u003e2. Neuroanatomy and Functional Neurology of the Subcortical Region.\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSECTION B: SUBCORTICAL LANGUAGE DISORDERS.\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e3. Models of Subcortical Participation in Language.\u003c\/p\u003e \u003cp\u003e4. Language Disorders Associated with Striatocapsular and Thalamic Lesions.\u003c\/p\u003e \u003cp\u003e5. Pallidal and Thalamic Involvement in Language: Evidence from Stereotactic Surgical Studies.\u003c\/p\u003e \u003cp\u003e6. Role of the Subthalamic Nucleus in Language.\u003c\/p\u003e \u003cp\u003e7. Influence of the Cerebellum on Language Function.\u003c\/p\u003e \u003cp\u003e8. Degenerative Subcortical Syndromes: Aetiology, Clinical Features, Medical Treatment and Associated Language Disorders.\u003c\/p\u003e \u003cp\u003e9. Assessment and Treatment of Subcortical Language Disorders.\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSECTION C: SUBCORTICAL SPEECH DISORDERS.\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e10. Role of the Subcortical Structures in Speech Motor Control.\u003c\/p\u003e \u003cp\u003e11. Dysarthria Associated with Subcortical Pathologies.\u003c\/p\u003e \u003cp\u003e12. Subcortical Dysarthrias: Assessment and Treatment.\u003c\/p\u003e","brand":"John Wiley \u0026 Sons Inc","offers":[{"title":"Default Title","offer_id":49402261995863,"sku":"9780470025734","price":56.95,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0817\/1739\/5799\/files\/9780470025734.jpg?v=1730479870"},{"product_id":"persisting-speech-difficulties-3-childrens-speech-and-literacy-difficulties-childrens-speech-literacy-difficulties-s-9780470027448","title":"Persisting Speech Difficulties 3 Childrens Speech","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003eThis is the third book in the series Children's Speech and Literacy Difficulties and is based on research and practice with school-age children with persisting speech and associated difficulties. It focuses on the psycholinguistic nature of their difficulties, how to design intervention programmes, and how intervention outcomes might be measured.\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTable of Contents\u003c\/b\u003e\u003cbr\u003eForeword.  \u003cp\u003ePreface.\u003c\/p\u003e \u003cp\u003eAcknowledgements.\u003c\/p\u003e \u003cp\u003eChapter 1: Persisting Speech Difficulties.\u003c\/p\u003e \u003cp\u003eChapter 2: Theory, Therapy and Methodology.\u003c\/p\u003e \u003cp\u003eChapter 3: Stimuli Design: Segments in Single Words.\u003c\/p\u003e \u003cp\u003eChapter 4: Working on Segments in Single Words.\u003c\/p\u003e \u003cp\u003eChapter 5: Stimuli Design: Consonant Clusters in Single Words.\u003c\/p\u003e \u003cp\u003eChapter 6: Working on Consonant Clusters.\u003c\/p\u003e \u003cp\u003eChapter 7: Stimuli Design: Connected Speech.\u003c\/p\u003e \u003cp\u003eChapter 8: Working on Connected Speech.\u003c\/p\u003e \u003cp\u003eChapter 9: Generalisation.\u003c\/p\u003e \u003cp\u003eChapter 10: Linking with Literacy.\u003c\/p\u003e \u003cp\u003eChapter 11: Intelligibility.\u003c\/p\u003e \u003cp\u003eChapter 12: Evaluating Intervention Outcomes.\u003c\/p\u003e \u003cp\u003eChapter 13: Service Delivery Issues.\u003c\/p\u003e \u003cp\u003eChapter 14: Putting the Speech back into Speech Therapy.\u003c\/p\u003e \u003cp\u003eAppendix 1: Speech processing profile.\u003c\/p\u003e \u003cp\u003eAppendix 2: Updated List of Examples of Tests for Each Question in the Psycholinguistic.\u003c\/p\u003e \u003cp\u003eAssessment Framework.\u003c\/p\u003e \u003cp\u003eAppendix 3: Speech processing model.\u003c\/p\u003e \u003cp\u003eAppendix 4: Template for Journal Review.\u003c\/p\u003e \u003cp\u003eAppendix 5: Examples of Core Vocabulary used with a child with PSDs.\u003c\/p\u003e \u003cp\u003eAppendix 6: Sample minimal pair lists.\u003c\/p\u003e \u003cp\u003eAppendix 7: Pro-forma for describing therapy tasks.\u003c\/p\u003e \u003cp\u003eAppendix 8: Child interview questions. \u003c\/p\u003e \u003cp\u003eGlossary.\u003c\/p\u003e \u003cp\u003eReferences.\u003c\/p\u003e \u003cp\u003eIndex.\u003c\/p\u003e","brand":"John Wiley \u0026 Sons Inc","offers":[{"title":"Default Title","offer_id":49402263699799,"sku":"9780470027448","price":60.75,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0817\/1739\/5799\/files\/9780470027448.jpg?v=1730479878"},{"product_id":"handbook-of-psychiatric-drugs-9780470028216","title":"Handbook of Psychiatric Drugs","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003eThe Handbook of Psychiatric Drugs is a comprehensive, clear, concise and quick reference to psychiatric drug therapies, designed to guide the clinician on the selection and implementation of treatment for mental illness.\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTrade Review\u003c\/b\u003e\u003cbr\u003e\"...an excellent little book...small enough that busy clinicians can easily read it cover to cover.\" (\u003ci\u003ePsychiatric Times\u003c\/i\u003e, June 2007)  \u003cp\u003e\"…a basic guide to drugs used to treat mental disorders…at a reasonable cost and in a handy format.\" (\u003ci\u003eAmerican Reference Books Annual\u003c\/i\u003e, March 2007)\u003c\/p\u003e \u003cp\u003e\"…a welcome addition…well-written, easy to use, and thorough in its coverage…psychiatry residents as well as practicing clinicians will find this a useful, quick referral source.\" (\u003ci\u003eDoody's Health Services\u003c\/i\u003e)\u003c\/p\u003e\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTable of Contents\u003c\/b\u003e\u003cbr\u003e\u003cb\u003ePreface.\u003c\/b\u003e  \u003cp\u003e\u003cb\u003eAcknowledgements.\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eDisclaimer.\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003e1 Antipsychotic Drugs.\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eIntroduction.\u003c\/p\u003e \u003cp\u003ePharmacology.\u003c\/p\u003e \u003cp\u003eChemistry.\u003c\/p\u003e \u003cp\u003eMechanism of Action.\u003c\/p\u003e \u003cp\u003ePharmacokinetics.\u003c\/p\u003e \u003cp\u003eIndications for Use of Antipsychotic Drugs.\u003c\/p\u003e \u003cp\u003eDrug Selection and Initiation of Treatment.\u003c\/p\u003e \u003cp\u003eDrug Selection for the Treatment of Schizophrenia.\u003c\/p\u003e \u003cp\u003eEffects of Antipsychotic Agents on Symptoms of Schizophrenia.\u003c\/p\u003e \u003cp\u003eDrug Selection for the Treatment of Bipolar Disorder.\u003c\/p\u003e \u003cp\u003eDrug Selection for the Treatment of Major Depression With Psychotic Features.\u003c\/p\u003e \u003cp\u003eDrug Selection for the Treatment of Delusional Disorder.\u003c\/p\u003e \u003cp\u003eDrug Selection for the Treatment of Delirium.\u003c\/p\u003e \u003cp\u003eDrug Selection for the Treatment of Psychosis and Agitation Associated with Dementia.\u003c\/p\u003e \u003cp\u003eDrug Selection for the Treatment of Mental Retardation and Developmental Disorders.\u003c\/p\u003e \u003cp\u003eDrug Selection for Huntington’s Disease and Tourette’s Disorder.\u003c\/p\u003e \u003cp\u003eSubstance-induced Psychoses.\u003c\/p\u003e \u003cp\u003eAdverse Effects of Antipsychotics.\u003c\/p\u003e \u003cp\u003eAcute Extrapyramidal Side Effects (Dystonia, Parkinsonism, Akathisia).\u003c\/p\u003e \u003cp\u003eTardive Dyskinesia and Other Tardive Syndromes.\u003c\/p\u003e \u003cp\u003eNeuroleptic Malignant Syndrome.\u003c\/p\u003e \u003cp\u003eEndocrine and Sexual Effects.\u003c\/p\u003e \u003cp\u003eMetabolic Effects.\u003c\/p\u003e \u003cp\u003eCardiovascular Effects.\u003c\/p\u003e \u003cp\u003eGastrointestinal Effects.\u003c\/p\u003e \u003cp\u003eHepatic Effects.\u003c\/p\u003e \u003cp\u003eHematological Effects.\u003c\/p\u003e \u003cp\u003eOther Side Effects.\u003c\/p\u003e \u003cp\u003eDrug Interactions and Antipsychotic Agents.\u003c\/p\u003e \u003cp\u003eAntipsychotic Medications and Pregnancy.\u003c\/p\u003e \u003cp\u003eAdditional Reading.\u003c\/p\u003e \u003cp\u003e\u003cb\u003e2 Antidepressants.\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eIntroduction.\u003c\/p\u003e \u003cp\u003ePharmacology.\u003c\/p\u003e \u003cp\u003eMechanisms of Action.\u003c\/p\u003e \u003cp\u003ePharmacokinetics.\u003c\/p\u003e \u003cp\u003eIndications for Use of Antidepressants.\u003c\/p\u003e \u003cp\u003ePanic Disorder (PD).\u003c\/p\u003e \u003cp\u003eObsessive–Compulsive Disorder (OCD).\u003c\/p\u003e \u003cp\u003eGeneralized Anxiety Disorder (GAD).\u003c\/p\u003e \u003cp\u003eSocial Phobias and Posttraumatic Stress Disorder (PTSD).\u003c\/p\u003e \u003cp\u003eBulimia.\u003c\/p\u003e \u003cp\u003eAnorexia Nervosa.\u003c\/p\u003e \u003cp\u003eBody Dysmorphic Disorder (BDD).\u003c\/p\u003e \u003cp\u003ePremenstrual Dysphoria (PMDD).\u003c\/p\u003e \u003cp\u003eChildhood Disorders.\u003c\/p\u003e \u003cp\u003eOther Psychiatric Disorders.\u003c\/p\u003e \u003cp\u003eOther Medical Conditions.\u003c\/p\u003e \u003cp\u003eDrug Selection and Initiation of Treatment for Major Depression.\u003c\/p\u003e \u003cp\u003eSpecial Considerations in the Selection of an Antidepressant.\u003c\/p\u003e \u003cp\u003eInitiation of Treatment.\u003c\/p\u003e \u003cp\u003eTherapeutic Drug Monitoring.\u003c\/p\u003e \u003cp\u003eEarly, or Pre-response, Period.\u003c\/p\u003e \u003cp\u003eResponse, or Acute Treatment, Period.\u003c\/p\u003e \u003cp\u003eTreatment of Partially Responsive and Nonresponsive Patients.\u003c\/p\u003e \u003cp\u003eAntidepressant Augmentation.\u003c\/p\u003e \u003cp\u003eChanging to a New Agent.\u003c\/p\u003e \u003cp\u003eContinuation and Maintenance Periods, and Discontinuation.\u003c\/p\u003e \u003cp\u003eSide Effects.\u003c\/p\u003e \u003cp\u003eAnticholinergic Effects.\u003c\/p\u003e \u003cp\u003eAutonomic Effects.\u003c\/p\u003e \u003cp\u003eNeurologic Effects.\u003c\/p\u003e \u003cp\u003eWeight Gain.\u003c\/p\u003e \u003cp\u003eGastrointestinal Symptoms.\u003c\/p\u003e \u003cp\u003eSexual Dysfunction.\u003c\/p\u003e \u003cp\u003eCardiac Conduction.\u003c\/p\u003e \u003cp\u003eSuicide Risk.\u003c\/p\u003e \u003cp\u003eAllergic and Hematologic Effects.\u003c\/p\u003e \u003cp\u003eOther Effects.\u003c\/p\u003e \u003cp\u003eCentral Serotonergic Syndrome.\u003c\/p\u003e \u003cp\u003eMonoamine Oxidase Inhibitors.\u003c\/p\u003e \u003cp\u003eDrug Interactions.\u003c\/p\u003e \u003cp\u003eTricyclic Antidepressants.\u003c\/p\u003e \u003cp\u003ePharmacokinetic Effects.\u003c\/p\u003e \u003cp\u003eMonoamine Oxidase Inhibitors.\u003c\/p\u003e \u003cp\u003eSerotonin Reuptake Inhibitors.\u003c\/p\u003e \u003cp\u003eOther Second-Generation Antidepressants.\u003c\/p\u003e \u003cp\u003eThird-Generation Antidepressants.\u003c\/p\u003e \u003cp\u003eSummary.\u003c\/p\u003e \u003cp\u003eRecommendations for the Use of Antidepressants.\u003c\/p\u003e \u003cp\u003eAdditional Reading.\u003c\/p\u003e \u003cp\u003e\u003cb\u003e3 Mood Stabilizers.\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eIntroduction.\u003c\/p\u003e \u003cp\u003ePharmacology.\u003c\/p\u003e \u003cp\u003eChemistry.\u003c\/p\u003e \u003cp\u003eMechanism of Action.\u003c\/p\u003e \u003cp\u003ePharmacokinetics.\u003c\/p\u003e \u003cp\u003eIndications.\u003c\/p\u003e \u003cp\u003eDrug Selection and Initiation of Treatment.\u003c\/p\u003e \u003cp\u003eAcute Mania.\u003c\/p\u003e \u003cp\u003eDrug Selection.\u003c\/p\u003e \u003cp\u003eRelative Efficacy of Different Agents.\u003c\/p\u003e \u003cp\u003eTreatment Initiation and Dose Titration.\u003c\/p\u003e \u003cp\u003eAcute Depression.\u003c\/p\u003e \u003cp\u003eDrug Selection.\u003c\/p\u003e \u003cp\u003eTreatment Initiation and Dose Titration.\u003c\/p\u003e \u003cp\u003eBreakthrough Episodes.\u003c\/p\u003e \u003cp\u003eMaintenance.\u003c\/p\u003e \u003cp\u003eRapid Cycling.\u003c\/p\u003e \u003cp\u003eCosts.\u003c\/p\u003e \u003cp\u003eAdverse Effects.\u003c\/p\u003e \u003cp\u003eDrug Interactions.\u003c\/p\u003e \u003cp\u003ePregnancy.\u003c\/p\u003e \u003cp\u003eSummary.\u003c\/p\u003e \u003cp\u003eAdditional Reading.\u003c\/p\u003e \u003cp\u003e\u003cb\u003e4 Anxiolytic Drugs.\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eIntroduction.\u003c\/p\u003e \u003cp\u003eA General Approach to Using Medication with Anxious Patients.\u003c\/p\u003e \u003cp\u003ePharmacology.\u003c\/p\u003e \u003cp\u003eAntidepressants.\u003c\/p\u003e \u003cp\u003eBenzodiazepines.\u003c\/p\u003e \u003cp\u003eBuspirone.\u003c\/p\u003e \u003cp\u003eBeta-Blocker Medications.\u003c\/p\u003e \u003cp\u003eAnticonvulsants.\u003c\/p\u003e \u003cp\u003eAntipsychotics.\u003c\/p\u003e \u003cp\u003eIndications for Use.\u003c\/p\u003e \u003cp\u003eAntidepressants.\u003c\/p\u003e \u003cp\u003eBenzodiazepines.\u003c\/p\u003e \u003cp\u003eBuspirone.\u003c\/p\u003e \u003cp\u003eBeta-blocker Medications.\u003c\/p\u003e \u003cp\u003eAnticonvulsants.\u003c\/p\u003e \u003cp\u003eAntipsychotics.\u003c\/p\u003e \u003cp\u003eAugmentation\/Adjuvant Treatments.\u003c\/p\u003e \u003cp\u003eDrug Selection, Dose, and Initiation of Treatment.\u003c\/p\u003e \u003cp\u003eSide Effects.\u003c\/p\u003e \u003cp\u003eDrug Interactions.\u003c\/p\u003e \u003cp\u003eContraindications and Special Precautions.\u003c\/p\u003e \u003cp\u003eSummary.\u003c\/p\u003e \u003cp\u003eAdditional Reading.\u003c\/p\u003e \u003cp\u003e\u003cb\u003e5 Sedative–Hypnotic Agents.\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eIntroduction.\u003c\/p\u003e \u003cp\u003eDiagnosis.\u003c\/p\u003e \u003cp\u003eTreatment Options.\u003c\/p\u003e \u003cp\u003eNon-prescription Agents.\u003c\/p\u003e \u003cp\u003ePrescription Medications.\u003c\/p\u003e \u003cp\u003ePharmacology.\u003c\/p\u003e \u003cp\u003eBenzodiazepines.\u003c\/p\u003e \u003cp\u003eChloral Hydrate.\u003c\/p\u003e \u003cp\u003eZolpidem.\u003c\/p\u003e \u003cp\u003eZaleplon.\u003c\/p\u003e \u003cp\u003eEszopiclone.\u003c\/p\u003e \u003cp\u003eRamelteon.\u003c\/p\u003e \u003cp\u003eDrug Selection.\u003c\/p\u003e \u003cp\u003eOther Prescription Hypnotics.\u003c\/p\u003e \u003cp\u003eTreatment Implementation.\u003c\/p\u003e \u003cp\u003eAdverse Effects.\u003c\/p\u003e \u003cp\u003eBenzodiazepines.\u003c\/p\u003e \u003cp\u003eChloral Hydrate.\u003c\/p\u003e \u003cp\u003eZolpidem.\u003c\/p\u003e \u003cp\u003eZaleplon.\u003c\/p\u003e \u003cp\u003eEszopiclone.\u003c\/p\u003e \u003cp\u003eRamelteon.\u003c\/p\u003e \u003cp\u003eDrug Interactions and Special Precautions.\u003c\/p\u003e \u003cp\u003eSummary.\u003c\/p\u003e \u003cp\u003eAdditional Reading.\u003c\/p\u003e \u003cp\u003e\u003cb\u003e6 Psychostimulants.\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eIntroduction.\u003c\/p\u003e \u003cp\u003ePharmacology.\u003c\/p\u003e \u003cp\u003eChemistry.\u003c\/p\u003e \u003cp\u003eMechanism of Action.\u003c\/p\u003e \u003cp\u003ePharmacokinetics.\u003c\/p\u003e \u003cp\u003eIndications and Contraindications.\u003c\/p\u003e \u003cp\u003eDrug Selection.\u003c\/p\u003e \u003cp\u003eTreatment Initiation and Dose Titration.\u003c\/p\u003e \u003cp\u003eTreatment Evaluation.\u003c\/p\u003e \u003cp\u003eMaintenance Treatment.\u003c\/p\u003e \u003cp\u003eTreatment Resistance.\u003c\/p\u003e \u003cp\u003eEffects of Treatment on Symptoms.\u003c\/p\u003e \u003cp\u003eADHD in Adults.\u003c\/p\u003e \u003cp\u003eAlternative Preparations to the Standard Stimulant Medications.\u003c\/p\u003e \u003cp\u003eNarcolepsy.\u003c\/p\u003e \u003cp\u003eOther Indications.\u003c\/p\u003e \u003cp\u003eCosts.\u003c\/p\u003e \u003cp\u003eAdverse Effects.\u003c\/p\u003e \u003cp\u003eDrug Interactions.\u003c\/p\u003e \u003cp\u003eSummary.\u003c\/p\u003e \u003cp\u003eAdditional Reading.\u003c\/p\u003e \u003cp\u003e\u003cb\u003e7 Cognitive Enhancers and Treatments for Alzheimer’s Disease.\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eIntroduction.\u003c\/p\u003e \u003cp\u003ePharmacology.\u003c\/p\u003e \u003cp\u003eMechanism of Action.\u003c\/p\u003e \u003cp\u003ePharmacokinetics.\u003c\/p\u003e \u003cp\u003eIndications.\u003c\/p\u003e \u003cp\u003eDrug Selection.\u003c\/p\u003e \u003cp\u003eTreatment Initiation.\u003c\/p\u003e \u003cp\u003eMaintenance Treatment.\u003c\/p\u003e \u003cp\u003eTreatment Evaluation.\u003c\/p\u003e \u003cp\u003eAdverse Effects.\u003c\/p\u003e \u003cp\u003eCholinesterase Inhibitors.\u003c\/p\u003e \u003cp\u003eDrug Interactions.\u003c\/p\u003e \u003cp\u003eSummary.\u003c\/p\u003e \u003cp\u003eAdditional Reading.\u003c\/p\u003e \u003cp\u003e\u003cb\u003e8 Drugs for Treating Substance Abuse Disorders.\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eIntroduction.\u003c\/p\u003e \u003cp\u003eSyndromes Associated with Intoxication.\u003c\/p\u003e \u003cp\u003eAlcohol Intoxication.\u003c\/p\u003e \u003cp\u003eSedative–Hypnotic Intoxication.\u003c\/p\u003e \u003cp\u003eOpiate Intoxication.\u003c\/p\u003e \u003cp\u003eCocaine and Amphetamine Intoxication.\u003c\/p\u003e \u003cp\u003eIntoxication by LSD, Mescaline, MDMA (‘Ecstasy’), and Psilocybin.\u003c\/p\u003e \u003cp\u003ePhencyclidine Intoxication.\u003c\/p\u003e \u003cp\u003eDrug Treatment of Withdrawal Syndromes.\u003c\/p\u003e \u003cp\u003eAlcohol Withdrawal.\u003c\/p\u003e \u003cp\u003eWithdrawal from Sedative–Hypnotics.\u003c\/p\u003e \u003cp\u003eWithdrawal from Opiates.\u003c\/p\u003e \u003cp\u003eManagement of Withdrawal in Patients with Multiple Dependencies.\u003c\/p\u003e \u003cp\u003eAgents to Aid Relapse Prevention.\u003c\/p\u003e \u003cp\u003eMedications for Alcohol Dependence.\u003c\/p\u003e \u003cp\u003eMedications for Cocaine Dependence.\u003c\/p\u003e \u003cp\u003eMedications for Opiate Dependence.\u003c\/p\u003e \u003cp\u003eSpecial Considerations.\u003c\/p\u003e \u003cp\u003eDrug Treatments for Nicotine Dependence.\u003c\/p\u003e \u003cp\u003ePharmacotherapies for Substance Abusers with Additional Psychiatric Illness.\u003c\/p\u003e \u003cp\u003ePharmacotherapy for Specific Psychiatric Disorders.\u003c\/p\u003e \u003cp\u003eDrug Interactions in Chemical Dependency.\u003c\/p\u003e \u003cp\u003eAdditional Reading.\u003c\/p\u003e \u003cp\u003e\u003cb\u003eIndex.\u003c\/b\u003e\u003c\/p\u003e","brand":"John Wiley \u0026 Sons Inc","offers":[{"title":"Default Title","offer_id":49402264125783,"sku":"9780470028216","price":30.35,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0817\/1739\/5799\/files\/9780470028216.jpg?v=1730479878"},{"product_id":"textbook-of-pharmacoepidemiology-9780470029244","title":"Textbook of Pharmacoepidemiology","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003eThe Textbook of Pharmacoepidemiology provides a streamlined text for evaluating the safety and effectiveness of medicines.  It includes a brief introduction to pharmacoepidemiology as well as sections on data sources, methodology and applications. Each chapter includes key points, case studies and essential references.\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTrade Review\u003c\/b\u003e\u003cbr\u003e\"…a useful textbook for upper-level undergraduate, graduate, and postdoctoral fellows in pharmacy, medical, and public health programs.\" (\u003ci\u003eThe Annals of Pharmacotherapy\u003c\/i\u003e, June 2007)  \u003cp\u003e\"This is a major text with far-reaching impact…recommended for all courses in public health or pharmacology…\" (\u003ci\u003eElectric Review\u003c\/i\u003e, March\/April 2007)\u003c\/p\u003e\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTable of Contents\u003c\/b\u003e\u003cbr\u003eList of Contributors.  \u003cp\u003ePreface.\u003c\/p\u003e \u003cp\u003eAcknowledgments.\u003c\/p\u003e \u003cp\u003eAcknowledgments from \u003ci\u003ePharmacoepidemiology, Fourth Edition\u003c\/i\u003e.\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSECTION I INTRODUCTION TO PHARMACOEPIDEMIOLOGY.\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e1. What is Pharmacoepidemiology? (\u003ci\u003eBrian L. Strom\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e2. Study Designs Available for Pharmacoepidemiology Studies (\u003ci\u003eBrian L. Strom\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e3. Sample Size Considerations for Pharmacoepidemiology Studies (\u003ci\u003eBrian L. Strom\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e4. Basic Principles of Clinical Pharmacology Relevant to Pharmacoepidemiology Studies (\u003ci\u003eSean Hennessy\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e5. When Should One Perform Pharmacoepidemiology Studies? (\u003ci\u003eBrian L. Strom\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e6. Views from Academia, Industry, and Regulatory Agencies (\u003ci\u003eLeanne K. Madre, Robert M. Califf, Robert F. Reynolds, Peter Arlett, and Jane Moseley\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSECTION II SOURCES OF PHARMACOEPIDEMIOLOGY DATA.\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e7. Spontaneous Reporting in the United States (\u003ci\u003eSyed Rizwanuddin Ahmad, Norman S. Marks, and Roger A. Goetsch\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e8. Global Drug Surveillance: The WHO Programme for International Drug Monitoring (\u003ci\u003eI. Ralph Edwards, Sten Olsson, Marie Lindquist, and Bruce Hugman\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e9. Case–Control Surveillance (\u003ci\u003eLynn Rosenberg, Patricia F. Coogan, and Julie R. Palmer\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e10. Prescription-Event Monitoring (\u003ci\u003eSaad A.W. Shakir\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e11. Overview of Automated Databases in Pharmacoepidemiology (\u003ci\u003eBrian L. Strom\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e12. Examples of Automated Databases (\u003ci\u003eAndy Stergachis, Kathleen W. Saunders, Robert L. Davis, Stephen E. Kimmel, Rita Schinnar, K. Arnold Chan, Deborah Shatin, Nigel S.B. Rawson, Sean Hennessy, Winanne Downey, MaryRose Stang, Patricia Beck, William Osei, Hubert G. Leufkens, Thomas M. MacDonald, and Joel M. Gelfand\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e13. Other Approaches to Pharmacoepidemiology Studies (\u003ci\u003eBrian L. Strom\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e14. How Should One Perform Pharmacoepidemiology Studies? Choosing Among the Available Alternatives (\u003ci\u003eBrian L. Strom\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e15. Validity of Pharmacoepidemiologic Drug and Diagnosis Data (\u003ci\u003eSuzanne L. West, Brian L. Strom, and Charles Poole\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSECTION III SPECIAL ISSUES IN PHARMACOEPIDEMIOLOGY METHODOLOGY.\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e16. Bias and Confounding in Pharmacoepidemiology (\u003ci\u003eIlona Csizmadi and Jean-Paul Collet\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e17. Determining Causation from Case Reports (\u003ci\u003eJudith K. Jones\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e18. Molecular Pharmacoepidemiology (\u003ci\u003eStephen E. Kimmel\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e19. Bioethical Issues in Pharmacoepidemiologic Research (\u003ci\u003eKevin Haynes, Jason Karlawish, and Elizabeth B. Andrews\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e20. The Use of Randomized Controlled Trials for Pharmacoepidemiology Studies (\u003ci\u003eSamuel M. Lesko and Allen A. Mitchell\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e21. The Use of Pharmacoepidemiology to Study Beneficial Drug Effects (\u003ci\u003eBrian L. Strom\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e22. Pharmacoeconomics: Economic Evaluation of Pharmaceuticals (\u003ci\u003eKevin A. Schulman, Henry A. Glick, and Daniel Polsky\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e23. Using Quality-of-Life Measurements in Pharmacoepidemiologic Research (\u003ci\u003eHolger Schünemann, Gordon H. Guyatt, and Roman Jaeschke\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e24. The Use of Meta-analysis in Pharmacoepidemiology (\u003ci\u003eCarin J. Kim and Jesse A. Berlin\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e25. Patient Adherence to Prescribed Drug Dosing Regimens in Ambulatory Pharmacotherapy (\u003ci\u003eJohn Urquhart and Bernard Vrijens\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e26. Novel Approaches to Pharmacoepidemiology Study Design and Statistical Analysis (\u003ci\u003eSamy Suissa\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSECTION IV SPECIAL APPLICATIONS OF PHARMACOEPIDEMIOLOGY.\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e27. Special Applications of Pharmacoepidemiology (\u003ci\u003eDavid Lee, Sumit R. Majumdar, Helene Levens Lipton, Stephen B. Soumerai, Sean Hennessy, Robert L. Davis, Robert T. Chen, Roselie A. Bright, Allen A. Mitchell, David J. Graham, David W. Bates, and Brian L. Strom\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e28. The Future of Pharmacoepidemiology (\u003ci\u003eBrian L. Strom and Stephen E. Kimmel\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003eAppendix A Sample Size Tables.\u003c\/p\u003e \u003cp\u003eAppendix B Glossary.\u003c\/p\u003e \u003cp\u003eIndex.\u003c\/p\u003e","brand":"John Wiley \u0026 Sons Inc","offers":[{"title":"Default Title","offer_id":49402265829719,"sku":"9780470029244","price":129.56,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0817\/1739\/5799\/files\/9780470029244.jpg?v=1730479880"},{"product_id":"hughes-outline-of-modern-psychiatry-9780470033920","title":"Hughes Outline of Modern Psychiatry","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003eHughes' Outline of Psychiatry, Fifth Edition presents a comprehensive account of current practice in psychiatry, summarising up-to-date knowledge of the subject in a concise way.  Part I touches on general classification, causes and prevention of mental disorders.\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTable of Contents\u003c\/b\u003e\u003cbr\u003e\u003cb\u003ePreface\u003c\/b\u003e.  \u003cp\u003ePART I: THE NATURE AND ASSESSMENT OF PSYCHIATRIC DISORDER.\u003c\/p\u003e \u003cp\u003e\u003cb\u003e1\u003c\/b\u003e \u003cb\u003eClassification\u003c\/b\u003e.\u003c\/p\u003e \u003cp\u003eThe basis of classification.\u003c\/p\u003e \u003cp\u003eReliability and validity.\u003c\/p\u003e \u003cp\u003eLimitations and problems of classification.\u003c\/p\u003e \u003cp\u003eCommon terms in psychiatric classification.\u003c\/p\u003e \u003cp\u003eClassification systems.\u003c\/p\u003e \u003cp\u003e\u003cb\u003e2\u003c\/b\u003e \u003cb\u003eCauses and Prevention\u003c\/b\u003e.\u003c\/p\u003e \u003cp\u003eCausation in clinical practice.\u003c\/p\u003e \u003cp\u003eHistorical background.\u003c\/p\u003e \u003cp\u003eGenetics.\u003c\/p\u003e \u003cp\u003eNeurochemistry.\u003c\/p\u003e \u003cp\u003eNeuroradiology.\u003c\/p\u003e \u003cp\u003eEpidemiology.\u003c\/p\u003e \u003cp\u003eIndividual life experience.\u003c\/p\u003e \u003cp\u003ePrevention of psychiatric disorder.\u003c\/p\u003e \u003cp\u003e\u003cb\u003e3 Assessment.\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eCircumstances of referral.\u003c\/p\u003e \u003cp\u003eThe psychiatric interview.\u003c\/p\u003e \u003cp\u003eMental state examination.\u003c\/p\u003e \u003cp\u003ePhysical examination.\u003c\/p\u003e \u003cp\u003eStructured interviews and questionnaires.\u003c\/p\u003e \u003cp\u003eFurther assessments.\u003c\/p\u003e \u003cp\u003ePhysical investigations.\u003c\/p\u003e \u003cp\u003ePART II: CLINICAL SYNDROMES.\u003c\/p\u003e \u003cp\u003e\u003cb\u003e4 Schizophrenia.\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eDefinition.\u003c\/p\u003e \u003cp\u003eFrequency.\u003c\/p\u003e \u003cp\u003eEpidemiology.\u003c\/p\u003e \u003cp\u003eCausation.\u003c\/p\u003e \u003cp\u003eClinical features.\u003c\/p\u003e \u003cp\u003eClinical types.\u003c\/p\u003e \u003cp\u003eDiagnostic criteria.\u003c\/p\u003e \u003cp\u003eDifferential diagnosis.\u003c\/p\u003e \u003cp\u003eTreatment.\u003c\/p\u003e \u003cp\u003ePrognosis.\u003c\/p\u003e \u003cp\u003e\u003cb\u003e5 Mood Disorders: Depressive Illness and Mania.\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eFrequency.\u003c\/p\u003e \u003cp\u003eEpidemiology.\u003c\/p\u003e \u003cp\u003eCauses.\u003c\/p\u003e \u003cp\u003eClinical features of depressive illness.\u003c\/p\u003e \u003cp\u003eTypes of depressive illness.\u003c\/p\u003e \u003cp\u003eDiagnosis of depressive illness.\u003c\/p\u003e \u003cp\u003eClinical features of mania.\u003c\/p\u003e \u003cp\u003eDifferential diagnosis of mood disorders.\u003c\/p\u003e \u003cp\u003eTreatment of depressive illness.\u003c\/p\u003e \u003cp\u003eTreatment of mania.\u003c\/p\u003e \u003cp\u003eProphylaxis of affective disorder.\u003c\/p\u003e \u003cp\u003e\u003cb\u003e6\u003c\/b\u003e \u003cb\u003eAnxiety and Stress-Related Disorders\u003c\/b\u003e.\u003c\/p\u003e \u003cp\u003eBoundaries of anxiety disorder.\u003c\/p\u003e \u003cp\u003eHierarchy of diagnosis.\u003c\/p\u003e \u003cp\u003eFrequency.\u003c\/p\u003e \u003cp\u003eEpidemiology.\u003c\/p\u003e \u003cp\u003eCauses.\u003c\/p\u003e \u003cp\u003eClinical features.\u003c\/p\u003e \u003cp\u003eDifferential diagnosis.\u003c\/p\u003e \u003cp\u003eTreatment.\u003c\/p\u003e \u003cp\u003ePrognosis.\u003c\/p\u003e \u003cp\u003eGeneralized anxiety disorder (anxiety state).\u003c\/p\u003e \u003cp\u003ePanic disorder.\u003c\/p\u003e \u003cp\u003eAgoraphobia.\u003c\/p\u003e \u003cp\u003eSocial phobia.\u003c\/p\u003e \u003cp\u003eSimple phobias (specific phobias, monophobias).\u003c\/p\u003e \u003cp\u003eObsessive-compulsive disorders.\u003c\/p\u003e \u003cp\u003eConversion and dissociative disorders.\u003c\/p\u003e \u003cp\u003ePost-traumatic stress disorder (PTSD).\u003c\/p\u003e \u003cp\u003eAdjustment disorders.\u003c\/p\u003e \u003cp\u003eBereavement.\u003c\/p\u003e \u003cp\u003e\u003cb\u003e7 Personality Disorders.\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eDefinition.\u003c\/p\u003e \u003cp\u003eClassification.\u003c\/p\u003e \u003cp\u003eTypes of personality disorder.\u003c\/p\u003e \u003cp\u003eEpidemiology.\u003c\/p\u003e \u003cp\u003eDifferential diagnosis.\u003c\/p\u003e \u003cp\u003eTreatment.\u003c\/p\u003e \u003cp\u003ePrognosis.\u003c\/p\u003e \u003cp\u003eSociopathic (dissocial) personality disorder.\u003c\/p\u003e \u003cp\u003e\u003cb\u003e8 Paranoid States.\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eDefinition.\u003c\/p\u003e \u003cp\u003ePredisposing factors.\u003c\/p\u003e \u003cp\u003eDifferential diagnosis of paranoid states.\u003c\/p\u003e \u003cp\u003eManagement.\u003c\/p\u003e \u003cp\u003eCulture-bound syndromes.\u003c\/p\u003e \u003cp\u003e\u003cb\u003e9\u003c\/b\u003e \u003cb\u003ePhysical Symptoms and Psychiatric Disorder\u003c\/b\u003e.\u003c\/p\u003e \u003cp\u003eIntroduction.\u003c\/p\u003e \u003cp\u003eAssessing physical symptoms in psychiatric practice.\u003c\/p\u003e \u003cp\u003eUnexplainedphysical symptoms.\u003c\/p\u003e \u003cp\u003eManagement.\u003c\/p\u003e \u003cp\u003eMalingering and exaggeration.\u003c\/p\u003e \u003cp\u003e\u003cb\u003e10\u003c\/b\u003e \u003cb\u003eOrganic Brain Syndromes\u003c\/b\u003e.\u003c\/p\u003e \u003cp\u003eCauses.\u003c\/p\u003e \u003cp\u003eClinical features.\u003c\/p\u003e \u003cp\u003eDelirium.\u003c\/p\u003e \u003cp\u003eDementia.\u003c\/p\u003e \u003cp\u003eFocal brain damage.\u003c\/p\u003e \u003cp\u003e\u003cb\u003e11\u003c\/b\u003e \u003cb\u003eLiaison Psychiatry\u003c\/b\u003e.\u003c\/p\u003e \u003cp\u003ePsychological influences on the course of physical disease.\u003c\/p\u003e \u003cp\u003eThe stresses of physical illness.\u003c\/p\u003e \u003cp\u003eAdjustment and coping.\u003c\/p\u003e \u003cp\u003eClinical depression in medically ill patients.\u003c\/p\u003e \u003cp\u003eManagement and prevention.\u003c\/p\u003e \u003cp\u003eLiaison psychiatry.\u003c\/p\u003e \u003cp\u003e\u003cb\u003e12\u003c\/b\u003e \u003cb\u003eDrug Misuse\u003c\/b\u003e.\u003c\/p\u003e \u003cp\u003eDefinitions.\u003c\/p\u003e \u003cp\u003eEpidemiology.\u003c\/p\u003e \u003cp\u003eCauses.\u003c\/p\u003e \u003cp\u003ePsychiatric and physical complications.\u003c\/p\u003e \u003cp\u003eLegal aspects.\u003c\/p\u003e \u003cp\u003ePharmacology.\u003c\/p\u003e \u003cp\u003ePrevention.\u003c\/p\u003e \u003cp\u003eTreatment.\u003c\/p\u003e \u003cp\u003eOpiates.\u003c\/p\u003e \u003cp\u003eAmphetamines (speed).\u003c\/p\u003e \u003cp\u003eCocaine and crack.\u003c\/p\u003e \u003cp\u003eCannabis (Indian hemp, hashish, pot).\u003c\/p\u003e \u003cp\u003eLysergic acid diethylamide (LSD, acid).\u003c\/p\u003e \u003cp\u003eMDMA (Ecstasy).\u003c\/p\u003e \u003cp\u003eGlues and solvents.\u003c\/p\u003e \u003cp\u003eTobacco.\u003c\/p\u003e \u003cp\u003eCaffeine.\u003c\/p\u003e \u003cp\u003eBarbiturates.\u003c\/p\u003e \u003cp\u003eBenzodiazepines.\u003c\/p\u003e \u003cp\u003e\u003cb\u003e13\u003c\/b\u003e \u003cb\u003eAlcohol Misuse\u003c\/b\u003e.\u003c\/p\u003e \u003cp\u003eSafe limits of drinking.\u003c\/p\u003e \u003cp\u003eFrequency.\u003c\/p\u003e \u003cp\u003eEpidemiology.\u003c\/p\u003e \u003cp\u003eCauses.\u003c\/p\u003e \u003cp\u003eEffects of alcohol.\u003c\/p\u003e \u003cp\u003eCourse of alcohol abuse.\u003c\/p\u003e \u003cp\u003eRecognition.\u003c\/p\u003e \u003cp\u003eTreatment.\u003c\/p\u003e \u003cp\u003ePrognosis.\u003c\/p\u003e \u003cp\u003ePrevention.\u003c\/p\u003e \u003cp\u003e\u003cb\u003e14\u003c\/b\u003e \u003cb\u003eDeliberate Self-Harm\u003c\/b\u003e.\u003c\/p\u003e \u003cp\u003eSuicide.\u003c\/p\u003e \u003cp\u003eNon-fatal deliberate self-harm (parasuicide, attempted suicide).\u003c\/p\u003e \u003cp\u003e\u003cb\u003e15\u003c\/b\u003e \u003cb\u003eEating Disorders: Anorexia Nervosa and Bulimia Nervosa\u003c\/b\u003e.\u003c\/p\u003e \u003cp\u003eIntroduction.\u003c\/p\u003e \u003cp\u003eAnorexia nervosa.\u003c\/p\u003e \u003cp\u003eBulimia nervosa.\u003c\/p\u003e \u003cp\u003eObesity.\u003c\/p\u003e \u003cp\u003e\u003cb\u003e16\u003c\/b\u003e \u003cb\u003eDisorders of Female Reproductive Life\u003c\/b\u003e.\u003c\/p\u003e \u003cp\u003ePregnancy.\u003c\/p\u003e \u003cp\u003ePuerperal psychosis.\u003c\/p\u003e \u003cp\u003ePost-natal depression and other neurotic syndromes.\u003c\/p\u003e \u003cp\u003eAbortion.\u003c\/p\u003e \u003cp\u003eStillbirth and perinatal death.\u003c\/p\u003e \u003cp\u003ePremenstrual syndrome.\u003c\/p\u003e \u003cp\u003eThe menopause.\u003c\/p\u003e \u003cp\u003eHysterectomy.\u003c\/p\u003e \u003cp\u003e\u003cb\u003e17\u003c\/b\u003e \u003cb\u003eSexual Problems\u003c\/b\u003e.\u003c\/p\u003e \u003cp\u003eSexual dysfunctions.\u003c\/p\u003e \u003cp\u003eSexual deviations.\u003c\/p\u003e \u003cp\u003eGender-identity disorders.\u003c\/p\u003e \u003cp\u003eHomosexuality.\u003c\/p\u003e \u003cp\u003e\u003cb\u003e18\u003c\/b\u003e \u003cb\u003eChild and Adolescent Psychiatry\u003c\/b\u003e.\u003c\/p\u003e \u003cp\u003ePredisposing factors.\u003c\/p\u003e \u003cp\u003eClassification.\u003c\/p\u003e \u003cp\u003eHistory taking and examination.\u003c\/p\u003e \u003cp\u003eTreatment.\u003c\/p\u003e \u003cp\u003eRelationship with adult disorder.\u003c\/p\u003e \u003cp\u003eNeurotic (emotional) disorders.\u003c\/p\u003e \u003cp\u003eConduct disorders.\u003c\/p\u003e \u003cp\u003eAttention deficit disorder.\u003c\/p\u003e \u003cp\u003ePsychoses.\u003c\/p\u003e \u003cp\u003eDelays in development.\u003c\/p\u003e \u003cp\u003eSymptomatic disorders.\u003c\/p\u003e \u003cp\u003eChild abuse.\u003c\/p\u003e \u003cp\u003ePsychiatry of adolescence.\u003c\/p\u003e \u003cp\u003e\u003cb\u003e19\u003c\/b\u003e \u003cb\u003eLearning disability\u003c\/b\u003e.\u003c\/p\u003e \u003cp\u003eFrequency.\u003c\/p\u003e \u003cp\u003eCauses.\u003c\/p\u003e \u003cp\u003eDiagnosis of learning disability.\u003c\/p\u003e \u003cp\u003eAssociated phenomena.\u003c\/p\u003e \u003cp\u003eManagement.\u003c\/p\u003e \u003cp\u003ePrognosis.\u003c\/p\u003e \u003cp\u003ePrevention.\u003c\/p\u003e \u003cp\u003eChromosomal abnormalities.\u003c\/p\u003e \u003cp\u003eGene abnormalities.\u003c\/p\u003e \u003cp\u003eAcquired handicap.\u003c\/p\u003e \u003cp\u003eMiscellaneous.\u003c\/p\u003e \u003cp\u003e\u003cb\u003e20\u003c\/b\u003e \u003cb\u003ePsychiatry of Old Age\u003c\/b\u003e.\u003c\/p\u003e \u003cp\u003eFrequency.\u003c\/p\u003e \u003cp\u003eClinical syndromes.\u003c\/p\u003e \u003cp\u003eAssessment.\u003c\/p\u003e \u003cp\u003eSpecific treatments.\u003c\/p\u003e \u003cp\u003eOrganization of services.\u003c\/p\u003e \u003cp\u003e\u003cb\u003e21\u003c\/b\u003e \u003cb\u003eForensic Psychiatry\u003c\/b\u003e.\u003c\/p\u003e \u003cp\u003eOffending behaviour.\u003c\/p\u003e \u003cp\u003ePredicting violence and dangerousness.\u003c\/p\u003e \u003cp\u003ePsychiatric aspects of specific offences.\u003c\/p\u003e \u003cp\u003eTreatment: general considerations.\u003c\/p\u003e \u003cp\u003eFacilities for mentally disordered offenders.\u003c\/p\u003e \u003cp\u003ePsychiatric reports: criminal.\u003c\/p\u003e \u003cp\u003ePART III: TREATMENT.\u003c\/p\u003e \u003cp\u003e\u003cb\u003e22\u003c\/b\u003e \u003cb\u003ePsychological Treatment\u003c\/b\u003e.\u003c\/p\u003e \u003cp\u003eHistorical background.\u003c\/p\u003e \u003cp\u003ePrinciples of psychotherapy today.\u003c\/p\u003e \u003cp\u003eCounselling.\u003c\/p\u003e \u003cp\u003eCognitive-behavioural therapy (CBT).\u003c\/p\u003e \u003cp\u003ePsychodynamic psychotherapy.\u003c\/p\u003e \u003cp\u003eGroup therapy.\u003c\/p\u003e \u003cp\u003eFamily and marital therapy.\u003c\/p\u003e \u003cp\u003eRecent advances.\u003c\/p\u003e \u003cp\u003e\u003cb\u003e23\u003c\/b\u003e \u003cb\u003ePsychopharmacology\u003c\/b\u003e.\u003c\/p\u003e \u003cp\u003eGeneral principles of using psychotropic drugs.\u003c\/p\u003e \u003cp\u003eAntipsychotics.\u003c\/p\u003e \u003cp\u003eAntidepressants.\u003c\/p\u003e \u003cp\u003eAntidepressants: tricyclic group.\u003c\/p\u003e \u003cp\u003eAntidepressants: SSRI group.\u003c\/p\u003e \u003cp\u003eAntidepressants: MAOI group.\u003c\/p\u003e \u003cp\u003eOther antidepressant drugs.\u003c\/p\u003e \u003cp\u003eBenzodiazepines.\u003c\/p\u003e \u003cp\u003eMood stabilizers.\u003c\/p\u003e \u003cp\u003eLithium.\u003c\/p\u003e \u003cp\u003e\u003cb\u003e24\u003c\/b\u003e \u003cb\u003eElectroconvulsive Therapy\u003c\/b\u003e \u003cb\u003e(ECT) and Psychosurgery\u003c\/b\u003e.\u003c\/p\u003e \u003cp\u003eIndications.\u003c\/p\u003e \u003cp\u003eMode of action.\u003c\/p\u003e \u003cp\u003eEfficacy and prediction of response.\u003c\/p\u003e \u003cp\u003eTiming and number of treatments.\u003c\/p\u003e \u003cp\u003ePracticalities of treatment.\u003c\/p\u003e \u003cp\u003eContraindications.\u003c\/p\u003e \u003cp\u003eBilateral versus unilateral ECT.\u003c\/p\u003e \u003cp\u003eUnwanted effects.\u003c\/p\u003e \u003cp\u003eConsent for ECT.\u003c\/p\u003e \u003cp\u003eMyths.\u003c\/p\u003e \u003cp\u003eFor the future.\u003c\/p\u003e \u003cp\u003ePsychosurgery.\u003c\/p\u003e \u003cp\u003e\u003cb\u003e25\u003c\/b\u003e \u003cb\u003eOrganization of Services\u003c\/b\u003e.\u003c\/p\u003e \u003cp\u003eIntroduction .\u003c\/p\u003e \u003cp\u003eBackground and history.\u003c\/p\u003e \u003cp\u003eCommunity care.\u003c\/p\u003e \u003cp\u003eThe psychiatric multidisciplinary team.\u003c\/p\u003e \u003cp\u003ePsychiatry in primary care.\u003c\/p\u003e \u003cp\u003eInpatient services.\u003c\/p\u003e \u003cp\u003eOutpatient clinics.\u003c\/p\u003e \u003cp\u003eCrisis and home treatment.\u003c\/p\u003e \u003cp\u003eDay hospitals.\u003c\/p\u003e \u003cp\u003eResource centres and day centres.\u003c\/p\u003e \u003cp\u003eRecovery and rehabilitation.\u003c\/p\u003e \u003cp\u003eThe care programme approach.\u003c\/p\u003e \u003cp\u003eAssertive outreach teams.\u003c\/p\u003e \u003cp\u003eNon-NHS health-care facilities.\u003c\/p\u003e \u003cp\u003e\u003cb\u003e26\u003c\/b\u003e \u003cb\u003eThe Mental Health Act 1983\u003c\/b\u003e.\u003c\/p\u003e \u003cp\u003eIntroduction.\u003c\/p\u003e \u003cp\u003eBackground.\u003c\/p\u003e \u003cp\u003eCompulsory admission.\u003c\/p\u003e \u003cp\u003ePatients already in hospital.\u003c\/p\u003e \u003cp\u003ePatients in the community.\u003c\/p\u003e \u003cp\u003eRelatives.\u003c\/p\u003e \u003cp\u003eApproved social workers (ASWs).\u003c\/p\u003e \u003cp\u003ePolice powers.\u003c\/p\u003e \u003cp\u003eMentally abnormal offenders.\u003c\/p\u003e \u003cp\u003eConsent to treatment.\u003c\/p\u003e \u003cp\u003eInformation for detained patients.\u003c\/p\u003e \u003cp\u003eMental Health Act Commission.\u003c\/p\u003e \u003cp\u003e\u003cb\u003eGlossary.\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eIndex\u003c\/b\u003e.\u003c\/p\u003e","brand":"John Wiley \u0026 Sons Inc","offers":[{"title":"Default Title","offer_id":49402267664727,"sku":"9780470033920","price":46.95,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0817\/1739\/5799\/files\/9780470033920.jpg?v=1730479892"},{"product_id":"biomimetic-bioresponsive-and-bioactive-materials-9780470056714","title":"Biomimetic Bioresponsive and Bioactive Materials","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003e\u003cp\u003e\u003cb\u003eThe accessible introduction to biomaterials and their applications in tissue replacement, medical devices, and more\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eMolecular and cell biology is being increasingly integrated into the search for high-performance biomaterials and biomedical devices, transforming a formerly engineering- and materials sciencebased field into a truly interdisciplinary area of investigation. Biomimetic, Bioresponsive, and Bioactive Materials presents a comprehensive introduction to biomaterials, discussing how they are selected, designed, and modified for integration with living tissue and how they can be utilized in the development of medical devices, orthopedics, and other related areas.\u003c\/p\u003e \u003cp\u003eExamining the physico chemical properties of widely used biomaterials and their uses in different clinical fields, the book explores applications including soft and hard tissue replacement; biointeractive metals, polymers, and ceramics; and in vitro, in vivo, and ex vivo biocompatibility tests and\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTable of Contents\u003c\/b\u003e\u003cbr\u003e\u003cb\u003ePreface xi\u003c\/b\u003e  \u003c\/p\u003e\u003cp\u003e\u003cb\u003eContributors xiii\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003e1 HISTORY OF BIOMIMETIC, BIOACTIVE, AND BIORESPONSIVE BIOMATERIALS 1\u003cbr\u003e \u003c\/b\u003e\u003ci\u003eMatteo Santin and Gary Phillips\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e1.1 The First Generation of Biomaterials: The Search for “The Bioinert” 1\u003c\/p\u003e \u003cp\u003e1.1.1 Bioinert: Myth, Reality, or Utopia? 4\u003c\/p\u003e \u003cp\u003e1.2 The Second Generation of Biomaterials: Biomimetic, Bioresponsive, Bioactive 5\u003c\/p\u003e \u003cp\u003e1.2.1 Hydroxyapatite (HA) and Bioglass®: Cell Adhesion and Stimulation 6\u003c\/p\u003e \u003cp\u003e1.2.2 Collagen, Fibrin Glue, and Hyaluronic Acid Hydrogels: Presenting the ECM 6\u003c\/p\u003e \u003cp\u003e1.2.3 Chitosan and Alginate: Replacing the ECM 9\u003c\/p\u003e \u003cp\u003e1.2.4 Poly(Lactic\/Glycolic) Acid Copolymers: Encouraging Tissue Remodeling by Safe Biodegradation 10\u003c\/p\u003e \u003cp\u003e1.2.5 Porous Metals: Favoring Mechanical Integration 11\u003c\/p\u003e \u003cp\u003e1.3 The Third-Generation Biomaterials: Biomimicking Natural Bioactive and Bioresponsive Processes 13\u003c\/p\u003e \u003cp\u003e1.3.1 Principal Phases of Tissue Regeneration 14\u003c\/p\u003e \u003cp\u003e\u003ci\u003e1.3.1.1 Cell Adhesion: The Cornerstone of Tissue Regeneration 16\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003ci\u003e1.3.1.2 Mechanisms of Tissue Mineralization 19\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e1.4 Principles of Biomimesis and Bioactivity 21\u003c\/p\u003e \u003cp\u003e1.4.1 Biomimicking of the ECM 22\u003c\/p\u003e \u003cp\u003e1.4.2 Biomimicking of Cell Membrane Components 24\u003c\/p\u003e \u003cp\u003e1.4.3 Biomimicking Cell Signaling Pathways 24\u003c\/p\u003e \u003cp\u003e\u003ci\u003e1.4.3.1 Modulation of the Growth Factor Signaling by Gene Expression: Bioactive Gene Delivery Systems 25\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e1.5 Bioactive Biomaterials from Different Natural Sources 26\u003c\/p\u003e \u003cp\u003e1.5.1 Silk Fibroin 26\u003c\/p\u003e \u003cp\u003e1.5.2 Soybean-Based Biomaterials 27\u003c\/p\u003e \u003cp\u003e1.6 Scope of This Book 29\u003c\/p\u003e \u003cp\u003eReferences 30\u003c\/p\u003e \u003cp\u003e\u003cb\u003e2 SOFT TISSUE STRUCTURE AND FUNCTIONALITY 35\u003cbr\u003e \u003c\/b\u003e\u003ci\u003eGabriela Voskerician\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e2.1 Overview 35\u003c\/p\u003e \u003cp\u003e2.2 Epithelial Tissue 36\u003c\/p\u003e \u003cp\u003e2.2.1 Background 36\u003c\/p\u003e \u003cp\u003e2.3 The Skin 37\u003c\/p\u003e \u003cp\u003e2.3.1 Structure and Functionality 37\u003c\/p\u003e \u003cp\u003e2.3.2 Repair, Healing, and Renewal 42\u003c\/p\u003e \u003cp\u003e2.4 Muscle Tissue 46\u003c\/p\u003e \u003cp\u003e2.4.1 Background 46\u003c\/p\u003e \u003cp\u003e2.4.2 Skeletal Muscle 48\u003c\/p\u003e \u003cp\u003e\u003ci\u003e2.4.2.1 Structure and Functionality 48\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003ci\u003e2.4.2.2 Repair, Healing, and Renewal 50\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e2.4.3 Smooth Muscle 51\u003c\/p\u003e \u003cp\u003e\u003ci\u003e2.4.3.1 Structure and Functionality 51\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003ci\u003e2.4.3.2 Repair, Healing, and Renewal 52\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e2.4.4 Cardiac Muscle 54\u003c\/p\u003e \u003cp\u003e\u003ci\u003e2.4.4.1 Structure and Functionality 54\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003ci\u003e2.4.4.2 Repair, Healing, and Renewal 55\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e2.5 Connective Tissue 56\u003c\/p\u003e \u003cp\u003e2.5.1 Background 56\u003c\/p\u003e \u003cp\u003e2.5.2 Embryonic Connective Tissue 57\u003c\/p\u003e \u003cp\u003e2.5.3 Connective Tissue Proper 58\u003c\/p\u003e \u003cp\u003e\u003ci\u003e2.5.3.1 Cells of the Connective Tissue Proper 59\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003ci\u003e2.5.3.2 Connective Tissue Proper Fibers 60\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003ci\u003e2.5.3.3 Ground Substance 63\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e2.5.4 Specialized Connective Tissues 64\u003c\/p\u003e \u003cp\u003e\u003ci\u003e2.5.4.1 Structure and Function 64\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003ci\u003e2.5.4.2 Repair, Healing, and Renewal of Hyaline Cartilage 66\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e2.6 The Foreign Body Response 68\u003c\/p\u003e \u003cp\u003eExercises\/Questions for Chapter 2 76\u003c\/p\u003e \u003cp\u003eReferences 76\u003c\/p\u003e \u003cp\u003e\u003cb\u003e3 HARD TISSUE STRUCTURE AND FUNCTIONALITY 81\u003cbr\u003e \u003c\/b\u003e\u003ci\u003eAntonio Merolli and Paolo Tranquilli Leali\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e3.1 Definition of Hard Tissues 81\u003c\/p\u003e \u003cp\u003e3.2 Articular Cartilage 81\u003c\/p\u003e \u003cp\u003e3.2.1 Structure of the Articular Cartilage 82\u003c\/p\u003e \u003cp\u003e3.2.2 Specifi c Mechanism Repair of the Articular Cartilage 83\u003c\/p\u003e \u003cp\u003e3.3 Bone Tissue 84\u003c\/p\u003e \u003cp\u003e3.3.1 The Structure of the Bony Tissues 85\u003c\/p\u003e \u003cp\u003e3.3.2 The Functions of Bone Tissue 86\u003c\/p\u003e \u003cp\u003e3.3.3 Cell Types Involved in Bone Homeostasis: The Osteoblasts and the Osteoclasts 88\u003c\/p\u003e \u003cp\u003e3.3.4 Ossifi cation, Turnover, and Remodeling 89\u003c\/p\u003e \u003cp\u003e3.3.5 Bone Composite Structure and Its Effect on Mechanical Performance 91\u003c\/p\u003e \u003cp\u003e3.4 Concluding Remarks 92\u003c\/p\u003e \u003cp\u003eExercises\/Questions for Chapter 3 92\u003c\/p\u003e \u003cp\u003eReferences 93\u003c\/p\u003e \u003cp\u003e\u003cb\u003e4 BIOMEDICAL APPLICATIONS OF BIOMIMETIC POLYMERS: THE PHOSPHORYLCHOLINE-CONTAINING POLYMERS 95\u003cbr\u003e \u003c\/b\u003e\u003ci\u003eAndrew L. Lewis and Andrew W. Lloyd\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e4.1 Historical Perspective 95\u003c\/p\u003e \u003cp\u003e4.2 Synthesis of PC-Containing Polymers 97\u003c\/p\u003e \u003cp\u003e4.3 Physicochemical Properties of PC-Containing Polymers 98\u003c\/p\u003e \u003cp\u003e4.3.1 Antifouling Mechanisms of Action 98\u003c\/p\u003e \u003cp\u003e4.3.2 Swelling Phenomena and Structural Aspects of PC Coatings 100\u003c\/p\u003e \u003cp\u003e4.4 Stability and Mechanical Property Considerations 102\u003c\/p\u003e \u003cp\u003e4.4.1 PC Coatings and Surface Treatments 102\u003c\/p\u003e \u003cp\u003e4.4.2 Bulk Hydrogels and Blends 104\u003c\/p\u003e \u003cp\u003e4.5 Biological Compatibility 105\u003c\/p\u003e \u003cp\u003e4.5.1 Interactions with Proteins, Eukaryotic Cells, and Bacteria 105\u003c\/p\u003e \u003cp\u003e4.5.2 Interaction with Other Tissues 107\u003c\/p\u003e \u003cp\u003e4.6. Applications of PC Polymers 107\u003c\/p\u003e \u003cp\u003e4.6.1 Cardiovascular Applications 107\u003c\/p\u003e \u003cp\u003e\u003ci\u003e4.6.1.1 PC-Coated Coronary Stents 108\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003ci\u003e4.6.1.2 Vascular Grafts 108\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003ci\u003e4.6.1.3 Extracorporeal Circuits 109\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e4.6.2 Ophthalmic Applications 110\u003c\/p\u003e \u003cp\u003e\u003ci\u003e4.6.2.1 Intraocular Lenses 110\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003ci\u003e4.6.2.2 Contact Lenses 111\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003ci\u003e4.6.2.3 Other Ocular Devices 112\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e4.6.3 Anti-Infective Applications 112\u003c\/p\u003e \u003cp\u003e\u003ci\u003e4.6.3.1 Urological Devices 112\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003ci\u003e4.6.3.2 Tympanostomy Tubes 112\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e4.6.4 Orthopedic Applications 113\u003c\/p\u003e \u003cp\u003e4.6.5 Biosensors and Diagnostics 113\u003c\/p\u003e \u003cp\u003e4.6.6 Separation Systems 115\u003c\/p\u003e \u003cp\u003e4.6.7 PC Polymers for Drug Delivery 116\u003c\/p\u003e \u003cp\u003e\u003ci\u003e4.6.7.1 Drug Delivery Coatings 116\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003ci\u003e4.6.7.2 Gel-Based Drug Delivery Systems 119\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003ci\u003e4.6.7.3 Nano\/Micro Particulate Drug and Gene Delivery 119\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003ci\u003e4.6.7.4 Drug Conjugates 122\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e4.6.8 Emerging Applications 122\u003c\/p\u003e \u003cp\u003e4.7 Summary 123\u003c\/p\u003e \u003cp\u003eExercises\/Questions for Chapter 4 124\u003c\/p\u003e \u003cp\u003eReferences 125\u003c\/p\u003e \u003cp\u003e\u003cb\u003e5 BIOMIMETIC, BIORESPONSIVE, AND BIOACTIVE MATERIALS: INTEGRATING MATERIALS WITH TISSUE 141\u003cbr\u003e \u003c\/b\u003e\u003ci\u003eRoberto Chiesa and Alberto Cigada\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e5.1 Introduction 141\u003c\/p\u003e \u003cp\u003e5.2 Mandatory Requirements for Metals as Implantable Materials 142\u003c\/p\u003e \u003cp\u003e5.2.1 Stiffness 142\u003c\/p\u003e \u003cp\u003e5.2.2 Strength 143\u003c\/p\u003e \u003cp\u003e5.2.3 Corrosion Resistance 144\u003c\/p\u003e \u003cp\u003e\u003ci\u003e5.2.3.1 General Corrosion 144\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003ci\u003e5.2.3.2 Crevice Corrosion 145\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003ci\u003e5.2.3.3 Fretting Corrosion 145\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003ci\u003e5.2.3.4 Galvanic Corrosion 145\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e5.3 Biocompatibility of Metals 145\u003c\/p\u003e \u003cp\u003e5.3.1 ISO Standardized Metal Family 146\u003c\/p\u003e \u003cp\u003e\u003ci\u003e5.3.1.1 Stainless Steels 146\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003ci\u003e5.3.1.2 Cobalt Alloys 148\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003ci\u003e5.3.1.3 Titanium and Titanium Alloys 149\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e5.4 Surface Treatments of Metals for Biomedical Applications 150\u003c\/p\u003e \u003cp\u003e5.4.1 Cathodic Deposition Treatments 152\u003c\/p\u003e \u003cp\u003e5.4.2 Anodic Oxidation 152\u003c\/p\u003e \u003cp\u003eExercises\/Questions for Chapter 5 157\u003c\/p\u003e \u003cp\u003eReferences 157\u003c\/p\u003e \u003cp\u003e\u003cb\u003e6 CERAMICS 161\u003cbr\u003e \u003c\/b\u003e\u003ci\u003eMontserrat Espanol, Román A. Pérez, Edgar B. Montufar, and Maria-Pau Ginebra\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e6.1 Historical Perspective 161\u003c\/p\u003e \u003cp\u003e6.2 Biostable Ceramics 162\u003c\/p\u003e \u003cp\u003e6.2.1 Alumina 163\u003c\/p\u003e \u003cp\u003e6.2.2 Zirconia 164\u003c\/p\u003e \u003cp\u003e6.3 Bioactive and Resorbable Ceramics 165\u003c\/p\u003e \u003cp\u003e6.3.1 Basic Concepts 165\u003c\/p\u003e \u003cp\u003e6.3.2 Glasses and Glass–Ceramics 166\u003c\/p\u003e \u003cp\u003e\u003ci\u003e6.3.2.1 Physicochemical Properties of Bioactive Glasses 167\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003ci\u003e6.3.2.2 Silicate-Based Glasses 168\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003ci\u003e6.3.2.3 Phosphate-Based Glasses 170\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003ci\u003e6.3.2.4 Processing of Glass and Glass–Ceramics 170\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e6.3.3 Calcium Phosphates 172\u003c\/p\u003e \u003cp\u003e\u003ci\u003e6.3.3.1 Physicochemistry of Calcium Phosphates 172\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003ci\u003e6.3.3.2 Processing of Calcium Orthophosphates 175\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e6.3.4 New Trends in Bioactive and Resorbable Materials Integration 178\u003c\/p\u003e \u003cp\u003eExercises\/Questions for Chapter 6 183\u003c\/p\u003e \u003cp\u003eReferences 184\u003c\/p\u003e \u003cp\u003e\u003cb\u003e7 BIOFUNCTIONAL BIOMATERIALS OF THE FUTURE 191\u003cbr\u003e \u003c\/b\u003e\u003ci\u003eMário Barbosa, Gary Phillips, and Matteo Santin\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e7.1 Clinically Led Next Generation Biomaterials 191\u003c\/p\u003e \u003cp\u003e7.1.1 Wound Dressings and Dermal Substitutes 192\u003c\/p\u003e \u003cp\u003e7.1.2 Vascular Grafts and Cardiovascular Stents 193\u003c\/p\u003e \u003cp\u003e7.1.3 Joint Implants and Cartilage Tissue Engineering 194\u003c\/p\u003e \u003cp\u003e7.1.4 Bone Fillers 195\u003c\/p\u003e \u003cp\u003e7.1.5 Nerve Guides 195\u003c\/p\u003e \u003cp\u003e7.1.6 Ophthalmologic Devices 195\u003c\/p\u003e \u003cp\u003e7.2 Biomacromolecule-Inspired Biomaterials 196\u003c\/p\u003e \u003cp\u003e7.2.1 Artificial Laminin 196\u003c\/p\u003e \u003cp\u003e7.2.2 Artificial Elastin 197\u003c\/p\u003e \u003cp\u003e7.2.3 Artificial Collagen 197\u003c\/p\u003e \u003cp\u003e7.2.4 GAG- and PGN-Mimicking Biomaterials 197\u003c\/p\u003e \u003cp\u003e7.3 Nanostructured Biomimetic, Bioresponsive, and Bioactive Biomaterials 198\u003c\/p\u003e \u003cp\u003e7.3.1 Nanofabrication of Biomaterials 198\u003c\/p\u003e \u003cp\u003e\u003ci\u003e7.3.1.1 2D Techniques 199\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003ci\u003e7.3.1.2 3D Techniques 199\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003ci\u003e7.3.1.3 Polymeric Dendrimers 200\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003ci\u003e7.3.1.4 Self-Assembling Peptides 201\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e7.4 Conclusions 202\u003c\/p\u003e \u003cp\u003eExercises\/Questions for Chapter 7 203\u003c\/p\u003e \u003cp\u003eReferences 203\u003c\/p\u003e \u003cp\u003e\u003cb\u003eIndex 207\u003c\/b\u003e\u003c\/p\u003e","brand":"John Wiley \u0026 Sons Inc","offers":[{"title":"Default Title","offer_id":49402273694039,"sku":"9780470056714","price":83.66,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0817\/1739\/5799\/files\/9780470056714.jpg?v=1730479910"},{"product_id":"handbook-of-neural-engineering-9780470056691","title":"Handbook of Neural Engineering","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003eThe Handbook of Neural Engineering provides the theoretical foundations and current applications from the leading researchers in this emerging new field. It focuses on the brain-computer interface, nano-neural engineering, neural prostheses, imaging the brain, neural signal processing, the brain and neurons.\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTrade Review\u003c\/b\u003e\u003cbr\u003e\"This handbook is an excellent and informative technical reference for researchers and undergraduate students with a basic background in electrical or biomedical engineering.\" (\u003ci\u003eIEEE Engineering in Medicine and Biology Magazine\u003c\/i\u003e, January\/February 2009)  \u003cp\u003e\"…a comprehensive summary of the latest trends and is an essential resource for researchers in this field.\" (\u003ci\u003eJournal of the American Medical Association\u003c\/i\u003e, August 22\/29, 2007)\u003c\/p\u003e \u003cp\u003e\"…very useful…for those already working in the discipline. It fills a void in the pertinent literature; there are few works that compare.\" (\u003ci\u003eDoody's Book Reviews\u003c\/i\u003e)\u003c\/p\u003e \u003cp\u003e\"This is a good quality book…useful as a current survey and resource for ideas, and the state of the art.\" (\u003ci\u003eDoody's Book Reviews\u003c\/i\u003e)\u003c\/p\u003e \u003cp\u003e\"...useful as a current survey and resource for ideas, and the state of the art.\" (\u003ci\u003eDoody's Health Services\u003c\/i\u003e)\u003c\/p\u003e\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTable of Contents\u003c\/b\u003e\u003cbr\u003ePREFACE.  \u003cp\u003eCONTRIBUTORS.\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePART I:\u003c\/b\u003e \u003cb\u003eNEURAL SIGNAL AND IMAGE PROCESSING AND MODELING.\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eCHAPTER 1: OPTIMAL SIGNAL PROCESSING FOR BRAIN–MACHINE INTERFACES (Justin C. Sanchez and Jose C. Principe).\u003c\/p\u003e \u003cp\u003eCHAPTER 2: MODULATION OF ELECTROPHYSIOLOGICAL ACTIVITY IN NEURAL NETWORKS: TOWARD A BIOARTIFICIAL LIVING SYSTEM (Laura Bonzano, Alessandro Vato, Michela Chiappalone, and Sergio Martinoia).\u003c\/p\u003e \u003cp\u003eCHAPTER 3: ESTIMATION OF POSTERIOR PROBABILITIES WITH NEURAL NETWORKS: APPLICATION TO MICROCALCIFICATION DETECTION IN BREAST CANCER DIAGNOSIS (Juan Ignacio Arribas, Jesús Cid-Sueiro, and Carlos Alberola-López).\u003c\/p\u003e \u003cp\u003eCHAPTER 4: IDENTIFICATION OF CENTRAL AUDITORY PROCESSING DISORDERS BY BINAURALLY EVOKED BRAINSTEM RESPONSES (Daniel J. Strauss, Wolfgang Delb, and Peter K. Plinkert).\u003c\/p\u003e \u003cp\u003eCHAPTER 5: FUNCTIONAL CHARACTERIZATION OF ADAPTIVE VISUAL ENCODING (Nicholas A. Lesica and Garrett B. Stanley).\u003c\/p\u003e \u003cp\u003eCHAPTER 6: DECONVOLUTION OF OVERLAPPING AUDITORY BRAINSTEM RESPONSES OBTAINED AT HIGH STIMULUS RATES (O. Ozdamar, R. E. Delgado, E. Yavuz, and N. Acikgoz).\u003c\/p\u003e \u003cp\u003eCHAPTER 7: AUTONOMIC CARDIAC MODULATION AT SINOATRIAL AND ATRIOVENTRICULAR NODES: OBSERVATIONS AND MODELS (S. Ward, R. Shouldice, C. Heneghan, P. Nolan, and G. McDarby).\u003c\/p\u003e \u003cp\u003eCHAPTER 8: NEURAL NETWORKS AND TIME–FREQUENCY ANALYSIS OF SURFACE ELECTROMYOGRAPHIC SIGNALS FOR MUSCLE CEREBRAL CONTROL (Bruno Azzerboni, Maurizio Ipsale, Fabio La Foresta, and Francesco Carlo Morabito).\u003c\/p\u003e \u003cp\u003eCHAPTER 9: MULTIRESOLUTION FRACTAL ANALYSIS OF MEDICAL IMAGES (Khan M. Iftekharuddin and Carlos Parra).\u003c\/p\u003e \u003cp\u003eCHAPTER 10: METHODS FOR NEURAL-NETWORK-BASED SEGMENTATION OF MAGNETIC RESONANCE IMAGES (Lia Morra, Silvia Delsanto, and Fabrizio Lamberti).\u003c\/p\u003e \u003cp\u003eCHAPTER 11: HIGH-RESOLUTION EEG AND ESTIMATION OF CORTICAL ACTIVITY FOR BRAIN–COMPUTER INTERFACE APPLICATIONS (F. Cincotti, M. Mattiocco, D. Mattia, F. Babiloni, and L. Astolfi)\u003c\/p\u003e \u003cp\u003eCHAPTER 12: ESTIMATION OF CORTICAL SOURCES RELATED TO SHORT-TERM MEMORY IN HUMANS WITH HIGHRESOLUTION EEG RECORDINGS AND STATISTICAL PROBABILITY MAPPING (L. Astolfi, D. Mattia, F. Babiloni, and F. Cincotti).\u003c\/p\u003e \u003cp\u003eCHAPTER 13: EXPLORING SEMANTIC MEMORY AREAS BY FUNCTIONAL MRI (G. Rizzo, P. Vitali, G. Baselli, M. Tettamanti, P. Scifo, S. Cerutti, D. Perani, and F. Fazio).\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePART II:\u003c\/b\u003e \u003cb\u003eNEURO–NANOTECHNOLOGY: ARTIFICIAL IMPLANTS AND NEURAL PROTHESES.\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eCHAPTER 14: RESTORATION OF MOVEMENT BY IMPLANTABLE NEURAL MOTOR PROSTHESES (Thomas Sinkjær and Dejan B. Popovic).\u003c\/p\u003e \u003cp\u003eCHAPTER 15: HYBRID OLFACTORY BIOSENSOR USING MULTICHANNEL ELECTROANTENNOGRAM: DESIGN AND APPLICATION (John R. Hetling, Andrew J. Myrick, Kye-Chung Park, and Thomas C. Baker).\u003c\/p\u003e \u003cp\u003eCHAPTER 16: RECONFIGURABLE RETINA-LIKE PREPROCESSING PLATFORM FOR CORTICAL VISUAL NEUROPROSTHESES (Samuel Romero, Francisco J. Pelayo, Christian A. Morillas, Antonio Martı´nez, and Eduardo Ferna´ndez).\u003c\/p\u003e \u003cp\u003eCHAPTER 17: BIOMIMETIC INTEGRATION OF NEURAL AND ACOUSTIC SIGNAL PROCESSING (Rolf Müller and Herbert Peremans).\u003c\/p\u003e \u003cp\u003eCHAPTER 18: RETINAL IMAGE AND PHOSPHENE IMAGE: AN ANALOGY (Luke E. Hallum, Spencer C. Chen, Gregg J. Suaning, and Nigel H. Lovell).\u003c\/p\u003e \u003cp\u003eCHAPTER 19: BRAIN-IMPLANTABLE BIOMIMETIC ELECTRONICS AS NEURAL PROSTHESES TO RESTORE LOST COGNITIVE FUNCTION (Theodore W. Berger, Ashish Ahuja, Spiros H. Courellis, Gopal Erinjippurath, Ghassan Gholmieh, John J. Granacki, Min Chi Hsaio, Jeff LaCoss, Vasilis Z. Marmarelis, Patrick Nasiatka, Vijay Srinivasan, Dong Song, Armand R. Tanguay, Jr., and Jack Wills).\u003c\/p\u003e \u003cp\u003eCHAPTER 20: ADVANCES IN RETINAL NEUROPROSTHETICS (Nigel H. Lovell, Luke E. Hallum, Spencer C. Chen, Socrates Dokos, Philip Byrnes-Preston, Rylie Green, Laura Poole-Warren, Torsten Lehmann, and Gregg J. Suaning).\u003c\/p\u003e \u003cp\u003eCHAPTER 21: TOWARDS A CULTURED NEURAL PROBE: PATTERNING OF NETWORKS AND THEIR ELECTRICAL ACTIVITY (W. L. C. Rutten, T. G. Ruardij, E. Marani, and B. H. Roelofsen).\u003c\/p\u003e \u003cp\u003eCHAPTER 22: SPIKE SUPERPOSITION RESOLUTION IN MULTICHANNEL EXTRACELLULAR NEURAL RECORDINGS: A NOVEL APPROACH (Karim Oweiss and David Anderson).\u003c\/p\u003e \u003cp\u003eCHAPTER 23: TOWARD A BUTTON-SIZED 1024-SITE WIRELESS CORTICAL MICROSTIMULATING ARRAY (Maysam Ghovanloo and Khalil Najafi).\u003c\/p\u003e \u003cp\u003eCHAPTER 24: PRACTICAL CONSIDERATIONS IN RETINAL NEUROPROSTHESIS DESIGN (Gregg J. Suaning, Luke E. Hallum, Spencer Chen, Philip Preston, Socrates Dokos, and Nigel H. Lovell).\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePART III:\u003c\/b\u003e \u003cb\u003eNEUROROBOTICS AND NEURAL REHABILATION ENGINEERING.\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eCHAPTER 25: INTERFACING NEURAL AND ARTIFICIAL SYSTEMS: FROM NEUROENGINEERING TO NEUROROBOTICS (P. Dario, C. Laschi, A. Menciassi, E. Guglielmelli, M. C. Carrozza, and S. Micera).\u003c\/p\u003e \u003cp\u003eCHAPTER 26: NEUROCONTROLLER FOR ROBOT ARMS BASED ON BIOLOGICALLY INSPIRED VISUOMOTOR COORDINATION NEURAL MODELS (E. Guglielmelli, G. Asuni, F. Leoni, A. Starita, and P. Dario).\u003c\/p\u003e \u003cp\u003eCHAPTER 27: MUSCLE SYNERGIES FOR MOTOR CONTROL (Andrea d’Avella and Matthew Tresch).\u003c\/p\u003e \u003cp\u003eCHAPTER 28: ROBOTS WITH NEURAL BUILDING BLOCKS (Henrik Hautop Lund and Jacob Nielsen)\u003c\/p\u003e \u003cp\u003eCHAPTER 29: DECODING SENSORY STIMULI FROM POPULATIONS OF NEURONS: METHODS FOR LONG-TERM LONGITUDINAL STUDIES (Guglielmo Foffani, Banu Tutunculer, Steven C. Leiser, and Karen A. Moxon)\u003c\/p\u003e \u003cp\u003eCHAPTER 30: MODEL OF MAMMALIAN VISUAL SYSTEM WITH OPTICAL LOGIC CELLS (J. A. Mart\u0026amp;ıacute;n-Pereda and A. González Marcos).\u003c\/p\u003e \u003cp\u003eCHAPTER 31: CNS REORGANIZATION DURING SENSORY-SUPPORTED TREADMILL TRAINING (I. Cikajlo, Z. Matja\u0026amp;ccaron;i\u0026amp;cacute;, and T. Bajd).\u003c\/p\u003e \u003cp\u003eCHAPTER 32: INDEPENDENT COMPONENT ANALYSIS OF SURFACE EMG FOR DETECTION OF SINGLE MOTONEURONS FIRING IN VOLUNTARY ISOMETRIC CONTRACTION (Gonzalo A. Garc\u0026amp;ıacute;a, Ryuhei Okuno, and Kenzo Akazawa).\u003c\/p\u003e \u003cp\u003eCHAPTER 33: RECENT ADVANCES IN COMPOSITE AEP\/EEG INDICES FOR ESTIMATING HYPNOTIC DEPTH DURING GENERAL ANESTHESIA? (Erik Weber Jensen, Pablo Martinez, Hector Litvan, Hugo Vereecke, Bernardo Rodriguez, and Michel M. R. F. Struys).\u003c\/p\u003e \u003cp\u003eCHAPTER 34: ENG RECORDING AMPLIFIER CONFIGURATIONS FOR TRIPOLAR CUFF ELECTRODES (I. F. Triantis, A. Demosthenous, M. S. Rahal, and N. Donaldson).\u003c\/p\u003e \u003cp\u003eCHAPTER 35: CABLE EQUATION MODEL FOR MYELINATED NERVE FIBER (P. D. Einziger, L. M. Livshitz, and J. Mizrahi).\u003c\/p\u003e \u003cp\u003eCHAPTER 36: BAYESIAN NETWORKS FOR MODELING CORTICAL INTEGRATION Paul Sajda, Kyungim Baek and Leif Finkel).\u003c\/p\u003e \u003cp\u003eCHAPTER 37: NORMAL AND ABNORMAL AUDITORY INFORMATION PROCESSING REVEALED BY NONSTATIONARY SIGNAL ANALYSIS OF EEG (Ben H. Jansen, Anant Hegde, Jacob Ruben, and Nashaat N. Boutros).\u003c\/p\u003e \u003cp\u003eCHAPTER 38: PROBING OSCILLATORY VISUAL DYNAMICS AT THE PERCEPTUAL LEVEL (H. Fotowat, H. Ö\u0026amp;gcaron;men, H. E. Bedell, and B. G. Breitmeyer).\u003c\/p\u003e \u003cp\u003eCHAPTER 39: NONLINEAR APPROACHES TO LEARNING AND MEMORY (Klaus Lehnertz).\u003c\/p\u003e \u003cp\u003eCHAPTER 40: SINGLE-TRIAL ANALYSIS OF EEG FOR ENABLING COGNITIVE USER INTERFACES (Adam D. Gerson, Lucas C. Parra, and Paul Sajda).\u003c\/p\u003e \u003cp\u003eINDEX.\u003c\/p\u003e \u003cp\u003eABOUT THE EDITOR.\u003c\/p\u003e","brand":"John Wiley \u0026 Sons Inc","offers":[{"title":"Default Title","offer_id":49402273759575,"sku":"9780470056691","price":178.16,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0817\/1739\/5799\/files\/9780470056691.jpg?v=1730479911"},{"product_id":"dictionary-for-clinical-trials-9780470058176","title":"Dictionary for Clinical Trials","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003eAs a result of the expansion in the area of pharmaceutical medicine there is an ever-increasing need for educational resources. The Dictionary of Clinical Trials, Second Edition comprehensively explains the 3000 words and short phrases commonly used when designing, running, analysing and reporting clinical trials.\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTrade Review\u003c\/b\u003e\u003cbr\u003e\"These succinct definitions effectively provide the researcher with a working understanding of the term, enabling one to understand the structure and outcomes of a clinical trial.\" (\u003ci\u003eAmerican Reference Books Annual\u003c\/i\u003e, March 2008)\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTable of Contents\u003c\/b\u003e\u003cbr\u003ePreface to the Second Edition.  \u003cp\u003ePreface to the First Edition.\u003c\/p\u003e \u003cp\u003eThe Ground Rules.\u003c\/p\u003e \u003cp\u003eBibliography.\u003c\/p\u003e \u003cp\u003eA to Z entries.\u003c\/p\u003e \u003cp\u003eAppendix 1: ICH \"Efficacy' Guidelines.\u003c\/p\u003e \u003cp\u003eAppendix 2: Pharmaceutical Forms (or Dosage Forms).\u003c\/p\u003e \u003cp\u003eAppendix 3: Routes of Administration.\u003c\/p\u003e","brand":"John Wiley \u0026 Sons Inc","offers":[{"title":"Default Title","offer_id":49402274808151,"sku":"9780470058176","price":41.75,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0817\/1739\/5799\/files\/9780470058176.jpg?v=1730479916"},{"product_id":"ethics-in-speech-and-language-therapy-9780470058886","title":"Ethics in Speech and Language Therapy","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003eEthics in Speech and Language Therapy  is a key text for students, practitioners and managers alike. The demands of practice, legislation, registration and the recognition of competencies all point to the need for speech and language therapists to be explicitly educated about ethics.\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTrade Review\u003c\/b\u003e\u003cbr\u003e\"This is really thought-provoking - far from a dry, dull book about ethical theories and principles . . . this book is an excellent resource for helping us think more deeply about our work-related ethical challenges.\" (Speech \u0026amp; Language Therapy in Practice, 1 July 2011)\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTable of Contents\u003c\/b\u003e\u003cbr\u003eList of contributors.  \u003cp\u003ePreface.\u003c\/p\u003e \u003cp\u003eAcknowledgements.\u003c\/p\u003e \u003cp\u003e1. Introduction.\u003c\/p\u003e \u003cp\u003e2. Practising Ethically.\u003c\/p\u003e \u003cp\u003e3. Dysphagia.\u003c\/p\u003e \u003cp\u003e4. Intellectual and Sensory Impairment.\u003c\/p\u003e \u003cp\u003e5. Acquired Language Disorders.\u003c\/p\u003e \u003cp\u003e6. Paediatric Speech and Language Disorders.\u003c\/p\u003e \u003cp\u003e7. Degenerative Conditions in Ageing.\u003c\/p\u003e \u003cp\u003e8. Service Provision and Management.\u003c\/p\u003e \u003cp\u003e9. Common Themes and Emerging Trends.\u003c\/p\u003e","brand":"John Wiley \u0026 Sons Inc","offers":[{"title":"Default Title","offer_id":49402275758423,"sku":"9780470058886","price":50.3,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0817\/1739\/5799\/files\/9780470058886.jpg?v=1730479918"},{"product_id":"the-old-age-psychiatry-handbook-a-practical-guide-9780470060155","title":"The Old Age Psychiatry Handbook A Practical Guide","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003eThe Old Age Psychiatry Handbook provides a comprehensive but concise overview of psychiatric, medical and practical issues that may arise within the speciality.  The book is written in an easy assimilated format, ideal for use in the clinic and on the ward.\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTrade Review\u003c\/b\u003e\u003cbr\u003e\"A practical guide to “coal-face” old age psychiatry. The book is packed with the kind of information it takes many years of practice to accumulate, and presents the information in a very easily digestible form. If the giants of old age psychiatry had told stories to trainees, this is what they would have told. It is clearly and concisely written.\" (\u003ci\u003eInternational Journal of Geriatric Psychiatry\u003c\/i\u003e, February 2009)  \u003cp\u003e\"The book is written in an easy assimilated format, ideal for use in the clinic and on the ward.\" (\u003ci\u003eDoody's\u003c\/i\u003e, June 2008)\u003c\/p\u003e\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTable of Contents\u003c\/b\u003e\u003cbr\u003e\u003cb\u003ePreface.\u003c\/b\u003e  \u003cp\u003e\u003cb\u003eAcknowledgements.\u003c\/b\u003e\u003c\/p\u003e 1 The Assessment of Patients in Old Age Psychiatry. \u003cp\u003eIntroduction.\u003c\/p\u003e \u003cp\u003eSetting.\u003c\/p\u003e \u003cp\u003eThe psychiatric history in older patients.\u003c\/p\u003e \u003cp\u003eThe Mental State Examination (MSE). \u003c\/p\u003e \u003cp\u003eAssessing cognition with limited time.\u003c\/p\u003e \u003cp\u003eAssessment of everyday functioning.\u003c\/p\u003e \u003cp\u003ePhysical examination.\u003c\/p\u003e \u003cp\u003eInvestigations.\u003c\/p\u003e \u003cp\u003eNeuropsychiatric testing and the memory clinic.\u003c\/p\u003e \u003cp\u003eAssessment of carers.\u003c\/p\u003e \u003cp\u003eSummary.\u003c\/p\u003e \u003cp\u003eFurther reading.\u003c\/p\u003e 2 Dementia. \u003cp\u003eDefinition and diagnosis of dementia.\u003c\/p\u003e \u003cp\u003eAssessment of a patient with dementia.\u003c\/p\u003e \u003cp\u003eGeneral management of dementia.\u003c\/p\u003e \u003cp\u003eBehavioural and psychological symptoms of dementia.\u003c\/p\u003e \u003cp\u003eWhy differentiate between the dementias?\u003c\/p\u003e \u003cp\u003eAlzheimer’s disease.\u003c\/p\u003e \u003cp\u003eVascular dementia.\u003c\/p\u003e \u003cp\u003eDementia with Lewy bodies.\u003c\/p\u003e \u003cp\u003eFrontotemporal dementia.\u003c\/p\u003e \u003cp\u003eLess common causes of dementia.\u003c\/p\u003e \u003cp\u003eMild cognitive impairment.\u003c\/p\u003e \u003cp\u003eFunctional and molecular neuroimaging in dementia.\u003c\/p\u003e \u003cp\u003eFurther reading.\u003c\/p\u003e 3 Depression. \u003cp\u003eEpidemiology.\u003c\/p\u003e \u003cp\u003eClinical features and diagnosis.\u003c\/p\u003e \u003cp\u003eRisk factors for depression in old age.\u003c\/p\u003e \u003cp\u003eTreatment.\u003c\/p\u003e \u003cp\u003eOutcome.\u003c\/p\u003e \u003cp\u003ePrevention of depression in the elderly.\u003c\/p\u003e \u003cp\u003eDepression and dementia.\u003c\/p\u003e \u003cp\u003eBereavement.\u003c\/p\u003e \u003cp\u003eSuicide.\u003c\/p\u003e \u003cp\u003eFurther reading.\u003c\/p\u003e 4 Bipolar Affective Disorder. \u003cp\u003eEpidemiology.\u003c\/p\u003e \u003cp\u003eAetiology.\u003c\/p\u003e \u003cp\u003eClinical features and diagnosis.\u003c\/p\u003e \u003cp\u003eManagement.\u003c\/p\u003e 5 Anxiety Disorders and Obsessive Compulsive Disorder. \u003cp\u003eAnxiety in the elderly.\u003c\/p\u003e \u003cp\u003eGeneralised anxiety disorder.\u003c\/p\u003e \u003cp\u003ePanic disorder.\u003c\/p\u003e \u003cp\u003ePhobic disorders.\u003c\/p\u003e \u003cp\u003ePost-traumatic stress disorder.\u003c\/p\u003e \u003cp\u003eOther reactions to stress.\u003c\/p\u003e \u003cp\u003eObsessive compulsive disorder.\u003c\/p\u003e \u003cp\u003eFurther reading.\u003c\/p\u003e 6 Psychotic Illness. \u003cp\u003eSchizophrenia.\u003c\/p\u003e \u003cp\u003eSchizoaffective disorder.\u003c\/p\u003e \u003cp\u003eDelusional disorder.\u003c\/p\u003e \u003cp\u003eFurther reading.\u003c\/p\u003e 7 Personality Disorders. \u003cp\u003ePersonality.\u003c\/p\u003e \u003cp\u003ePersonality and age.\u003c\/p\u003e \u003cp\u003eDefinition and classification of personality disorders.\u003c\/p\u003e \u003cp\u003ePersonality disorders in old age.\u003c\/p\u003e \u003cp\u003eManagement of personality disorder in old age.\u003c\/p\u003e \u003cp\u003eFurther reading.\u003c\/p\u003e 8 Alcohol. \u003cp\u003eCurrent guidelines for alcohol consumption.\u003c\/p\u003e \u003cp\u003eDefinitions.\u003c\/p\u003e \u003cp\u003eEpidemiology.\u003c\/p\u003e \u003cp\u003eDetection and screening.\u003c\/p\u003e \u003cp\u003eConsequences.\u003c\/p\u003e \u003cp\u003eManagement.\u003c\/p\u003e \u003cp\u003eFurther reading.\u003c\/p\u003e 9 Insomnia. \u003cp\u003eSleep architecture.\u003c\/p\u003e \u003cp\u003eCircadian rhythm.\u003c\/p\u003e \u003cp\u003eInsomnia and consequences in the elderly.\u003c\/p\u003e \u003cp\u003eCauses of insomnia.\u003c\/p\u003e \u003cp\u003eAssessment of a patient with insomnia.\u003c\/p\u003e \u003cp\u003eNon-pharmacological management.\u003c\/p\u003e \u003cp\u003ePharmacological management.\u003c\/p\u003e \u003cp\u003eFurther reading.\u003c\/p\u003e 10 Psychopharmacology. \u003cp\u003ePrinciples of drug treatment in old age psychiatry.\u003c\/p\u003e \u003cp\u003eAdherence.\u003c\/p\u003e \u003cp\u003ePharmacokinetics and pharmacodynamics.\u003c\/p\u003e \u003cp\u003eAdverse drug reactions and interactions.\u003c\/p\u003e \u003cp\u003eAntidepressant drugs.\u003c\/p\u003e \u003cp\u003eLithium.\u003c\/p\u003e \u003cp\u003eAnticonvulsant mood stabilisers.\u003c\/p\u003e \u003cp\u003eAntipsychotic drugs.\u003c\/p\u003e \u003cp\u003eAnxiolytics and hypnotics.\u003c\/p\u003e \u003cp\u003eDrugs used in dementia.\u003c\/p\u003e \u003cp\u003eFurther reading.\u003c\/p\u003e 11 Electroconvulsive Therapy. \u003cp\u003eIndications.\u003c\/p\u003e \u003cp\u003eMechanism of action.\u003c\/p\u003e \u003cp\u003eEfficacy.\u003c\/p\u003e \u003cp\u003eAdverse effects.\u003c\/p\u003e \u003cp\u003eCautions.\u003c\/p\u003e \u003cp\u003eConsent.\u003c\/p\u003e \u003cp\u003eECT and the Mental Health Act.\u003c\/p\u003e \u003cp\u003ePre-ECT physical work-up.\u003c\/p\u003e \u003cp\u003eMedication and ECT.\u003c\/p\u003e \u003cp\u003eECT procedure.\u003c\/p\u003e \u003cp\u003ePrevention of relapse.\u003c\/p\u003e \u003cp\u003eFurther reading.\u003c\/p\u003e 12 Psychological Therapies. \u003cp\u003eCognitive behavioural therapy.\u003c\/p\u003e \u003cp\u003eBehavioural therapy.\u003c\/p\u003e \u003cp\u003ePsychoanalytic psychotherapy.\u003c\/p\u003e \u003cp\u003eFurther reading.\u003c\/p\u003e 13 Practical, Legal and Social Issues. \u003cp\u003eProvision of services.\u003c\/p\u003e \u003cp\u003eLegal issues in old age psychiatry.\u003c\/p\u003e \u003cp\u003eSocial and financial issues in old age.\u003c\/p\u003e \u003cp\u003eFurther reading.\u003c\/p\u003e 14 Physical Illness and Old Age Psychiatry. \u003cp\u003eDelirium.\u003c\/p\u003e \u003cp\u003eVascular disease.\u003c\/p\u003e \u003cp\u003eNeurological disease.\u003c\/p\u003e \u003cp\u003eRheumatological disease.\u003c\/p\u003e \u003cp\u003eEndocrinological disease.\u003c\/p\u003e \u003cp\u003eNutritional deficit.\u003c\/p\u003e \u003cp\u003eNeoplastic disease.\u003c\/p\u003e \u003cp\u003ePalliative care.\u003c\/p\u003e \u003cp\u003eFurther reading.\u003c\/p\u003e Appendices. \u003cp\u003e\u003cb\u003eIndex.\u003c\/b\u003e\u003c\/p\u003e","brand":"John Wiley \u0026 Sons Inc","offers":[{"title":"Default Title","offer_id":49402276381015,"sku":"9780470060155","price":52.2,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0817\/1739\/5799\/files\/9780470060155.jpg?v=1730479920"},{"product_id":"computer-modeling-in-bioengineering-9780470060353","title":"Computer Modeling in Bioengineering","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003eBioengineering is a broad-based engineering discipline that applies engineering principles and design to challenges in human health and medicine, dealing with bio-molecular and molecular processes, product design, sustainability and analysis of biological systems. Applications that benefit from bioengineering include medical devices, diagnostic equipment and biocompatible materials, amongst others.  \u003cp\u003e\u003ci\u003eComputer Modeling in Bioengineering\u003c\/i\u003e offers a comprehensive reference for a large number of bioengineering topics, presenting important computer modeling problems and solutions for research and medical practice. Starting with basic theory and fundamentals, the book progresses to more advanced methods and applications, allowing the reader to become familiar with different topics to the desired extent. It includes unique and original topics alongside classical computational modeling methods, and each application is structured to explain the physiological background, phenomena that ar\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTable of Contents\u003c\/b\u003e\u003cbr\u003eContributors.  \u003c\/p\u003e\u003cp\u003ePreface.\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart I: Theoretical Background of Computational Methods.\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e1. Notation - Matrices and Tensors.\u003c\/p\u003e \u003cp\u003e2. Fundamentals of Continuum Mechanics.\u003c\/p\u003e \u003cp\u003e3. Heat Transfer, Diffusion, Fluid Mechanics, and Fluid Flow through Porous Deformable Media.\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart II: Fundamentals of Computational Methods.\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e4. Isoparametric Formulation of Finite Elements.\u003c\/p\u003e \u003cp\u003e5. Dynamic Finite Element Analysis.\u003c\/p\u003e \u003cp\u003e6. Introduction to Nonlinear Finite Element Analysis.\u003c\/p\u003e \u003cp\u003e7. Finite Element Modeling of Field Problems.\u003c\/p\u003e \u003cp\u003e8. Discrete Particle Methods for Modeling of Solids and Fluids.\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart III: Computational Methods in Bioengineering.\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e9. Introduction to Bioengineering.\u003c\/p\u003e \u003cp\u003e10. Bone Modeling.\u003c\/p\u003e \u003cp\u003e11. Biological Soft Tissue.\u003c\/p\u003e \u003cp\u003e12. Skeletal Muscles.\u003c\/p\u003e \u003cp\u003e13. Blood Flow and Blood Vessels.\u003c\/p\u003e \u003cp\u003e14. Modeling Mass Transport and Thrombosis in Arteries.\u003c\/p\u003e \u003cp\u003e15. Cartilage Mechanics.\u003c\/p\u003e \u003cp\u003e16. Cell Mechanics.\u003c\/p\u003e \u003cp\u003e17. Extracellular Mechanotransduction: Modeling Ligand Concentration Dynamics in the Lateral Intercellular Space of Compressed Airway Epithelial Cells.\u003c\/p\u003e \u003cp\u003e18. Spider Silk: Modeling Solvent Removal during Synthetic and Nephila clavipes Fiber Spinning.\u003c\/p\u003e \u003cp\u003e19. Modeling in Cancer Nanotechnology.\u003c\/p\u003e \u003cp\u003eIndex.\u003c\/p\u003e","brand":"John Wiley \u0026 Sons Inc","offers":[{"title":"Default Title","offer_id":49402276544855,"sku":"9780470060353","price":117.85,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0817\/1739\/5799\/files\/9780470060353.jpg?v=1730479921"},{"product_id":"understanding-and-treating-psychogenic-voice-disorder-9780470061220","title":"Understanding and Treating Psychogenic Voice","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003eThis book offers the speech and language therapist studying or working in the field of psychogenic voice disorders a comprehensive understanding of how they present, a classification system and guidance on assessment and treatment.\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTrade Review\u003c\/b\u003e\u003cbr\u003e\"This text is value for money, easy to dip into and a comprehensive resource for any level of experience.... Its style is accessible and it is widely referenced with an invaluable summary at the end of each chapter.\" (\u003ci\u003eSpeech \u0026amp; Language Therapy in Practice\u003c\/i\u003e, Summer 2009)  \u003cp\u003e\"This book fleshes out areas which have been ignored and malnourished in the understanding and treatment of voice.\" (\u003ci\u003eDoody's Health Services\u003c\/i\u003e)\u003c\/p\u003e\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTable of Contents\u003c\/b\u003e\u003cbr\u003e\u003cp\u003eAbout the Authors ix\u003c\/p\u003e \u003cp\u003eForeword xi\u003c\/p\u003e \u003cp\u003eForeword xiii\u003c\/p\u003e \u003cp\u003ePreface xv\u003c\/p\u003e \u003cp\u003eAcknowledgements xvii\u003c\/p\u003e \u003cp\u003e1 Psychogenic Voice Disorders – A New Model 1\u003c\/p\u003e \u003cp\u003e2 Introducing the Cognitive Behaviour Therapy Model 31\u003c\/p\u003e \u003cp\u003e3 Cognitive Behaviour Therapy: Essential Assessment Principles and Therapist Skills 39\u003c\/p\u003e \u003cp\u003e4 Assessment of Voice and Personal History 57\u003c\/p\u003e \u003cp\u003e5 Symptomatic Voice Therapy Approaches 89\u003c\/p\u003e \u003cp\u003e6 Assessing Anxiety in Voice Patients 105\u003c\/p\u003e \u003cp\u003e7 Treating Anxiety in Voice Patients 119\u003c\/p\u003e \u003cp\u003e8 Treating Lowered Mood in Voice Patients 139\u003c\/p\u003e \u003cp\u003e9 Psychological Disorders: Deciding When Not to Treat 157\u003c\/p\u003e \u003cp\u003e10 Case Studies 175\u003c\/p\u003e \u003cp\u003eReferences 207\u003c\/p\u003e \u003cp\u003eIndex 213\u003c\/p\u003e","brand":"John Wiley \u0026 Sons Inc","offers":[{"title":"Default Title","offer_id":49402277101911,"sku":"9780470061220","price":64.76,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0817\/1739\/5799\/files\/9780470061220.jpg?v=1730479922"},{"product_id":"injury-biomechanics-and-control-9780470100158","title":"Injury Biomechanics and Control","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003eWith this book as their guide, readers will discover how to design better protective equipment and devices such as helmets, seat belts, and wheelchairs in order to minimize the risk or the extent of injury to people subjected to impact loads. It is based on the theory of optimal shock isolation, first developed in the 1950s to protect missile systems from intensive shock loads.  \u003cp\u003eUsing examples from automotive, aviation, and military areas, the authors demonstrate how optimal shock isolation theory enables designers to improve the performance of protective equipment by incorporating control and optimization methods developed for shock isolation systems.\u003c\/p\u003e \u003cp\u003eThe first part of \u003ci\u003eInjury Biomechanics and Control\u003c\/i\u003e lays down the engineering foundation, setting forth core principles and techniques, including:\u003c\/p\u003e \u003cul\u003e \u003cli\u003e \u003cp\u003eFundamentals of impact and shock isolation systems\u003c\/p\u003e \u003c\/li\u003e \u003cli\u003e \u003cp\u003eBasic optimal shock isolation for single-degree-of-freedom systems\u003c\/p\u003e \u003c\/li\u003e \u003cli\u003e \u003cp\u003eOptima\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTable of Contents\u003c\/b\u003e\u003cbr\u003ePREFACE.  \u003c\/p\u003e\n\u003cp\u003e\u003cb\u003eBASIC TERMINOLOGY.\u003c\/b\u003e \u003c\/p\u003e \u003cp\u003e\u003cb\u003eCHAPTER 1 INTRODUCTION.\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e1.1 The Structure of the Book.\u003c\/p\u003e \u003cp\u003e1.2 Related Studies.\u003c\/p\u003e \u003cp\u003eReferences.\u003c\/p\u003e \u003cp\u003e\u003cb\u003eCHAPTER 2 FUNDAMENTALS OF IMPACT AND SHOCK ISOLATION.\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e2.1 Shock Loading: Basic Models and Characteristics.\u003c\/p\u003e \u003cp\u003e2.2 Shock Isolation.\u003c\/p\u003e \u003cp\u003e2.3 The Isolator as a Control Medium: Active and Passive Isolators.\u003c\/p\u003e \u003cp\u003e2.4 Does Isolation of an Object from the Base Always Lead to a Reduction in the Shock Load Transmitted to the Object?.\u003c\/p\u003e \u003cp\u003eReferences.\u003c\/p\u003e \u003cp\u003e\u003cb\u003eCHAPTER 3 BASIC OPTIMAL SHOCK ISOLATION: SINGLE DEGREE OF FREEDOM SYSTEMS.\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e3.1 Basic Problems.\u003c\/p\u003e \u003cp\u003e3.2 Limiting Performance Analysis: Basic Concept and Analytical Results.\u003c\/p\u003e \u003cp\u003e3.3 Limiting Performance Analysis: Computational Approach.\u003c\/p\u003e \u003cp\u003e3.4 Parametric Optimization.\u003c\/p\u003e \u003cp\u003e3.5 Pre-Acting Control for Shock Isolators.\u003c\/p\u003e \u003cp\u003e3.6 Best and Worst Disturbance Analyses.\u003c\/p\u003e \u003cp\u003eReferences.\u003c\/p\u003e \u003cp\u003e\u003cb\u003eCHAPTER 4 OPTIMAL SHOCK ISOLATION FOR MULTI-DEGREE-OF-FREEDOM SYSTEMS.\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e4.1 Optimal Shock Isolation for a Two-Component Viscoelastic Object.\u003c\/p\u003e \u003cp\u003e4.2 Optimal Shock Isolation for Three-Component Structures.\u003c\/p\u003e \u003cp\u003eReferences. \u003c\/p\u003e \u003cp\u003e\u003cb\u003eCHAPTER 5 SPINAL INJURY CONTROL.\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e5.1 Description of the Model.\u003c\/p\u003e \u003cp\u003e5.2 Minimization of the Occupant’s Displacement subject to a Constraint Imposed on the Spinal Compressive Force.\u003c\/p\u003e \u003cp\u003e5.3 Spinal Injury Control System with two Shock Isolators.\u003c\/p\u003e \u003cp\u003e5.4 MADYMO Simulation for the Limiting Performance Analysis.\u003c\/p\u003e \u003cp\u003eReferences.\u003c\/p\u003e \u003cp\u003e\u003cb\u003eCHAPTER 6 THORACIC INJURY CONTROL.\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e6.1 Smart Restraint Systems.\u003c\/p\u003e \u003cp\u003e6.2 Basic Concept of Restraint Force Control.\u003c\/p\u003e \u003cp\u003e6.3 Limiting Performance Analysis for the Prevention of Thoracic Injuries in a Frontal Car Crash.\u003c\/p\u003e \u003cp\u003e6.4 Feedback Control of the Elastic Restraint Force on the Basis of the Two-Mass Thorax Injury Model.\u003c\/p\u003e \u003cp\u003e6.5 Conclusions.\u003c\/p\u003e \u003cp\u003eReferences.\u003c\/p\u003e \u003cp\u003e\u003cb\u003eCHAPTER 7 HEAD INJURY CONTROL.\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e7.1 Head Injury Criterion: Historical Perspectives.\u003c\/p\u003e \u003cp\u003e7.2 Minimization of the Deceleration Distance for Constrained HIC.\u003c\/p\u003e \u003cp\u003e7.3 Minimization of the HIC for Constrained Deceleration Distance.\u003c\/p\u003e \u003cp\u003e7.4 Alternative Control Laws.\u003c\/p\u003e \u003cp\u003eReferences.\u003c\/p\u003e \u003cp\u003e\u003cb\u003eCHAPTER 8 INJURY CONTROL FOR WHEELCHAIR OCCUPANTS.\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e8.1 Introduction.\u003c\/p\u003e \u003cp\u003e8.2 Optimal Shock Isolation of Single-Degree-of-Freedom System.\u003c\/p\u003e \u003cp\u003e8.3 Simulation Using MADYMO.\u003c\/p\u003e \u003cp\u003e8.4 Discussion.\u003c\/p\u003e \u003cp\u003eReferences.\u003c\/p\u003e \u003cp\u003eIndex.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"John Wiley \u0026 Sons Inc","offers":[{"title":"Default Title","offer_id":49402286571863,"sku":"9780470100158","price":104.36,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0817\/1739\/5799\/files\/9780470100158.jpg?v=1730479950"},{"product_id":"quantitative-imaging-tools-for-lung-cancer-drug-assessment-9780470118801","title":"Quantitative Imaging Tools for Lung Cancer Drug","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003eThis book presents chapters written by leading clinical researchers in the field of lung cancer, where high resolution 3-D imaging technology appears to hold the greatest near-term promise.\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTable of Contents\u003c\/b\u003e\u003cbr\u003ePreface (Thomas M. Baer and James L. Mulshine).  \u003cp\u003eChapter 1: Incorporating Imaging into Drug Development: An Industry Perspective (Philip S. Murphy and Debasish Roychowdhury).\u003c\/p\u003e \u003cp\u003eChapter 2: Developing Imaging Tools for Drug Development: Critical Technology, Clinical Data and Regulatory (Rafal Dziadziuszko, Fred R. Hirsch and Paul A. Bunn, Jr).\u003c\/p\u003e \u003cp\u003eChapter 3: Quantitative Imaging in CT Lung Cancer Drug Development and Evaluation (Ricardo S. Avila).\u003c\/p\u003e \u003cp\u003eChapter 4: Volumetric CT Imaging for Response Assessment in Lung Cancer: A Platform for Translational Research (Binsheng Zhao and Lawrence H. Scwhartz).\u003c\/p\u003e \u003cp\u003eChapter 5: Emerging Radiological Software Standards and Development Technologies: Impact on Clinical Translation and Trials (John Pearson, Lawrence Tarbox, Gianluca Paladini, John G. Wolodzko, Paula M. Jacobs, and Zhenghong Lee).\u003c\/p\u003e \u003cp\u003eChapter 6: Statistical Considerations Underlying Therapeutic Response Criteria for Lung Cancer: A Review in the Context of Emergence of Multi-Slice CT Scanner and Computer Assisted Diagnostic Algorithm for Volumetric Assessment (Madhu Mazumdar and Xi Kathy Zhou).\u003c\/p\u003e \u003cp\u003eChapter 7: Programs Supporting Quantitative Imaging in Biomedicine at the National Institute for Standards and Technology (Thomas M. Baer and Charles W. Clark).\u003c\/p\u003e \u003cp\u003eAppendix A: Evolving Imaging Resources: Public Access Databases (Laurence Clarke).\u003c\/p\u003e \u003cp\u003eAppendix B: Biomedical Imaging Archive Network (Thomas M. Baer and James L. Mulshine).\u003c\/p\u003e \u003cp\u003eAppendix C: Developing CT Image-Processing Tools to Accelerate Progress in Lung Cancer Drug Development (James L. Mulshine, Ricardo S. Avila, Fred R. Hirsch, and David Yankelevitz).\u003c\/p\u003e","brand":"John Wiley \u0026 Sons Inc","offers":[{"title":"Default Title","offer_id":49402289127767,"sku":"9780470118801","price":125.96,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0817\/1739\/5799\/files\/9780470118801.jpg?v=1730479960"},{"product_id":"biosensing-using-nanomaterials-wiley-nanoscience-and-nanotechnology-series-9780470183090","title":"Biosensing Using Nanomaterials Wiley Nanoscience","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003eThis book introduces novel concepts in the area of bioanalysis based on nanomaterials, opening new opportunities for basic research and new tools for real bioanalytical applications. Each chapter provides a theoretical overview of a different topic and includes an annex that describes the most interesting aspect related to the bioanalytical system.\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTable of Contents\u003c\/b\u003e\u003cbr\u003eCONTRIBUTORS.  \u003cp\u003eSERIES PREFACE.\u003c\/p\u003e \u003cp\u003ePREFACE.\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePART I CARBON NANOTUBES.\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003e1. Carbon Nanotube–Based Sensors and Biosensors\u003c\/b\u003e (\u003ci\u003eRichard G. Compton, Gregory G. Wildgoose, and Elicia L. S. Wong\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e1.1. Introduction to the Structure of Carbon Nanotubes.\u003c\/p\u003e \u003cp\u003e1.2. Electroanalysis Using CNT-Modified Electrodes.\u003c\/p\u003e \u003cp\u003e1.3. Advantageous Application of CNTs in Sensors: pH Sensing.\u003c\/p\u003e \u003cp\u003e1.4. Carbon Nanotube–Based Biosensors.\u003c\/p\u003e \u003cp\u003e1.5. Using CNTs in Biosensor Production for Medical Diagnostics and Environmental Applications.\u003c\/p\u003e \u003cp\u003eReferences.\u003c\/p\u003e \u003cp\u003e\u003cb\u003e2. Isotropic Display of Biomolecules on CNT-Arrayed Nanostructures\u003c\/b\u003e (\u003ci\u003eMark R. Contarino, Gary Withey, and Irwin Chaiken\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e2.1. Introduction: CNT Arrays for Biosensing.\u003c\/p\u003e \u003cp\u003e2.2. Functionalization of CNTs: Controlling Display Through Covalent Attachment.\u003c\/p\u003e \u003cp\u003e2.3. Self-Assembling Interfaces: Anchor-Probe Approach.\u003c\/p\u003e \u003cp\u003e2.4. Molecular Wiring of Redox Enzymes.\u003c\/p\u003e \u003cp\u003e2.5. Multiplexing Biomolecules on Nanoscale CNT Arrays.\u003c\/p\u003e \u003cp\u003e2.6. Conclusions.\u003c\/p\u003e \u003cp\u003eReferences.\u003c\/p\u003e \u003cp\u003e\u003cb\u003e3. Interaction of DNA with CNTs: Properties and Prospects for Electronic Sequencing\u003c\/b\u003e (\u003ci\u003eSheng Meng and Efthimios Kaxiras\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e3.1. Introduction.\u003c\/p\u003e \u003cp\u003e3.2. Structural Properties of Combined DNA–CNT Systems.\u003c\/p\u003e \u003cp\u003e3.3. Electronic Structure.\u003c\/p\u003e \u003cp\u003e3.4. Optical Properties.\u003c\/p\u003e \u003cp\u003e3.5. Biosensing and Sequencing of DNA Using CNTs.\u003c\/p\u003e \u003cp\u003e3.6. Summary.\u003c\/p\u003e \u003cp\u003eReferences.\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePART II NANOPARTICLES.\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003e4. Improved Electrochemistry of Biomolecules Using Nanomaterials\u003c\/b\u003e (\u003ci\u003eJianxiu Wang, Andrew J. Wain, Xu Zhu, and Feimeng Zhou\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e4.1. Introduction.\u003c\/p\u003e \u003cp\u003e4.2. CNT-Based Electrochemical Biosensors.\u003c\/p\u003e \u003cp\u003e4.3. Nanoparticle-Based Electrochemical Biosensors.\u003c\/p\u003e \u003cp\u003e4.4. Quantum Dot–Based Electrochemical Biosensors.\u003c\/p\u003e \u003cp\u003e4.5. Conclusions and Outlook.\u003c\/p\u003e \u003cp\u003eReferences.\u003c\/p\u003e \u003cp\u003e\u003cb\u003e5. The Metal Nanoparticle Plasmon Band as a Powerful Tool for Chemo- and Biosensing\u003c\/b\u003e (\u003ci\u003eAudrey Moores and Pascal Le Floch\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e5.1. Introduction.\u003c\/p\u003e \u003cp\u003e5.2. The SPB: An Optical Property of Metal NPs.\u003c\/p\u003e \u003cp\u003e5.3. Plasmon Band Variation Upon Aggregation of Nanoparticles.\u003c\/p\u003e \u003cp\u003e5.4. Plasmon Band Variation on the Environment or Ligand Alteration.\u003c\/p\u003e \u003cp\u003e5.5. Metal Nanoparticles as Labels.\u003c\/p\u003e \u003cp\u003e5.6. Conclusions.\u003c\/p\u003e \u003cp\u003eReferences.\u003c\/p\u003e \u003cp\u003e\u003cb\u003e6. Gold Nanoparticles: A Versatile Label for Affinity Electrochemical Biosensors\u003c\/b\u003e (\u003ci\u003eAdriano Ambrosi, Alfredo de la Escosura-Mun˜ iz, Maria Teresa Castaneda, and Arben Merkoci\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e6.1. Introduction.\u003c\/p\u003e \u003cp\u003e6.2. Synthesis of AuNPs.\u003c\/p\u003e \u003cp\u003e6.3. Characterization of AuNPs.\u003c\/p\u003e \u003cp\u003e6.4. AuNPs as Detecting Labels for Affinity Biosensors.\u003c\/p\u003e \u003cp\u003e6.5. Conclusions.\u003c\/p\u003e \u003cp\u003eReferences.\u003c\/p\u003e \u003cp\u003e\u003cb\u003e7. Quantum Dots for the Development of Optical Biosensors Based on Fluorescence\u003c\/b\u003e (\u003ci\u003eW. Russ Algar and Ulrich J. Krull\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e7.1. Introduction.\u003c\/p\u003e \u003cp\u003e7.2. Quantum Dots.\u003cbr\u003e \u003c\/p\u003e \u003cp\u003e7.3. Basic Photophysics and Quantum Confinement.\u003c\/p\u003e \u003cp\u003e7.4. Quantum Dot Surface Chemistry and Bioconjugation.\u003c\/p\u003e \u003cp\u003e7.5. Bioanalytical Applications of Quantum Dots as Fluorescent Labels.\u003c\/p\u003e \u003cp\u003e7.6. Fluorescence Resonance Energy Transfer and Quantum Dot Biosensing.\u003c\/p\u003e \u003cp\u003e7.7. Summary.\u003c\/p\u003e \u003cp\u003eReferences.\u003c\/p\u003e \u003cp\u003e\u003cb\u003e8. Nanoparticle-Based Delivery and Biosensing Systems: An Example\u003c\/b\u003e (\u003ci\u003eAlmudena Mun˜oz Javier, Pablo del Pino, Stefan Kudera, and Wolfgang J. Parak\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e8.1. Introduction.\u003c\/p\u003e \u003cp\u003e8.2. Functional Colloidal Nanoparticles.\u003c\/p\u003e \u003cp\u003e8.3. Polyelectrolyte Capsules as a Functional Carrier System.\u003c\/p\u003e \u003cp\u003e8.4. Uptake of Capsules by Cells.\u003c\/p\u003e \u003cp\u003e8.5. Delivery and Sensing with Polyelectrolyte Capsules.\u003c\/p\u003e \u003cp\u003e8.6. Conclusions.\u003c\/p\u003e \u003cp\u003eReferences.\u003c\/p\u003e \u003cp\u003e\u003cb\u003e9. Luminescent Quantum Dot FRET-Based Probes in Cellular and Biological Assays\u003c\/b\u003e (\u003ci\u003eLifang Shi, Nitsa Rosenzweig, and Zeev Rosenzweig\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e9.1. Introduction.\u003c\/p\u003e \u003cp\u003e9.2. Luminescent Quantum Dots.\u003c\/p\u003e \u003cp\u003e9.3. Fluorescence Resonance Energy Transfer.\u003c\/p\u003e \u003cp\u003e9.4. Quantum Dot FRET-Based Protease Probes.\u003c\/p\u003e \u003cp\u003e9.5. Summary and Conclusions.\u003c\/p\u003e \u003cp\u003eReferences.\u003c\/p\u003e \u003cp\u003e\u003cb\u003e10. Quantum Dot–Polymer Bead Composites for Biological Sensing Applications\u003c\/b\u003e (\u003ci\u003eJonathan M. Behrendt and Andrew J. Sutherland\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e10.1. Introduction.\u003c\/p\u003e \u003cp\u003e10.2. Quantum Dot–Composite Construction.\u003c\/p\u003e \u003cp\u003e10.3. Applications of QD Composites.\u003c\/p\u003e \u003cp\u003e10.4. Future Directions.\u003c\/p\u003e \u003cp\u003eReferences.\u003c\/p\u003e \u003cp\u003e\u003cb\u003e11. Quantum Dot Applications in Biomolecule Assays\u003c\/b\u003e (\u003ci\u003eYing Xu, Pingang He, and Yuzhi Fang\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e11.1. Introduction to QDs and Their Applications.\u003c\/p\u003e \u003cp\u003e11.2. Preparation of QDs for Conjugation with Biomolecules and Cells.\u003c\/p\u003e \u003cp\u003e11.3. Special Optoelectronic Properties in the Bioemployment of QDs.\u003cbr\u003e \u003c\/p\u003e \u003cp\u003e11.4. Employment of QDs as Biosensing Indicators.\u003c\/p\u003e \u003cp\u003eReferences.\u003c\/p\u003e \u003cp\u003e\u003cb\u003e12. Nanoparticles and Inductively Coupled Plasma Mass Spectroscopy–Based Biosensing\u003c\/b\u003e (\u003ci\u003eArben Merkoc¸i, Roza Allabashi, and Alfredo de la Escosura-Muniz\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e12.1. ICP-MS and Application Possibilities.\u003c\/p\u003e \u003cp\u003e12.2. Detection of Metal Ions.\u003c\/p\u003e \u003cp\u003e12.3. Detection of Nanoparticles.\u003c\/p\u003e \u003cp\u003e12.4. Analysis of Metal-Containing Biomolecules.\u003c\/p\u003e \u003cp\u003e12.5. Bioanalysis Based on Labeling with Metal Nanoparticles.\u003c\/p\u003e \u003cp\u003e12.6. Conclusions.\u003c\/p\u003e \u003cp\u003eReferences.\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePART III NANOSTRUCTURED SURFACES.\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003e13. Integration Between Template-Based Nanostructured Surfaces and Biosensors\u003c\/b\u003e (\u003ci\u003eWalter Vastarella, Jan Maly, Mihaela Ilie, and Roberto Pilloton\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e13.1. Introduction.\u003c\/p\u003e \u003cp\u003e13.2. Nanosphere Lithography.\u003c\/p\u003e \u003cp\u003e13.3. Nanoelectrodes Ensemble for Biosensing Devices.\u003c\/p\u003e \u003cp\u003e13.4. Concluding Remarks.\u003c\/p\u003e \u003cp\u003eReferences.\u003c\/p\u003e \u003cp\u003e\u003cb\u003e14. Nanostructured Affinity Surfaces for MALDI-TOF-MS–Based Protein Profiling and Biomarker Discovery\u003c\/b\u003e (\u003ci\u003eR. M. Vallant, M. Rainer, M. Najam-Ul-Haq, R. Bakry, C. Petter, N. Heigl, G. K. Bonn, and C. W. Huck\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e14.1. Proteomics and Biomarkers.\u003c\/p\u003e \u003cp\u003e14.2. MALDI in Theory and Practice.\u003c\/p\u003e \u003cp\u003e14.3. Carbon Nanomaterials.\u003c\/p\u003e \u003cp\u003e14.4. Near-Infrared Diffuse Reflection Spectroscopy of Carbon Nanomaterials.\u003c\/p\u003e \u003cp\u003eReferences.\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePART IV NANOPORES.\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003e15. Biosensing with Nanopores\u003c\/b\u003e (\u003ci\u003eIvan Vlassiouk and Sergei Smirnov\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e15.1. Nanoporous Materials in Sensing.\u003c\/p\u003e \u003cp\u003e15.2. Nanochannel and Nanopore Fabrication.\u003cbr\u003e \u003c\/p\u003e \u003cp\u003e15.3. Surface Modification Chemistry\u003c\/p\u003e \u003cp\u003e15.4. Nonelectrical Nanoporous Biosensors.\u003c\/p\u003e \u003cp\u003e15.5. Electrical Nanoporous Biosensors.\u003c\/p\u003e \u003cp\u003e15.6. Summary.\u003c\/p\u003e \u003cp\u003eReferences.\u003c\/p\u003e \u003cp\u003eINDEX.\u003c\/p\u003e","brand":"John Wiley \u0026 Sons Inc","offers":[{"title":"Default Title","offer_id":49402301481303,"sku":"9780470183090","price":152.06,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0817\/1739\/5799\/files\/9780470183090.jpg?v=1730479995"}],"url":"https:\/\/bookcurl.com\/collections\/medical-specialties-branches-of-medicine.oembed?page=6","provider":"Book Curl","version":"1.0","type":"link"}